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1. Abstract  
 
The work reported in this thesis outlines the gold(I)-catalysed synthesis of cyclic 
sulfamidates by intramolecular allene hydroamination. Work carried out in an attempt to 
prepare a novel acyl anion equivalent is also included but endeavours were halted after 
one year of study. The thesis is divided into six chapters: 
 
Chapter one provides an introduction to the reactivity of gold, current metal-catalysed 
hydroamination reactions and allene structure, synthesis and reactivity. The current 
synthetic methods for the preparation of sulfamidates and their uses is also covered. 
 
Chapter two outlines the attempted use of the Burgess reagent to prepare olefinically 
substituted sulfamidates and the attempts to reverse regioselectivity in sulfamidate 
synthesis. 
 
Chapter three includes an initial proof of concept in gold(I) catalysis and an account of 
substrate synthesis. Allenes were synthesised by Crabbé homologation or Johnson-
Claisen rearrangement reactions. The allenes were then converted to the corresponding 
sulfamates. 
 
Chapter four outlines our studies of gold(I)-catalysed hydroamination. This includes 
optimisation of catalyst and the effects of substitution on reaction rate and 
stereochemical hypothesis. The current scope and limitations of this chemistry is also 
discussed.  
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Chapter five outlines the research work attempted within the first year of study. The 
work focussed on the attempted preparation of a thermally unmasked acyl anion 
equivalent. 
 
Chapter six provides a formal report of the experimental procedures. 
 
Stereochemical abstract: All compounds with stereogenic centres were prepared as 
racemic mixtures but only one enantiomer is represented in the schemes.  
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Chapter One: Introduction 
 
This thesis will focus on gold(I)-catalysed hydroamination of allenes in the preparation of 
cyclic sulfamidates. This introductory chapter will cover the topics of gold catalysis, 
hydroamination, preparation and reactivity of allenes and sulfamidate chemistry. 
 
1.1 Gold - the element 
 
Gold has been a valuable and highly sought-after metal to mankind from the very early 
days.1  The precious metal has always been held in high regard as shown by King Midas 
in Greek mythology.  Most of the gold found on earth is located in the core and it is 
believed that the high density of the metal led to it sinking there.  Most gold that is mined 
today is believed to come from later meteorite deposits.2 
 
Besides its widespread monetary and symbolic functions, gold has many practical uses.  
Gold has applications in medicine due to its high biocompatibility in the metallic form.  
Gold is used in dentistry, the treatment of arthritis and recently has been of interest in 
cancer research.3 
 
Its high malleability, ductility, resistance to corrosion and most other chemical reactions 
and conductivity of electricity led to many uses of gold including electric wiring, 
coloured-glass production and gold leafing.4 
 
Although gold is the most inert of the noble metals, it still forms many diverse 
compounds.  The oxidation state of gold in its compounds ranges from -1 to +5, but 
gold(I) and gold (III) dominate its chemistry.5  Gold(I), referred to as the aurous ion, is 
the most common oxidation state.  With soft ligands such as thioethers, thiolates and 
tertiary phosphines, gold(I) complexes have typically linear geometry at the metal.6   
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While the stoichiometric chemistry of gold has intensively and continuously been 
investigated, this close relationship between gold and chemical applications was lost 
during the development of metal-catalysed reactions.  It is likely a low catalytic activity 
was mistakenly deduced from the inertness of elemental gold that only dissolves in aqua 
regia or oxidants such as air, the latter only in the presence of strong ligands such as 
cyanide.7  It is also likely that gold has been overlooked as a suitable catalyst as many 
may perceive it as costly.  However, gold is often less expensive than other metals used in 
large-scale processes such as rhodium, palladium and platinum.4  Gold is often recycled 
from stoichiometric reactions unlike platinum and with thousands of tons produced 
through mining every year the price of gold is much more stable compared to other noble 
metals.4  It must also be noted that often the cost of the ligand is responsible for elevated 
catalyst prices. 
 
1.1.1 Reactivity of gold 
 
The electronic structure of gold can provide an insight into its observed reactivity.  The 
key factor influencing the characteristics of gold with regard to the electronic structure are 
the strong relativistic effects.  Beyond the large Au-L bond strengths, further 
corroboration of this distortion from the otherwise expected electronic structure lies in the 
phenomenon of “aurophilicity”,8 the tendency for gold-gold interactions to be stabilising 
on the order of hydrogen bonds, and also in the large first ionisation potential observed 
for gold (9.22eV versus 7.57eV for Ag).  
 
Unlike copper(I) and silver(I) complexes, which tend to adopt tricoordinate and 
tetracoordinate geometries9 respectively, gold(I) adopts a linear bicoordinate geometry.  It 
is usually necessary to abstract a ligand from neutral bicoordinate gold(I) species to 
induce catalytic reactivity.  Compared to the corresponding copper complexes, 
organogold(I) complexes are not very nucleophilic and this is due to the 5d electrons 
being held more strongly than the 3d electrons due to decreased electron/electron 
repulsion in the diffuse 5d orbitals, resulting in a less electron-rich metal which is not 
susceptible to oxidative addition.10   
3 
 
Studies on reductive elimination from LR3Au(III) complexes shows that this is also 
disfavoured.10  Gold(I) species are therefore quite tolerant of oxygen so often reactions 
can be run in the presence of air.  However, there is limited scope for gold-catalysed 
transformations which tolerate the presence of water.11  
 
With the increasing use of gold as a catalyst, there has been growing interest in gaining a 
deeper understanding of the fundamental properties of gold.  Gold (Z = 79) has the atomic 
configuration [Xe]4f145d106s1.  Gold(I) is strongly Lewis acidic with respect to C-C π-
systems, and this coupled with its ability to stabilise cationic reaction intermediates leads 
to catalysts with unique reactivity which can be exploited in gold catalysis.  Relativistic 
effects are key in theoretically rationalising the observed reactivity.12   
 
HΨ = EΨ 
Figure 1: Schrödinger equation 
 
The Schrödinger equation (Figure 1), from which all of our concepts in theoretical 
chemistry are derived is nonrelativistic in the sense that the possibility of velocity-
dependent mass is not admitted.  It assumes that the velocity of light is infinite.  
Einstein’s Theory of relativity postulates that the mass m of a particle increases as its 
speed ν moves toward that of light c, according to  
 
 = 
(1 − 	
)/
 
Figure 2: Relativistic mass 
 
where m0 is its rest mass.  For atoms with an atomic number greater than ~50 (Sn), the 1s 
electrons are sufficiently influenced by the nuclear mass that their speed approaches that 
of light and their mass increases accordingly as outlined in Figure 2.  The innermost s 
orbital therefore contracts, and the outer s shells shrink in sympathy; electrons in p-
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orbitals are also affected to some extent, but those in d and f orbitals less so, because their 
probability of being close to the nucleus is low.  The effective potentials of d and f 
electrons are, however, better screened because of the relative contractions of the s and p 
shells, and their orbitals, therefore increase in energy and expand radially.  The so-called 
“relativistic contraction” of the 6s orbital becomes greater on moving across the Third 
Transition Series and is greatest for gold (Figure 3).  
 
 
Figure 3: Calculated relativistic contraction of the 6s orbital 
 
The colour of gold can also be explained by considering the relativistic effects of the 
metal.  Excitation of the 5d electrons to the Fermi level occurs with a band gap of 2.38eV 
and this leads to the absorption of blue light.  The band gap in silver is much larger, so 
absorption occurs in the UV region. 
 
Cationic gold(I) species, with an empty 6s orbital, are superior Lewis acids compared 
with other group 11 metals for many transformations, and intuitively it seems that 
relativistic contraction of the valence s or p orbitals of gold should be responsible, 
because they should correspond to a relatively low-lying lowest unoccupied molecular 
orbital (LUMO) and therefore strong Lewis acidity. 
 
Many developments in gold catalysis depend on the propensity of gold to activate C=C π-
systems to nucleophilic addition.  The bonding situation in transition-metal complexes 
with alkenes and alkynes as π ligands is usually discussed within the framework of the 
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Dewar-Chatt-Duncanson (DCD) model,13 which considers the bond as a donor-acceptor 
interaction between two closed shell fragments.  The DCD model assumes that a σ bond 
is formed by overlap of the π system of the ligand with an empty metal orbital of suitable 
symmetry.  A π interaction then results through back-donation of electron density from a 
filled metal d-orbital into an antibonding π* orbital of the alkene or alkyne.14  
 
 
Figure 4: Metal-alkyne bonding orbitals 
 
There are four principal components that can contribute to the bonding of alkynes as 
ligands (Figure 4).  The in-plane πǁ orbitals are responsible for a σ-symmetric M←L 
donation as well as for the π-symmetric M→L back-donation referred to above.  The 
orthogonal, out–of-plane π┴ orbitals can engage in M←L donation referred to above.  The 
orthogonal, out-of-plane π┴ orbitals can engage in M←L π donation (an interaction of 
importance in alkyne complexes in which the ligand serves as a four-electron donor), 
while mixing of an occupied d orbital of the metal and the empty π┴* orbital of the alkyne 
can result in an additional component of M→L back-donation.  This latter interaction, 
however, has δ symmetry, which results in only a weak overlap, and therefore leads to a 
minute contribution to the bonding.   
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1.1.2 Gold catalysis 
 
The first examples of gold catalysis were recorded in the 1980’s.  An early example was 
described by Ito in which benzaldehyde and methyl isocyanate were reacted with a chiral 
ferrocenylphosphine ligand and cationic gold(I) compound (Au(cHexCN)2)BF4 to form a 
chiral oxazoline (Scheme 1).15 
 
 
Scheme 1: An early example of gold catalysis 
 
The most common use of gold in catalysis is nucleophilic addition to C-C multiple 
bonds.16  Alkynes are the most popular substrates with olefins and allenes also having 
been investigated.  The simplest example is shown in Scheme 2 where gold interacts with 
the π-system of substrate 4 to afford the intermediate 5.  Isotopic labelling experiments 
show that nucleophilic attack normally occurs anti to gold to give a vinylgold species 6.16  
Protodemetallation liberates the gold species and affords product 7.  
 
 
Scheme 2: Gold activation of alkynes to nucleophilic attack 
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The preparation of α,β-unsaturated esters from alkoxy-alkynes was reported by Dudley et 
al. via a AuCl3-catalysed Meyer-Schuster type rearrangement (Scheme 3).17  It is 
interesting to note that propargylic alcohols did not react with Utimoto’s catalysts.  These 
substrates would be difficult to prepare by the Horner-Wadsworth-Emmons olefination as 
it would not tolerate bulky R1 and R2 substituents.  It should be noted that the E/Z 
selectivity was poor for these reactions. 
 
 
Scheme 3: Meyer-Schuster rearrangement to give α,β-unsaturated esters 
 
Major advances were made when Teles introduced cationic gold(I)-phosphane complexes 
as catalysts for the addition of alcohols to alkynes (Scheme 4).18  Teles was the first to use 
acidic promoters for the in situ generation of the catalyst. This type of homogenous 
catalyst, especially the Ph3PAu+X- system, is still the most commonly used system for 
these transformations.  It was found to have very high activity (TON up to 105 and TOF 
up to 5400h-1).  In Scheme 4 methanol attacks the alkyne 10 at the sterically less hindered 
position and forms the enol ether 12 in very small amounts as a by-product.  Under these 
conditions propargylic alcohols 13 give rise to cyclic acetal 14. 
 
 
Scheme 4: Hydroalkoxylation of acetylenes 
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Another key transformation is the gold-catalysed intramolecular nucleophilic addition to 
propargylic acetates.19  Cavallo et al. have shown that propargylic acetates can undergo 
1,2- or 1,3-acyloxy migrations leading to the formation of vinyl gold(I) carbenoid species 
16 or allene gold(I) complexes 17 which could be in rapid equilibrium (Scheme 5).20  A 
double 1,2-shift, which also leads to 17 was found to be energetically more favoured than 
the direct 1,3-shift, although different substitution at the substrate could significantly 
influence this preference. 
 
 
Scheme 5: Key intermediates in the propargylic migrations 
 
In 2004, Echavarren highlighted that gold can be used in 1,6-enyne cycloisomerisations 
(Scheme 6).  The catalyst employed Au(PPh3)+ was generated in situ from the reaction of 
Au(PPh3)Cl with AgSbF6.  This class of cycloisomerisation reaction is very useful in 
synthetic chemistry as it leads to diene products like 20 with functionality that can 
undergo further reaction. 
 
 
Scheme 6: Enyne cycloisomerisation 
 
In 2000, the first gold-catalysed intramolecular addition of a hydroxy group to an 
activated alkene was reported by Hashmi et al. in the formation of the spirocycle 23 
(Scheme 7).21 
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Scheme 7: Early example of intramolecular gold-catalysis 
 
In 2004, Li et al. have shown C-C bond formation by the intermolecular addition of 1,3-
diketones to styrenes in the presence of catalytic AuCl3 and a silver salt.22  The silver salt 
used affects the yield of the reaction and the absence of a silver salt leads to very low 
reactivity.  Li et al. propose that the reaction proceeds via the activation of the C-H bond 
in the nucleophile via gold insertion (Scheme 8).  However it is possible that the reaction 
proceeds by enolate addition to the alkene. 
 
 
Scheme 8: Gold-catalysed ketone addition to styrenes  
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1.2 Hydroamination 
 
Hydroamination is the addition of a N-H bond across an unsaturated C-C bond (Scheme 
9) and is important in the preparation of many compounds of chemical importance 
particularly pharmaceutical and speciality bulk chemicals. It is known that intramolecular 
hydroamination is more favourable than intermolecular hydroamination (kinetically and 
thermodynamically).23  
 
 
Scheme 9: Examples of intermolecular and intramolecular hydroamination 
reactions of alkenes and alkynes 
 
Hydroamination via noble metal catalysis is an atom economical method for the synthesis 
of amines and derivatives.23-26  Transition metal-catalysed hydroaminations have been 
focussed on the use of early transition metals (groups 3-5) and late transition metals 
(groups 8-10).23  For unactivated substrates, the functionality tolerated is limited, 
selectivities are modest and the slow rates of reaction are observed.  Particularly, the 
hydroamination of unactivated alkenes remains limited, often needing higher 
temperatures.  
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It is known that gold can catalyse an intermolecular addition of a nitrogen containing 
compound prior to a cyclisation.  This has been demonstrated by Demir et al. in the 
preparation of 2-aminopyrroles from 4-pentynenitriles (Scheme 10).27   
 
Scheme 10: Intermolecular hydroamination followed by a cyclisation 
 
Other reactions can occur in which a diverse range of unsaturated functionalities are 
involved in different subsequent reactions instead of this ring closure step.  
Hydroamination of alkenes, alkynes etc., have afforded many transformations including 
ring expansions, cyclisations and cycloisomerisations.28  Alternatively the heteroatom can 
be introduced first and then undergo a subsequent cyclisation. 
 
1.2.1 Hydroamination of alkynes 
 
Arnold and Bergman have shown that tantalum can be employed for hydroamination 
reactions of alkynes with anilines (Scheme 11).29  It should be noted that this required 
high reaction temperatures and lengthy reaction times.  The yields were very low when 
aromatic substituents were introduced onto the alkyne. 
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Scheme 11: Tantalum-catalysed hydroamination of an alkyne 
 
A similar hydroamination can be achieved using vanadium and titanium (Scheme 12).  
Lorber et al. have shown that vanadium catalysts gave better selectivity compared to 
titanium catalysts.30  The highest yield (94%) was obtained when [Ti(NPh)(NHPh)2] was 
used, with the highest selectivity 99:1 (Markovnikov/Anti-Markovnikov) achieved with 
V(carb)2(NMe2)2.  
 
 
Scheme 12: Vanadium and Zirconium catalysed hydroamination 
 
Utimoto et al. investigated the intramolecular hydroamination reaction of alkynes.31  It 
was found that gold(III) catalysts were more effective than palladium(II) catalysts for the 
6-exo-dig cyclisations (Scheme 13).  Hydroamination initially gives the enamine 
intermediate 41 which undergoes tautomerisation to the more stable imine 42.  They used 
sodium tetrachloroaurate as the catalyst with loadings of 5 mol %.   
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Scheme 13: Intramolecular hydroamination of alkynes 
 
The first intermolecular gold-catalysed hydroamination was reported by Tanaka et al. 
forming imines from the corresponding alkyne and aniline substrates (Scheme 14).32  
With terminal alkynes Markovnikov regioselectivity was observed.  (Ph3P)AuMe was 
used as catalyst in loadings as low as 0.01 mol% with H3PW12O40 added as an acidic 
promoter.  These reactions were carried out in solvent free conditions and were not 
successful when aliphatic amines were used.  This was likely due to the Lewis basicity of 
the amines in this case.   
 
 
Scheme 14: First intermolecular gold-catalysed hydroamination 
 
 
 
14 
 
Dyker et al. have demonstrated that intermediate 47, prepared from an Ugi four-
component reaction, reacts to give the cyclic systems 48 and 50.33  The 6-endo-dig 
cyclisation affords 48 as only the diastereoisomer shown and the 5-exo-dig cyclisation 
affords 50, arising from the aromatisation of the intermediate 49 (Scheme 15).  
 
 
Scheme 15: Intramolecular hydroamination of an alkyne 
 
Another example of an intramolecular hydroamination in a complex system is in the 
formation of the Communesin ring system 53 (Scheme 16) outlined by Crawley and 
Funk.34  Compound 52 undergoes an intramolecular 7-exo-dig closure to afford the 
sterically encumbered enamine 53. 
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Scheme 16: Communesin ring formation 
 
1.2.2 Hydroamination of alkenes 
 
Hydroamination of alkenes using sulfonamides as the nitrogen source is often achieved 
by gold salts along with a silver salt co-catalyst, for example AuPPh3Cl/AgOTf.  Alkenes 
are less reactive to hydroamination compared to alkynes and allenes and therefore require 
higher reaction temperatures.35  The active gold catalyst PPh3Au+OTf- is formed by 
counterion exchange.  However, the disadvantage of this catalyst is the poor stability at 
high temperatures leading to the formation of gold mirror and nanoparticles.14  Nájera et 
al. investigated different catalysts for the intermolecular addition of sulfonamides to 
alkenes and conjugated dienes (Scheme 17).  They postulated that stronger electron-
withdrawing ligands would increase the interaction of the LAu+ with the C-C double bond 
and consequently a greater activity could be achieved.  They have shown 
triphenylphosphitegold(I) chloride and silver triflate to be an efficient catalytic mixture 
for the transformation outlined in Scheme 17 as compared to the PPh3 complex.  
Sulfonamides are considerably less nucleophilic than the corresponding amine and 
therefore less likely to interact unfavourably with the catalyst. 
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Scheme 17: Intermolecular addition of sulfonamides to alkenes and dienes 
 
Coulson demonstrated that rhodium and iridium could be used for intermolecular 
hydroamination of ethene with secondary amines.36  It has been shown that platinum salts 
give high turnover numbers for the addition of ethene to aniline (Scheme 18).37  Anilines 
with electron-withdrawing substituents, therefore less basic, gave mostly the N-alkylated 
product 60 and less quinoline 61 was formed. 
 
 
Scheme 18: Platinum catalysed hydroamination 
 
Ruthenium38, platinum39, 40 and palladium41-43 have been shown to catalyse such reactions 
but require fairly harsh conditions and in the case of palladium, β-hydride elimination 
usually occurs as a side reaction (Scheme 19).  
 
 
Scheme 19: β-hydride elimination by product 
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Widenhoefer and Bender have shown that platinum can be used for the intramolecular 
hydroamination of unactivated alkenes.40   
 
 
Scheme 20: Platinum-catalysed intramolecular hydroamination of unactivated 
alkenes 
 
This reaction does not proceed for intermolecular systems such as ethylene with 
alkylamines.  Mechanistically, C-N bond formation presumably occurs via intramolecular 
ligand exchange followed by outer-sphere attack of the pendant amine on the olefin of 68 
to form 69 (Scheme 21).  The next step is deprotonation/chloride displacement from 6 
followed by intermolecular protonolysis of the Pt-C bond of 70, presumably via a Pt(IV) 
hydride intermediate such as 71.  Ligand exchange from Pt-amine complex 72 would 
release 66 and regenerate 67. 
 
Scheme 21: Mechanism of platinum-catalysed hydroamination 
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Hartwig et al. have used enantiopure bisphosphines to provide nonracemic amine 
products (Scheme 22).42  This also provides evidence that this reaction is irreversible. 
 
 
Scheme 22: Asymmetric palladium-catalysed intermolecular hydroamination 
 
Michon and Agbossou-Niedercorn have shown that gold-catalysed asymmetric 
hydroamination of alkenes can be achieved with phosphoramidite ligands  44  
 
 
Scheme 23: Asymmetric hydroamination of alkenes  
 
1.2.3 Hydroamination of allenes 
 
Widenhoefer et al. investigated regioselectivity in the hydroamination of allenes using 
carbamates in the presence of gold(I) complexes (Scheme 24).45  The Markovnikov 
adduct was formed at the more substituted terminus of the allene when a range of N-
unsubstituted carbamates were reacted with monosubstituted, 1,1- and 1,3-disubstituted, 
trisubstituted and tetrasubstituted allenes.  
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Scheme 24: Mechanism of allene hydroamination 
 
Hydrothiolation of allenes has been achieved by Krause et al. by the utilisation of AuCl 
under mild reaction conditions, to convert thiocarbinols to the corresponding 2,5-
dihydrothiophenes (Scheme 25).46 
 
 
Scheme 25: Hydrothiolation of allenes 
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1.3 Structure, synthesis and reactivity of allenes 
 
Given that much of the work done in this project depends upon synthesis and reactivity of 
allenes, a brief summary of synthesis and properties of allenes is presented. 
 
1.3.1 Structure and bonding of allenes 
 
It is important to discuss the structure of allenes in order to understand their chemical 
reactivity (Figure 5).  A molecular orbital treatment of the parent allene molecule 
correctly predicts that the most stable bonding arrangement involves two mutually 
perpendicular π-bonds, with the central atom (sp-hybridised) joined in a straight line to 
the two terminal carbon atoms (sp2-hybridised).47 
 
 
Figure 5: Arrangement of allenic π-bonds 
 
In an unsubstituted allene the hydrogen atoms at one end of the molecule are projected 
above and below the plane containing the rest of the molecule.  The two π-bonds are not 
co-planar and therefore are not conjugated.  The C-C bond in an allene is known to 
undergo contraction with a bond length of 1.309 – 1.312Å compared to that of ethylene, 
1.33Å.  This is due to hyperconjugation (σ-π overlap) which suggests partial triple bond 
character. 
 
Allenes with two different substituents on the sp2-hybridised carbon will have axial 
chirality. This can be determined by considering the substituents on the front atom 
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followed by the back atom when viewed along the allene axis. The priority of the groups 
is assigned according to the Cahn-Ingold-Prelog priority rule. 
 
 
Figure 6: Chirality of allenes 
 
Since the prediction of allenes by Van’t Hoff in 1875,48 many efforts have been made to 
synthesise allenes.  The first allene synthesis was reported by Burton and von Pechmann 
in 1887.49  It was thought that this class of compound was highly unstable and this 
hampered the development of allene chemistry.50  
 
1.3.2 Synthesis of allenes 
 
Allenes have many applications as building blocks in organic chemistry.51  With interest 
increasing in allene chemistry there has been a focus on developing facile synthetic 
pathways to access these useful intermediates.  Allenes have the potential to undergo 
regio- and stereoselective C-C and C-X bond forming transformations.52 
 
The most commonly used starting material in the synthesis of allenes is their alkyne 
isomers (Scheme 26).  This is reflected in the early methods for the synthesis of allenes 
such as isomerisation of the FG-CH2-C≡C moiety in the presence of a base.53 
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Scheme 26: Allene synthesis by alkyne isomerisation 
 
Allenes can also be prepared from functionalised alkene precursors via a 1,2-elimination 
(Scheme 27), such as a dehydrohalogenation of 2-halopropene derivatives.54  
 
 
Scheme 27: Elimination reactions to give allenes 
 
Wu et al. have shown that using Knochel’s Mg-Br exchange protocol, it is possible to 
prepare 1,3-disubstituted enantioenriched allenes from optically active alkenyl iodides 87 
in good yield and high stereoselectivity (Scheme 28).55  (S,E)-8-((tert-
butyldimethylsilyl)oxy)-3-iodooct-2-ene-1,4-diyl diacetate 87 was converted, with highly 
efficient chirality transfer from the allylic stereogenic centre to the allene axis, to the 
product 88.  
 
 
Scheme 28: Knochel’s Mg-Br exchange protocol 
 
Tu et al. have developed a one-pot synthesis of substituted allenes from enones (Scheme 
29).  Tosylhydrazone derivatives are generated in situ from α,β-unsaturated enones which 
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then undergo a loss of N2 and an intramolecular H-transfer of the diazene intermediate to 
give the desired allene.56 
 
 
Scheme 29: One-pot synthesis of allenes from enones  
 
The Wittig reaction has also been employed in the synthesis of allenes by reacting 
phosphorus ylides with ketenes (Scheme 30).  Palladium-catalysed allylic alkylation in 
the presence of a Pd/Trost racemic ligand system afforded a new class of allylic 
phosphorus ylides which reacted with various ketenes giving rise to tetrasubstituted 
allenes in good overall yields.57  
 
 
Scheme 30: Wittig reaction for allene preparation 
 
Nagao et al. have shown that by utilising a retro-Dieckmann-type reaction of α-alkynyl-α-
ethoxy-carbonyl cyclopentanone and cyclohexanone derivatives, under basic conditions, 
can also produce allenes (Scheme 31).58 
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Scheme 31: Retro-Dieckmann-type reaction 
 
Haloallenes have been prepared from propargyl alcohols with N-halosuccinimides and 
triphenylphosphine (Scheme 32).59  This is a mild method for the synthesis of haloallenes 
and tolerates a diverse range of aromatic substituents on the propargyl alcohols. 
 
 
Scheme 32: Mechanism for haloallene formation 
 
Crabbé has shown organocopper reagents can be employed to transform 1-
ethynylcycloalkanol acetates to alkyl allenes.60  LiMe2Cu and Li-n-Bu2Cu were used as 
the reagents in this transformation (Scheme 33).  The allene system is formed due to the 
synergistic effect brought about by the reagent, acting on the triple bond and the acetoxyl 
group.  This early work of Crabbé does not tolerate unprotected alcohol groups in the 
substrate which was disadvantageous for our studies.  (vide infra Chapter 3, Scheme 62)  
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Scheme 33: Early Crabbé allene synthesis 
 
Preparation of allenes can also be achieved by the Johnson-Claisen rearrangement, a 
powerful carbon-carbon bond forming reaction (Scheme 34).61-63  Allenic alcohols can be 
generated by reaction of the propargyl alcohol in the presence of triethylorthoacetate to 
afford the propargyl vinyl ether which undergoes a [3,3]-sigmatropic rearrangement to 
give the allenic ester which is subsequently reduced to the allenic alcohol.64 
 
 
Scheme 34: Mechanism of Johnson-Claisen reaction of propargyl alcohols 
 
1.4 Sulfamidate chemistry 
 
Our experimental endeavours will focus on gold-catalysed hydroamination to produce 
sulfamidates and a review of the current uses of sulfamidates is given.  Furthermore, it 
was important to consider the current methods of sulfamidate formation and the 
limitations therein.  
 
Cyclic sulfamidites and sulfamidates are useful intermediates for the preparation of 
functionalised amines (Figure 7).  Cyclic sulfamidites are key intermediates in the 
production of antimicrobial agents used in deodorants and shampoos.65 
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Figure 7: Sulfamidite and sulfamidate compounds 
 
1.4.1 Synthesis of sulfamidates 
 
Synthesis of cyclic sulfamidates from the corresponding amino alcohol with a reagent 
which directly installs the –SO2- moiety would appear the most direct synthetic route.  
However, approaches based upon the use of sulfuryl chloride or sulfuryl diimidazole have 
been unsuccessful on the whole with only the desired sulfamidate produced in cases 
involving conformationally constrained 1,2- amino alcohols, such as prolinol and amino 
sugar variants (Scheme 35).66, 67  Prolinol reacts with sulfuryl chloride to afford the 
desired sulfamidate, but notably only at low temperatures. There are very few examples 
of similar processes. 
 
 
Scheme 35: Sulfamidate synthesis from prolinol 
 
Competing aziridination has also been seen with attempts to form sulfamidates directly 
from 1,2-aminoethanols and sulfuryl chloride.69, 71  Deyrup et al. have shown that the 
desired sulfamidate could not be isolated when 1-phenyl-2-t-butylaminoethanol was 
reacted with sulfuryl chloride.  Small amounts of the 1-t-butyl-2-phenylaziridine were 
formed (Scheme 36). 
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Scheme 36: Competing aziridination in sulfamidate formation 
 
Treatment of 1,2- or 1,3-amino alcohols with thionyl chloride in the presence of 
imidazole as a nucleophilic catalyst leads to the efficient formation of 1,2- and 1,3- cyclic 
sulfamidites as a mixture of epimers at sulphur (Scheme 37).68,69  The resulting 
sulfamidite is then oxidised to the corresponding sulfamidate by one of many methods, m-
CPBA67 and KMnO470 have been employed as oxidants, however the use of catalytic 
RuO4, RuCl3 and NaIO4 in aqueous solvent produces the desired sulfamidate in yields 
greater than 80%. 
 
 
 
Scheme 37: Synthesis of sulfamidates from amino alcohols 
 
This method of formation requires isolation of the sulfamidite species prior to oxidation 
as both triethylamine and imidazole inhibit ruthenium oxidants.72  Functionality is limited 
to that which can withstand the harsh oxidation conditions therefore sulfamidates bearing 
alkene moieties cannot be prepared using this method.  
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Scheme 38: Utilisation of the Burgess reagent in sulfamidate formation 
 
Nicolaou and co-workers have employed a double alcohol activation mechanism to form 
1,2-cyclic sulfamidates from the corresponding 1,2-diols by utilising the Burgess reagent 
119 (Scheme 38).73  Double sulfonylation was proposed to convert the diol to an 
intermediate which undergoes cyclisation via an SN2 mechanism with departure of the 
better leaving group.  Limitations in regiochemistry of the product are dependent on the 
stereoelectronic preferences of the substrates involved.  A range of modified Burgess-type 
reagents allow access to different classes of N-carbamate-protected cyclic sulfamidates.  
 
Many 1,2-diols are available in an enantioenriched form and this method allows direct 
conversion to the electrophile which can undergo several further transformations.  This 
chemistry has been further exploited by Nicolaou to enable the formation of either 5- or 
6-ring cyclic sulfamidates (substrate dependent) from allylic alcohol-derived epoxides.74  
 
Hudlicky et al. have shown that the Burgess reagent 119 can be used to convert simple 
epoxides to the corresponding 5-ring cyclic sulfamidates but in modest yields (Scheme 
39).75  
 
Scheme 39: Preparation of sulfamidates from epoxides 
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Du Bois et al. have demonstrated that Rh-catalysis can afford cyclic sulfamidates by 
intramolecular amidation of C-H bonds (Scheme 40).76  This is achieved through γ-C-H 
bond amination.  The appropriate alcohol is reacted with sulfamoyl chloride which is 
formed in situ from formic acid and chlorosulfonyl isocyanate to yield the desired 
sulfamate ester.  This cyclisation favours the formation of 6-membered rings but where 
this is not possible 1,2-cyclic sulfamidates are formed.  
 
 
Scheme 40: Rh-catalysis for the preparation of sulfamidates 
 
Du Bois has shown that a Rh-nitrene intermediate 131 is key in sulfamidate formation 
(Scheme 41).77 The oxidant complex could present in many forms including the 
iminoiodinane 129. The iminoiodinane 129 will react quickly with the rhodium catalyst to 
form the nitrene which will undergo a C-H insertion to afford the sulfamidate 132.  
  
 
Scheme 41: Proposed mechanism for Rh-nitrene formation 
 
The bias towards formation of the oxathiazinane can be accounted for by the elongated S-
O and S-N bonds (1.58 Å) and the obtuse N-S-O angle (103°) of the sulfamate, which 
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match closely the metrical parameters of the heterocycle.  The catalyst is commercially 
available and the reaction is high yielding.  Silver-catalysed protocols have also been 
reported.78  When there are two different γ-C-H bonds the rate of reaction is tertiary C-H 
bonds > secondary/benzylic/allylic > primary C-H bonds. 
 
 
Scheme 42: Rh-catalysed aminations of allenic sulfamates 
 
Robertson et al. have shown that Rh-catalysed intramolecular amination of allenes can be 
used to form the 1-acetoxy-1-aminocyclopropane 134 from allene 133 (Scheme 42).79  
This reaction currently proceeds in moderate yields with the products having limited 
further reactivity.  When the methyl group is replaced with the bulkier tert-butyl group, a 
cyclic enamine by-product is observed (Scheme 43).   
 
 
Scheme 43: Enamine by-product produced with bulky substituents 
 
Blakey has shown that sulfamidates can be synthesised via a metallonitrene 
intermediate.80  This metallonitrene/alkyne metathesis reaction proceeds through a 
zwitterionic intermediate which then undergoes a [1,3] metal shift to complete the 
metathesis, generating an imine which undergoes a further C-O bond forming cascade 
reaction. 
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Scheme 44: Proposed mechanism for the Rh(II)-catalysed cascade reaction 
 
Zhou et al. have shown that enantioenriched 1,2-cyclic sulfamidates can be prepared by 
asymmetric hydrogenation of an imine precursor (Scheme 45) .81  Aryl- and alkyl-
substituted α-hydroxyketones when treated with sulfamoyl chloride afforded the 
corresponding cyclic imines after acid-promoted condensation.  Hydrogenation of the 
imine product 146 using a Pd-catalyst modified with f-binaphane, a chiral ferrocene-
derived bis-phosphine, affords the corresponding N-unsubstituted cyclic sulfamidates 147 
in near quantitative yields, and with excellent levels of asymmetric induction.  This 
method is limited to the synthesis of 1,2-cyclic sulfamidates with substituents at the 
nitrogen bearing carbon only. 
 
 
Scheme 45: Preparation of sulfamidates via imines 
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Donohoe had previously investigated tethered aminohydroxylation of allylic 
carbamates.82  Kenworthy and Taylor adapted this method to prepare sulfamidates from 
the reaction of homoallylic alcohols with an osmium catalyst, providing a route to 6-
membered cyclic sulfamidates possessing pendant alcohols (Scheme 46).83  This proceeds 
in modest yields and does not tolerate substituted alkenes. 
 
 
Scheme 46: Cyclic sulfamidate bearing a pendant alcohol 
 
Paradine and White have employed iron-catalysis in the synthesis of cyclic sulfamidates 
(Scheme 47).84  An iron phthalocyanine complex [FePc]Cl, an inexpensive industrial ink 
additive, was the most effective catalyst in their screen.  
 
 
Scheme 47: Iron-catalysis for sulfamidate preparation 
 
This catalyst has a strong preference for allylic C-H amination over aziridination and all 
other C-H bond types.  Scheme 48 shows that there are two possible sulfamidate products 
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from either reaction at the β or β’ position and the most reactive C-H bond will undergo 
amination. (i.e. allylic > benzylic > ethereal > 3° > 2° >> 1°)  
 
 
Scheme 48: Reactivity trends for allylic C-H amination 
 
Moreover, in polyolefinic substrates, the site selectivity can be controlled by the 
electronic and steric character of the allylic C-H bond.  Although this reaction is shown to 
proceed via a stepwise mechanism, the stereoretentive nature of the C-H amination of 3° 
aliphatic C-H bonds suggests a very rapid radical rebound step (Scheme 49). 
 
 
Scheme 49: Amination of tertiary aliphatic C-H bonds to give stereospecific 
formation of sulfamidates 
 
1.4.2 Reactivity of sulfamidates 
 
Cyclic sulfamidates are versatile electrophiles.  Nucleophilic attack occurs at the oxygen 
bearing carbon via an SN2 mechanism to provide an N-sulfate intermediate which is then 
hydrolysed to give a substituted amine (Scheme 50).85  
34 
 
 
Scheme 50: Nucleophilic ring opening of cyclic sulfamidates 
 
Lactams can be synthesised from a range of cyclic sulfamidates undergoing reaction with 
the sodium enolate of dialkyl malonates in DMF (Scheme 51).86  5-Membered cyclic 
sulfamidates are more reactive than 6-membered cyclic sulfamidates due to ring strain.  
Gallagher et al. have shown that higher temperatures and longer reaction times were 
required to effect C-O bond cleavage of the 6-membered sulfamidates.  After the 
formation of the C-C bond, a small amount of aqueous HCl hydrolyses the N-sulfate and 
induces lactam formation.  Formation of 5-membered cyclic sulfamidates is more facile 
than the 6-membered counterparts.  
 
 
Scheme 51: Preparation of lactams from sulfamidates 
 
Alkylidene pyrrolidines have been prepared from the opening of cyclic sulfamidates with 
the dianion of ethyl acetoacetate (Scheme 52).  Nucleophilic cleavage occurs with 
moderate ease, N-sulfate hydrolysis is followed by condensation to give the target 167.  
 
 
Scheme 52: Preparation of alkylidene pyrrolidines from sulfamidates 
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Gallagher et al. have also shown that thiomorpholines have been prepared from the 
corresponding 1,2-cyclic sulfamidates (Scheme 53).  Reaction with a thiol possessing a 
pendant ester can undergo nucleophilic ring cleavage, N-sulfate hydrolysis followed by 
cyclisation to give substituted and enantioenriched thiomorpholines.  Bulky substituents 
on the cyclic sulfamidate are tolerated and give rise to the corresponding thiomorpholines 
in excellent yields. 
 
 
Scheme 53: Preparation of thiomorpholines from sulfamidates 
 
1.4.3 Sulfamidates in target synthesis 
 
Piperidines are part of a therapeutic heterocyclic class and it is of interest to access 
enantiopure 3,4-disubstituted piperidines.87  Sulfamidate chemistry has been used in the 
synthesis of the anti-depressant (-)-paroxetine.  Gallagher et al. have demonstrated 
cleavage of the C-3-aryl-substituted 1,3-cyclic sulfamidate with an enolate nucleophile.88  
The route to (-)-paroxetine (Scheme 54) involves asymmetric hydrogenation of β-
ketoester 171 affording alcohol 172 in excellent yield and high enantiopurity.  With 
amino alcohol 174 in hand, the sulfamidate 174 can be prepared by treatment of 173 with 
SOCl2 followed by Ru-catalysed oxidation.  Treatment of this species with the anion of 
malonate, followed by N-sulfate hydrolysis and thermally promoted lactamisation 
delivers the target 3,4-disubstituted piperidinone 176 in excellent yield and with no 
detectable loss of enantiopurity, thereby demonstrating clean SN2 cleavage of the C-3-
arylated 1,3-cyclic sulfamidate.  Intermediate 176 is then easily converted to (-)-
paroxetine 177.  
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Scheme 54: Synthesis of paroxetine 
 
(-)-Levofloxacin 182 is an antibiotic drug which is active against both gram-positive and 
gram-negative bacteria and is prescribed for a wide range of infections.89  The biggest 
synthetic hurdle faced in the synthesis of Levofloxacin is identifying a concise 
asymmetric entry to the chiral benzoxazine core 181 (Scheme 55).  Alanine-derived 
cyclic sulfamidate 178 was reacted with phenol 179.  Treatment of cyclic sulfamidate 178 
with the anion of 179 resulted in the smooth nucleophilic ring cleavage to generate adduct 
180 in essentially quantitative yield.  In this case concomitant removal of both the N-
sulfate and N-Boc moieties could be achieved in the same pot by employing 10% H2SO4 
in dioxane for the hydrolysis step.  Exposure of 180 to Pd(0)-mediated ring closure 
conditions then cleanly afforded the core 181 of levofloxacin 182 in 84% yield.  
Conversion of this intermediate to Levofloxacin in three further steps has been reported.90 
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Scheme 55: Synthesis of Levofloxacin 
 
Du Bois has shown a stereoselective synthesis of (+)-saxitoxin, a paralytic shellfish 
poison, via a sulfamidate intermediate.91   
 
Scheme 56: (+)-Saxitoxin synthesis 
 
Sulfamidates have widespread application in organic synthesis.  With recent advances in 
the synthesis of cyclic sulfamidates from common starting materials they are becoming 
ever more useful building blocks.  Sulfamidates can undergo reaction to give a wide range 
of diverse intermediates that are important precursors of chemically and biologically 
important molecules. 
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Initial investigations into novel sulfamidate formation was focussed on use of the Burgess 
reagent.  In Chapter 2 we outline the attempts at reversal of regioselectivity in sulfamidate 
synthesis. 
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Attempted Reversal of the Regioselectivity in the 
Burgess-Reagent Mediated Sulfamidate Synthesis 
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Chapter 2: Attempted reversal of the regioselectivity in the Burgess-Reagent 
mediated sulfamidate synthesis 
 
There are relatively few examples of simple vinyl-substituted sulfamidates known in the 
literature (Scheme 57).  Du Bois has shown that 6-membered cyclic sulfamidate 187 can 
be synthesised using Rh or Ru catalysis (Scheme 57).91  White has also synthesised 
similar sulfamidates using Fe catalysis.84  The most common method for sulfamidate 
formation involves the synthesis of the sulfamidite which is then subsequently oxidised to 
the sulfamidate.67-70  The harsh oxidation conditions required to convert the sulfamidite 
intermediate to the sulfamidate are not compatible with alkenes (Scheme 36, Chapter 1). 
 
 
Scheme 57: Simple vinyl-substituted sulfamidates 
 
Synthesis of sulfamidates 188 with vinyl groups on the oxygen-bearing carbon (not 
currently known in the literature) (Scheme 58) would be of interest as this functionality 
would provide a means by which to access a wide range of different compounds.  
Nucleophilic attack typically occurs at the oxygen bearing carbon (SN2) but we might also 
envisage nucleophilic attack at the allylic position (SN2’).  At present there are no known 
methods for the preparation of such sulfamidates.  
 
 
Scheme 58: Possible reactions of vinyl-substituted sulfamidates 
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Nicolaou and co-workers have employed a double alcohol activation mechanism to form 
1,2-cyclic sulfamidates from the corresponding 1,2-diols by utilising the Burgess reagent 
(Scheme 59).73  The reaction is regioselective dependent on the substituents present.   
 
 
Scheme 59: Nicolaou’s route to sulfamidates derived from diols 
 
2.1 Initial attempts at vinyl sulfamidate synthesis 
 
We initially investigated the synthesis of the 5-membered sulfamidate 195 (Scheme 60).  
By building upon Nicolaou’s methodology we intended to prepare this highly 
functionalised sulfamidate, bearing two olefinic substituents, aiming to investigate its 
reactivity. 
 
 
Scheme 60: Potential route to sulfamidate 195 
 
The preparation of Burgess reagent 119 was initially attempted using the conditions 
outlined by Burgess et al., substituting benzene with toluene.92  Chlorosulfonyl isocyanate 
196 did not afford Burgess reagent when reacted as outlined in Scheme 61, with toluene 
as the solvent.  When benzene was used the Burgess reagent was isolated in a 94% yield.  
Recrystallisation of Burgess reagent using hot toluene was also problematic and led to 
substantial decomposition of the desired material, therefore recrystallisation was 
42 
 
attempted at room temperature and at -78 °C which also led to considerable 
decomposition.  The Burgess reagent also decomposed after 1 week in the freezer so it 
had to be used quickly once prepared. 
 
 
Scheme 61: Preparation of Burgess reagent 119  
 
It was first envisaged that the sulfamidate 201 could be synthesised from the 
corresponding symmetrical diol 200 by treatment with 2 equivalents of Burgess reagent.  
A synthetic route to the diol 200 was undertaken starting from D-mannitol 197 (Scheme 
62).93  The primary alcohol groups were displaced with acetyl bromide followed by 
conversion of the secondary alcohol groups to the corresponding acetyl protected moieties 
giving 198.  Elimination of this more favourable leaving group afforded a crude mixture 
of the diene 199.  Attempted hydrolysis of the crude mixture followed by distillation led 
to decomposition.  Attempts to reprepare 199 were relatively unsuccessful with mono-
eliminated material being the main product from the reaction.  It was decided that a new 
route to the diol 200 should be investigated. 
 
Scheme 62: Potential route to sulfamidate 201 via diol 200 
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Acrolein 202 was reacted in the presence of zinc in attempts to prepare the racemic diol 
mixture 203 outlined in Scheme 63, using reaction conditions employed by Trost et al.94  
The crude reaction mixture did not look promising and it was noted that Trost et al. 
reacted this crude material further.  It was envisaged that a clean sample of the diol would 
be required in order to investigate reactivity with the Burgess reagent and difficulties in 
purification led to isolation attempts being terminated. 
  
 
Scheme 63: Preparation of the racemic diol mixture 203 
 
2.2 Initial investigations in regioselectivity switching 
 
We next theorised that we could promote formation of the normally less favourable 
sulfamidate 206 by the prior introduction of a leaving group (Scheme 64).  Initially the 
primary alcohol group would be converted to a leaving group to give 205 and then we 
supposed that the secondary alcohol group would react with the Burgess reagent and 
displace the pre-existing leaving group.  This method would be used to overcome the 
natural substrate-controlled regioselectivity observed by Nicolaou. 
 
Scheme 64: Potential route to regioselective sulfamidate formation 
 
Further efforts to prepare sulfamidates with unsaturated substituents were investigated.  
Commercially available, 3,4-dihydroxy-1-butene 204 was reacted in the presence of 
Burgess reagent (Scheme 65).73   
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We investigated the reaction of diol 204 with 2.5 equivalents of Burgess reagent as a 
control.  It was expected that depending on the more reactive alcohol we would see 
formation favouring one of the two possible products 207 or 208 outlined in Scheme 65.  
With a phenyl substituent Nicolaou recorded a 92% yield (93:7 ratio of regioisomers).  
The starting material 204 was consumed when refluxed for 1 h in the presence of the 
Burgess reagent with no sign of product by NMR.  
 
 
Scheme 65: Possible sulfamidates formed from reaction of diol 204 with Burgess 
reagent 
 
The reaction was repeated at room temperature and after 30 minutes starting material was 
observed by TLC.  The reaction mixture was stirred for a further 75 minutes and 
consumption of starting material was observed.  Purification by column chromatography 
led to the isolation of a small amount of material which did not appear to be the desired 
product.  It is possible that the activated alcohol group underwent an SN2 reaction to 
afford the 7-membered ring 205 shown in Scheme 66.  A similar by-product was 
evidenced by Metcalf when reacting diols bearing aromatic substituents in the presence of 
Burgess reagent.95  It is also possible that this intermediate could undergo intermolecular 
polymerisation reactions that could account for the low mass recovery from column 
chromatography. 
 
 
Scheme 66: Possible side reaction 
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Monotosylation of 3,4-dihydroxybut-1-ene96 204 was next undertaken in order to 
investigate the possibility of forming sulfamidates by reacting tosylated alcohols with a 
slight excess of Burgess reagent (Scheme 67).  When the tosylated alcohol 205 was 
reacted with Burgess reagent at room temperature the starting material was consumed 
after 2 hours.  NMR analysis did indicate consumption of the starting material but again 
there was no evidence of product formation.  We decided to reflux the reaction mixture in 
the hope that if an activated Burgess intermediate had formed that this would undergo 
reaction to the desired sulfamidate.  Purification by column chromatography of the 
complex mixture was attempted, but was unsuccessful so we decided to refocus our 
endeavours. 
 
 
Scheme 67:Attempts at switching regioselectivity in sulfamidate preparation  
 
We decided to do a control reaction and attempted to prepare the known sulfamidate 210 
using the same conditions as Nicolaou (Scheme 68).73  Nicolaou obtained a 92% yield, 
we attempted this on a small scale and it appeared to have undergone 28% conversion to 
the desired material by NMR but was not reproducible when scaled up to 300mg. 
 
 
Scheme 68: Test reaction preparing a sulfamidate using Burgess reagent  
 
Hudlicky et al. have shown that the half-life of the Burgess reagent is 19 minutes at reflux 
in tetrahydrofuran, with the reagent completely decomposing in less than 1 hour.95  They 
also report a yield of 77% compared to a 92% yield reported by Nicolaou for the 
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transformation outlined in Scheme 68.  Hudlicky observes the formation of the 7-
membered by-product 211 also under these conditions (Scheme 69). 
 
 
Scheme 69: Hudlicky’s preparation of phenylated sulfamidate 210 
 
Attempted scale up of this reaction was unsuccessful and so it was decided that we would 
investigate the possibility of simply switching regioselectivity rather than continue efforts 
into preparation of vinyl-substituted 5-membered sulfamidates.  
 
2.3 More general attempts at regioselectivity switching 
 
As Nicolaou et al. have shown that the phenylated 1,2-diol 209 reacts to give the 
sulfamidate 210 (Scheme 69) we decided to try and prepare the less favoured sulfamidate 
by attempting displacement of the tosylated diol to give the other sulfamidate regioisomer 
213 (Scheme 70).  This proved unsuccessful with consumption of starting material and no 
product formation. 
 
 
Scheme 70: Attempts at switching substrate-biased regioselectivity in sulfamidate 
formation  
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The initial exploratory work outlined in this chapter, and the lack of success we 
encountered, led us to consider a different approach to the formation of cyclic 
sulfamidates and work was therefore focussed on metal-catalysed routes. 
 
We therefore decided to investigate the possibility of preparing sulfamidates by possible 
gold(I)-catalysed hydroamination reactions and this work is outlined in Chapters 3 and 4 
of this thesis. 
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Chapter 3 
Preparation of Substrates for Allene 
Hydroamination 
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Chapter Three – Preparation of Substrates for Allene Hydroamination and Proof of 
Principle for gold(I)-catalysis 
 
We were interested in testing the hypothesis that gold(I) could be used catalytically to 
form cyclic sulfamidates via a redox-neutral method, namely intramolecular 
hydroamination. 
 
 
Figure 8: Hypothesis for Au(I)-catalysed sulfamidate formation 
 
It was envisaged, by retrosynthetic analysis that the desired allenic sulfamates required 
for our investigations into gold-catalysed cyclic sulfamidate formation could be prepared 
from the corresponding allenic alcohol which could be accessed from Johnson-Claisen 
rearrangement of a suitably substituted propargyl alcohol, or alternatively from Crabbé 
homologation of homopropargyl alcohols (Figure 9).97, 98  These two approaches give a 
wide range of substitution patterns. 
 
 
Figure 9: Retrosynthetic approaches to allenic sulfamates 
  
We initially prepared the sulfamate 216 in order to test the gold methodology.  The 
sulfamate was prepared from the corresponding allenic alcohol 215 via a Crabbé 
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homologation.  The allenic alcohol was prepared by a Barbier-type reaction from the 
homopropargyl alcohol 214 (Scheme 71).  We were very pleased to find that the 
sulfamate did indeed give the cyclic sulfamidate 217, in a 74% yield, when 
PPh3AuCl/AgOTf was used as a catalyst.  With this promising result a range of 
sulfamates were prepared to test the scope of this reaction.   
  
 
Scheme 71: Initial proof of concept 
 
3.1 The Crabbé approach 
3.1.1 Preparation of homopropargyl alcohols 
 
 
Scheme 72: Propargylation of aldehydes to give homopropargyl alcohols 
 
In order to investigate the Crabbé homologation, we first needed a viable method for the 
preparation of homopropargyl alcohols.  A range of homopropargyl alcohols were 
prepared utilising Barbier-type reaction conditions.  The Barbier reaction is the reaction 
of an alkyl halide with a carbonyl group in the presence of a metal or a metallic salt 
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(Scheme 72).99  Often confused with the Grignard reaction, but a crucial difference is that 
the Barbier involves in situ generation of the organometallic reagent in the presence of the 
electrophile, and in many cases proceeds in water. 
 
The Barbier reaction mechanism was investigated by Moyano et al., showing that this 
reaction proceeds via radical intermediates.100  Barbier reactions of unsaturated carbonyl 
compounds should involve firstly the formation of a carbonyl radical anion and proceed 
through path B (Scheme 73).  If a saturated carbonyl compound undergoes reaction the 
initial step should be the formation of the halide radical anion (path A).  The mechanism 
is easily predicted from the electron affinities of the reactants, with the radical anion 
being formed from the reactant with the highest electron affinity. 
 
 
Scheme 73: Mechanism of the Barbier reaction  
 
Ma has shown that aldehydes undergo reaction at room temperature with propargyl 
bromide in the presence of a Zn-Cu couple to give homopropargyl alcohols in excellent 
yields.101  Zn-Cu couple was a favourable reagent due to the non-toxicity and low-cost.  
Unfortunately, when this reaction was attempted using trans-cinnamaldehyde we saw 
little conversion to the desired product.  Ma achieved an 85% yield in the transformation 
utilising trans-cinnamaldehyde and we therefore concluded that the preparation of the Zn-
Cu couple was ineffective.  After a few attempts at this preparation it was decided to 
focus our efforts on a different Barbier-type reaction, employing aluminium as the metal. 
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When aluminium and mercuric chloride were employed we prepared cyclohexylbut-3-yn-
1-ol 214 in a 88% yield (Table 1).  Trans-cinnamaldehyde was transformed to the 
corresponding alcohol in a 87% yield.102 
 
 
Starting material Product Yield  
 
 
88% 
  
87% 
Table 1: Propargylation of aldehydes 
 
Further Barbier-type reactions were undertaken using similar conditions but magnesium 
and mercuric chloride in diethyl ether were favoured as reagents as the start of the 
reaction could be observed clearly by the boiling of the diethyl ether solvent (Table 2).103, 
104
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Starting material Product Yield  
 
 
58% 
  
33% 
  
98% 
Table 2: Propargylation of aldehydes using magnesium 
 
Crabbé developed a one-step homologation of acetylenes to allenes with mild reaction 
conditions and good functional group tolerance (Scheme 74).98  The use of copper 
bromide, paraformaldehyde and diisopropylamine as the reagents affords the desired 
transformation and is tolerant of alcohol, ether and ester groups (Scheme 74).  This new 
method outlined by Crabbé is a clean and fast procedure and the lack of strong reducing 
agents is the key in functional group tolerance. 
 
 
Scheme 74: Improved Crabbé homologation conditions 
 
A range of allenes were synthesised to facilitate hydroamination studies.  Allenes which 
did not bear substitutents at the terminal position were synthesised by the Crabbé 
homologation method (Table 3). 
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Starting material Product Yield  
220
OH
Ph
 
 
37% 
226
OH
Ph
  
48% 
 
 
52% 
 
 
33% 
  
 
40% 
 
 
42% 
 
 
48% 
Table 3: Allenes prepared by Crabbé homologation 
 
3.2 The Johnson-Claisen approach 
 
Another method employed for preparing acetylenic alcohols was by alkyne lithiation 
followed by subsequent reaction with paraformaldehyde.105  4-Methylpent-2-yn-1-ol 238 
was the first alcohol prepared by this method (Table 4).  This was achieved in a 96% 
yield (calculated by NMR) and reacted on crude.  Other substrates were also prepared by 
this method (Table 4).  
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Starting material Product Yield  
  
96% 
 
 
73% 
 
 
85% 
  
 
86% 
 
 
50% 
Table 4: Preparation of acetylenic alcohols 
 
A range of catalysts have been used in the Claisen rearrangement such as Lewis acids, 
Brønsted acids and bases.106  For the preparation of allenic alcohols from terminally 
substituted propargyl alcohols we used propionic acid as the catalyst following 
methodology outlined by Ma (Table 5).107 
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Starting material Product Yield  
 
 
72% 
 
 
38% 
 
 
66% 
 
 
40% 
  
 
42% 
 
 
21% 
Table 5: Allenic alcohols from Claisen rearrangement 
 
By replacing the triethylorthoacetate with triethylorthopropionate it was possible to 
introduce a methyl substituent as shown below (Table 6)108  This was advantageous as it 
allowed for further investigation into substituent tolerance, with the methyl group being 
close to the reactive allene during the gold-catalysed sulfamidate formation. 
 
57 
 
The following methyl-substituted allenes were prepared to give a range of varying 
methyl-substituted sulfamidates.  Aromatic and aliphatic functionality were both tolerated 
under these reaction conditions with similar yields achieved for all substrates. 
 
 
Starting material Product Yield  
 
 
48% 
 
 
47% 
 
 
48% 
Table 6: Methyl substituted allenic alcohols 
 
With this range of allenic alcohols in hand we were then able to convert these to the 
desired sulfamates required to investigate the gold catalysis synthesis of cyclic 
sulfamidates. 
 
3.3 Sulfamate formation 
 
Initial sulfamate formation was achieved by converting the corresponding alcohol to the 
sulfamate using conditions outlined by Okada et al.109  Okada has shown that using DMA 
as a solvent accelerated the reaction compared to the solvents previously used in this 
reaction.  DMF was shown to be a poor solvent choice for this reaction as DMF is 
involved in a side reaction with the sulfamoyl chloride and often the DMF adduct is 
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obtained (-O3S-+NH=CH-NMe2).110  Previous sulfamoylation reactions were carried out 
in the presence of excess base but it was shown that by eliminating the base higher yields 
were obtained.  
 
We synthesised a range of sulfamates with deca-3,4-dien-1-yl sulfamate 263 being 
prepared from the allenic alcohol 262 (Table 7).  Sulfamoyl chloride (1.5 eq.) was formed 
in situ overnight and DMA was added.  To this solution was then added the allenic 
alcohol 262 in DMA. This gave the desired sulfamate in a 62% yield. 
 
Further sulfamates were prepared by reaction of the allenic alcohols with sulfamoyl 
chloride generated in situ with DMA as the solvent.  The propyl substituted allenic 
alcohol 254 was converted to the sulfamate 264.  This provided a suitable precursor to 
probe the possibility of forming quaternary-centred sulfamidates which are known to be 
difficult to prepare by conventional sulfamidate methods known at this time.  Other 
substituents were also introduced to diversify chain length such as the hexyl substituted 
sulfamate 265 and differing functional group tolerance with the preparation of the 
benzylated sulfamate 266. 
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Starting material Product Yield  
  
 
62% 
  
43% 
  
43% 
  
45% 
  
58% 
Table 7: Sulfamate formation 
 
The allenic alcohol 268 was the next substrate exposed to the sulfamoylation reaction 
conditions and this proved to be unsuccessful with several products observed by TLC 
(Scheme 75).  In this case the hydroxyl group is alpha to the allene and this may be one 
of the factors leading to the formation of unwanted by-products.79 
  
 
Scheme 75: Unsuccessful sulfamate formation 
60 
 
Kenworthy and Taylor83 reacted homoallylic alcohols to give the corresponding sulfamate 
ester either by using the conditions outlined above or by using DCM as the solvent and 
pyridine (1.5 eq.) as a base.  We employed pyridine as a base and DMA as the solvent in 
attempt to synthesise the desired sulfamate 269 but this was unsuccessful.  
 
The reaction was attempted as above (Scheme 75) but the solvent changed to DCM.  This 
showed mainly starting material after 5 hours.  Further reaction conditions were 
investigated such as addition of pyridine to the reaction or pyridine and DMAP.  All of 
the reactions had starting material present after 72 hours.  Use of dichloromethane led 
also to the decomposition of the starting material. 
 
We decided to attempt the synthesis of the conjugated sulfamate 270 from (E)-1-
phenylhepta-1,5,6-trien-3-ol 227 (Scheme 76).  TLC analysis looked promising but when 
loaded onto a column the crude mixture turned brown.  It appears that the product, if 
formed, is not stable as no sulfamate was isolated from purification by column 
chromatography.  
 
 
Scheme 76: Attempts at formation of unsaturated sulfamates 
 
We attempted to synthesise the sulfamate 271 to investigate the effect of a less conjugated 
starting alcohol 230.  The reaction mixture turned brown within one hour following the 
addition of the allenic alcohol, and starting material was consumed by TLC.  NMR 
analysis of the crude reaction material showed no sign of product formation. 
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Investigation of larger sulfamidate ring sizes could be investigated by preparing hexa-4,5-
dien-1-yl sulfamate 272 (Scheme 77).  This was achieved in a moderate yield and will 
potentially provide a potential route to the 7-membered cyclic sulfamidate 273. 
 
 
Scheme 77: Sulfamate for 7-membered cyclic sulfamidate investigations 
 
Diversity of sulfamates was further extended by the preparation of a sterically 
encumbered sulfamate (Scheme 78).  This reaction gave a relatively low yield (29%) of 
the sulfamate but this may be due to the bulk around the alcohol group in the starting 
material. 
 
 
Scheme 78: Sterically restricted sulfamate formation 
 
Further improvement on the sulfamoylation reaction conditions was sought at this 
stage.111  Previously the sulfamoyl chloride was prepared neat and stirred overnight.  The 
new reaction conditions are the same as above but acetonitrile was added to the neat 
sulfamoyl chloride solution and stirred overnight, leading to a dramatic increase in 
yield.112, 113  Pyridine when added to one of the reactions with the allenic alcohol in DMA 
did not give any improvement.  
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Starting material Product Yield  
  
71% 
  
41% 
  
71% 
 
 
54% 
  
76% 
  
65% 
  
67% 
  
78% 
Table 8: Sulfamates prepared using optimised conditions 
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Further substitution was investigated with novel sulfamates being prepared by utilising 
the optimised reaction conditions (Table 8).  Sulfamate 277 was prepared in order to test 
the tolerance of aromatic rings to our sulfamidate formations. 
 
With the optimised conditions we revisited the preparation of precursors to quaternary 
centred sulfamidates synthesising the iPr-substituted sulfamate 278 (Table 8) with a 
greatly improved yield compared to the nPr-substituted sulfamate 264 which was isolated 
in a 51% yield (Table 7). 
 
Preparation of a methylated sulfamate was also of interest to investigate the tolerance of 
substitution at the 2-position.  The preparation of the 2-methyl substituted allenic 
sulfamates 280, 281 and 282 added diversity to the potential sulfamidates that could be 
synthesised with a methyl group in the 2-position.  
 
With this diverse range of sulfamates in hand, gold(I)-catalysed synthesis of cyclic 
sulfamidates could be investigated.  
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Chapter Four - Sulfamidate synthesis by Au(I)-catalysed hydroamination - 
optimisation and controls  
 
4.1 Initial investigations into gold(I)-catalysed hydroamination of allenes 
We decided to investigate gold(I)-catalysis for the formation of cyclic sulfamidates from 
allenic alcohol precursors (Scheme 79).  We initially investigated the use of the 
PPh3AuCl/AgOTf as the gold catalyst in the formation of sulfamidate 217 (Table 9). 
 
 
Scheme 79: Retrosynthetic analysis of cyclic sulfamidates 
 
We initially investigated the use of the PPh3AuCl/AgOTf as the gold catalyst in the 
formation of sulfamidate 217 and this was achieved in a 74% yield.  We then carried out a 
catalyst screen to investigate the effect a change of catalyst would have on this reaction. 
Gagosz’s complex 287 (PPh3AuNTf2) provided the highest yields (Table 9, overleaf).  
 
Figure 10: Catalyst Structures 
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We investigated a range of ligands on gold, such as the electron-rich carbene complex 
288, as well as the electron-poor phosphite complexes, ligands 289 and 290 (Figure 10).  
The yield was better in the case of the electron-poor ligand but it is not clear if this is 
solely due to the ligand being more weakly held by the gold or whether the bulk of the 
ligand may also play a part in the yields observed.  
 
We altered ligands and various counterions which gave better diastereoselectivity in some 
cases, but to the detriment of the yield.  Control experiments without any catalyst, with 
AgOTf only and with TfOH confirmed that the gold complex was necessary for reaction 
to occur (Table 9). 
 
 
Entry Catalyst Yield 2/% dr cis/trans 
1 None 0 NA 
2 AgOTf 0 NA 
3 TfOH 0 NA 
4 (PPh3)AuCl/AgOTf (286) 74 1.7 : 1 
5 (PPh3)AuNTf2 (287) 99 1.2 : 1 
6 IPrAuCl/AgOTf (288) 48 1 : 1 
7 (2,4-Di-tBuPhO)3PAuCl/AgOTf (289) 43 2 : 1 
8 (2,4-Di-tBuPhO)3PAuCl/AgNTf2 (290) 82 1 : 1 
Table 9: Catalyst screen in the formation of 217 
 
With the highest yields from the catalyst screen achieved with Gagosz’s complex we 
decided to investigate the reactivity of other sulfamates in the presence of this catalyst.  
Sulfamidate 292 was formed as exclusively the E-alkene (Table 10).  Substitution can be 
tolerated at the terminal position of the allene, with 4-cyclohexylidenebut-3-en-1-yl 
sulfamate 267 leading to the formation of sulfamidate 293 containing a trisubstituted 
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olefin.  Secondary alcohols were reacted to afford sulfamates 275, 276 and 277, which 
gave mixtures of 1,3-cis and trans isomers with modest selectivity analogous to the 
diastereoselectivity observed in similar reactions.77, 84, 114, 115 
 
Entry Sulfamate Products Yield  
1 
 
 
94%  
2 
 
 
66%  
3 
 
 
95%  (1.8:1)  
4 
 
 
93% (2 :1)  
5 
 
 
95% (1.8 : 1)  
6 
 
 
75% (3 : 1)  
Table 10: Sulfamidates prepared 
 
In the case of the sulfamidate 217 the diastereomers were separable and the major product 
was shown to be the 1,3-cis isomer (cis-217) by a single crystal X-ray diffraction study 
(Appendix A), the other 1,3-disubstituted products were assigned by analogy.   
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A control experiment, performed by subjecting the separable diastereomer cis-217 to the 
original reaction conditions, showed that no equilibrium existed between the 
diastereomers.  This is consistent with a kinetically-controlled cyclisation, which is 
common in other gold-catalysed hydroaminations.116-118  The addition of protic additives 
(H2O, AcOH, TfOH) to the reaction mixture did not accelerate the reaction to a 
measurable extent, suggesting that the final protonation is not the rate-determining step of 
this process. 
 
The 2-substituted product 297 was formed as a 3:1 mixture of diastereomers and the 
relative stereochemistry of the major product could not be determined immediately.  This 
was due to the CHNH overlapping with the NH signal in the 1H NMR making it 
impossible to determine which isomer was more abundant from this data alone, due to an 
inability to observe the coupling constants. 
 
We therefore planned to convert the diastereomeric mixture into the corresponding 
known119 syn- and anti- tosyl-protected amino alcohols 298 to elucidate the nature of the 
major product (Scheme 80).  There were no examples of ring opening of unprotected 
sulfamidates so we decided to try a different protecting group (Boc) when tosylation 
failed. 
 
 
Scheme 80: Determination of diastereoselectivity 
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However, we did not ultimately need to carry out this lengthy sequence in full.  Boc-
protection of the mixture 297 led unexpectedly to the isolation of a single diastereomeric 
product 299 in moderate yield.  
 
We were once again unable to crystallise this compound, but attempted ring-opening 
using water in boiling acetonitrile leading only to slow loss of the Boc group (presumably 
by a thermal mechanism) (Scheme 81) to give a single diastereomer of 300.  Crystals 
suitable for an X-ray diffraction study were then obtained, revealing this product to be 
2,3-cis-300.  Comparison of the 1H and 13C NMR data with those obtained from the 
mixture arising from the gold-catalysed cyclisation confirmed that the cis diastereomer 
was indeed the original major product. 
 
 
Scheme 81: Thermal mechanism for Boc-deprotection 
 
Notably, the substitution patterns available are complementary to the work of Du Bois 
using Rh-nitrene chemistry of sulfamidates.76  Du Bois has shown insertion into tertiary 
C-H bonds is faster than that into allylic and benzylic C-H bonds, and aziridination often 
predominates over allylic C-H insertion (Scheme 40, Chapter 1).   
 
4.2 Preparation of N-quaternary-centred sulfamidates 
 
We next decided to determine whether the reaction was suitable for the formation of N-
substituted quaternary centres, since this is very rare for catalytic hydroaminations (vide 
infra Section 1.5.1, Chapter 1).  This was successful with a range of N-substituted 
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quaternary sulfamidates 302, 303, 304 and 305 being synthesised in varying yields from 
the cyclisation of sulfamates 264, 265, 266 and 279 (Table 11).  
 
When the steric bulk was increased at this quaternary centre we saw a reduction in yield 
and we reached the limits of the method in the case of substrate 278 (Table 11).  This 
gave only a trace (~3%) of product 306 after 5 days at 40 °C.  These unsaturated amine 
derivatives are difficult to access by other methods and have considerable potential for 
further functionalisation due to the presence of the olefinic group.  
 
Entry Sulfamate Producta Yield 
1 
 
 
92% 
2 
OSO2NH2
n-Hex
265
 
 
68% 
3 
 
 
37% 
4 
 
 
90% 
5 
 
 
Trace 
Table 11: N-substituted quaternary sulfamidates 
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4.3 Sulfamidate reactivity 
 
We decided to investigate the reactivity of the quaternary cyclic sulfamidates we had 
prepared.  We initially attempted the preparation of piperidinone 308 from the allyl-
protected sulfamidate 307 (Scheme 82).  As this was unsuccessful we decided to focus on 
ring-opening of a quaternary sulfamidate instead.  
 
 
Scheme 82: Attempted piperidinone formation 
 
Allylation of 302 to give 309 and ring-opening with cyanide ion occurred as expected to 
give the cyanoamine 310 after acid hydrolysis of the N-sulfate intermediate (Scheme 83, 
overleaf).  We attempted to perform a ring closing metathesis reaction on 310 to give the 
cyclic amine 313 but no conversion was observed.  We also attempted to protect the 
amine 310 to perform further transformations however the Boc-protection was 
unsuccessful.  We attempted a further protection of 310 using methyl chloroformate and 
harsher conditions in an attempt to form 312 but to no avail.   
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Scheme 83: Attempted synthesis of cyclic amine 44 
 
During our investigations into the reactivity of these sulfamidates, we did however 
discover unusual behaviour leading to a novel acyl amidine synthesis (Scheme 84).  
Standard acylation conditions of 310 did not give the expected acetamide, but a product 
ultimately identified as the amidine 314.  Presumably the intermolecular acylation of the 
amine is slow relative to its 5-exo-dig cyclisation onto the nitrile, giving a more 
nucleophilic amidine, which then undergoes acylation rapidly to give 314.  Related 
reactions are normally carried out in strong acid or base in two separate steps, rather than 
the relatively mild one-pot conditions found here.120   
 
 
Scheme 84: An unusual acylamidine synthesis 
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4.4 Possible stereochemical rationale 
 
Mechanistically, we anticipate that the reaction occurs via an outer sphere mechanism121-
126
 leading to an anti aminoauration of the allene (Scheme 85).  The cis and trans 
diastereomeric products may arise from the chair-like conformations 316 and 318 
indicated.  
 
Protonation of the vinyl gold intermediates 317 and 319 would then give the observed 
products and regenerate the catalyst. 
 
 
Scheme 85: Stereochemical rationale 
 
The diastereoselectivity observed in the formation of 217, 294, 295 and 296 is lower than 
that normally found in related cyclisations, which is typically 4:1 to 7:1.121  The 
explanation for this is currently unclear.  At present, we postulate that 316 and 318 are in 
equilibrium127 and that the observed diastereoselectivity for the cis products is due to 
faster and irreversible cyclisation of 316, which has both the substituent R and the allene 
in equatorial positions.  This would compare favourably with cyclisation of 318, where 
the allene is in the axial position.  
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The observed diastereoselectivity in the formation of the 2-substituted system 297 was 
initially somewhat surprising and does not seem to have such a straightforward 
explanation.  If the major product arose simply from a reactive conformation with the 
maximum possible number of equatorial substituents, then the major diastereomer would 
be expected to arise from conformation 320, with both the gold-bound allene and the 
methyl group in equatorial positions (Scheme 86).  This would lead to the preferential 
formation of the trans product, but we have demonstrated unequivocally that the major 
product is cis-297.  Assuming a chair-like transition state, two reactive conformations 
leading to the cis-product are 324 and 326 leading to 325 and 327 respectively.  There is 
no obvious reason why 324, with the allene in the axial position, would be favoured over 
320, and indeed the steric bulk of the nearby substituent R is likely to clash with the 
metal-ligand assembly.  Conformation 326 is thus probably more likely to be responsible 
for the formation of the major product - the gold-bound allene is equatorial, and although 
the group R is now axial, it is now less likely to interfere with the metal-allene binding.  
This would also be consistent with our analysis of the 1,3-disubstituted systems – the 
allene is equatorial in the suggested favoured conformation 316, but substituent R is 
perhaps in this case sufficiently distant not to affect the metal-allene interaction when in 
the equatorial position.  A fourth possible conformation of 281 that would give rise to 
trans-297, with both substituents in axial positions, 321, was considered energetically 
unlikely. 
 
Scheme 86: Stereochemical rationale for diastereoselectivity of sulfamidate 297 
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In summary, we have demonstrated the first gold-catalysed preparation of cyclic 
sulfamidates, leading to a range of substituted and sterically hindered products under mild 
conditions.  
 
4.5 Unsuccessful substrates 
 
When there is an unsaturated group on the oxygen bearing carbon, e.g. 271, the sulfamate 
proved unstable to chromatographic purification attempts (Figure 11).  1H NMR indicated 
sulfamoylation had occurred (new signal at 5.65 ppm corresponding to CHOSO2NH2). 
Sulfamates with bulky substituents such as 274, 280 and 282 proved unsuccessful in 
forming the corresponding sulfamidates, this is likely due to steric hindrance.  Formation 
of a 7-membered cyclic sulfamidate was attempted from sulfamate 272 but after several 
days no noticeable conversion was detected.  Had we been able to prepare 269 we could 
have investigated the possibility of preparing sulfamidates with a smaller ring size but 
decomposition occurred rapidly upon subjecting the alcohol to the sulfamoylation 
conditions. 
 
 
Figure 11: Unsuccessful sulfamate substrates 
 
 
 
 
76 
 
4.6 Future Work  
 
The best success was noted in the forming of 6-membered sulfamidates.  Initial forays at 
forming 5- and 7-membered sulfamidates were unsuccessful but with a little furtherth a 
little further investigation this may have been possible. 
 
A general catalytic asymmetric approach to C-tertiary amines has so far proved elusive.  
Given our results, this new hydroamination reaction has the potential to address this 
important problem.  It is known that for gold(I) complexes the chiral information 
imparted by the two electron donor ligand is at 180° from the potential reacting centre.  
Impressive levels of enantioselectivity have been obtained with similar substrates128-130 
such as in the formation of 331 as outlined by Toste and coworkers using digold 
complexes (Scheme 87).131 By exploring the use of chiral gold ligands, digold complexes 
or counterions it may be possible to prepare enantioselective cyclic sulfamidates from the 
corresponding allenes. 
 
 
Scheme 87: Enantioselective cyclisation of δ-allenyl sulfonamide to corresponding 
pyrrolidines 
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Chapter 5:  Earlier work: Attempts to Prepare a Thermally Unmasked Acyl 
Anion Equivalent 
 
This work was undertaken at the beginning of my doctoral studies with the aim of 
producing a novel acyl anion equivalent.  This chapter provides an introduction to this 
field and outlines the efforts undertaken to synthesis a novel acyl anion equivalent. 
 
5.1 Acyl Anion Equivalent Methodology 
 
The stereoselective preparation of 1,n-dioxygenated compounds (n=2-6) is of vital 
importance in synthesis.132  Versatile reagents were sought to facilitate preparation of a 
variety of compounds which would form building blocks for natural products and 
pharmaceuticals.  It was thought to be of great importance to develop reagents that would 
permit catalytic asymmetric synthesis and multiple one-pot bond-forming reactions which 
would allow the rapid preparation of complex molecular frameworks. 
 
Figure 12: An α,β-unsaturated acyl anion equivalent 
 
The development of the substituted dioxin 335 (Figure 12) would have given rise to an 
acyl anion equivalent which would have permitted the catalytic asymmetric synthesis of 
1,2- and 1,4- deoxygenated compounds.  It is possible to facilitate the 1,2- and 1,4- 
asymmetric additions to enones.  Walsh133 and Hayashi134, 135 have developed catalytic 
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systems to catalyse the asymmetric additions of sp2-hybridised nucleophiles to ketones.  
We envisaged using this chemistry to perform similar reactions with our proposed 
metallated dioxin 335.   
 
The dioxin would subsequently have been converted to the carbonyl derivative by a 
thermally-induced retro-Diels-Alder reaction132 (Scheme 88), therefore facilitating 
multiple one-pot C-C bond forming reactions. 
 
 
Scheme 88: Thermally-induced retro-Diels-Alder reaction 
 
It was envisaged that dioxin 335 would undergo reaction with a broad range of 
electrophiles as outlined in Scheme 89 giving rise to an array of possible products once 
unmasked. 
 
 
Scheme 89: Examples of possible electrophilic trapping with dioxin 335 
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The generalised target organometallic dioxin 335 was proposed to be synthesised from 
the corresponding lactone 344 (Scheme 90).  We thought that dioxin 335 would come 
from a lithium-halogen exchange with bromide 340 or a lithium-tin exchange from the 
stannane 342.  The stannane 342 would be generated from the corresponding triflate 343 
afforded from the lactone 344, whilst the bromide 340 could be derived from the 
phosphonate ester 341 which in turn could be generated from the lactone 344.  This 
strategy was designed to ensure low temperature α-metallation.   
 
 
Scheme 90: Retrosynthetic analysis of metallated dioxin 335 
 
At present many α,β-unsaturated acyl anion equivalents have low regioselectivity of 
electrophilic attack and require acidic conditions for the hydrolysis step.  This limits 
further reactivity in the same vessel and would affect acid sensitive groups that may be 
present in the complex target molecules.  Some masked unsaturated acyl anion 
equivalents have already been synthesised based on metallated allenyl ethers or thioethers 
(Figure 13).136 
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Figure 13: Examples of synthetic equivalents for acyl anion equivalent 335 
 
5.2 Current approaches to the preparation of acyl anion equivalents 
 
The use of reagents that are able to reverse their functional polarity is an area of 
continuing interest and has great potential applications allowing unusual disconnection 
strategies.  These reagents are known as umpolung reagents and were given the name by 
German chemist Dieter Seebach.137  
 
The benzoin condensation has been known for over one hundred years and is one of the 
most direct methods of producing an umpolung reagent.138  Initially only aromatic 
aldehydes could be coupled to afford α-hydroxyketones (Scheme 91).  Attack of a 
cyanide ion gives rise to a cyanohydrin intermediate which after deprotonation leads to 
the conversion of the originally electrophilic carbon to a nucleophilic centre. 
 
 
Scheme 91: Benzoin condensation 
 
Major advances have been made in the last decade with Müller and co-workers 
developing the first cross-benzoin condensation (Scheme 92).139  
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Scheme 92: Cross-benzoin condensation 
 
This makes it possible to predict the preferred product for a given pair of aldehydes.  
Aromatic aldehydes reacted in the presence of an enzyme catalyst giving rise to high 
regioselectivity and enantio-enriched products. 
 
 
Scheme 93: Formation of umpolung reagent 
 
The umpolung reagent formed in Scheme 93 reacts in the Stetter reaction. The Stetter 
reaction is a 1,4 conjugate addition of an aldehyde to an α,β-unsaturated compound which 
is catalysed by cyanide or a thiazolium salt (Scheme 94).140  The Stetter reaction 
competes with the benzoin reaction outlined above which leads to the corresponding 1,2-
addition.  As the benzoin side reaction is reversible the main product from the Stetter 
reaction will be the 1,4-addition product which is the thermodynamic product.  The above 
nucleophile 357 is generated in situ and reacts with an α,β-unsaturated compound to give 
the desired product. 
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Scheme 94: Mechanism of the Stetter reaction 
 
In recent years the asymmetric conjugate addition of nucleophiles to α,β-unsaturated 
carbonyl compounds has advanced with interest in tandem reactions coming to the fore.141  
By trapping the anionic intermediate formed it is possible to form two contiguous 
stereocentres.  Rovis et al. have carried out highly enantio- and diastereoselective 
intramolecular Stetter reactions as shown in Scheme 95.142 
 
 
Scheme 95: Enantio- and diastereoselective intramolecular Stetter reaction 
 
Recently Rovis et al. have demonstrated that intermolecular Stetter reactions of 
unsaturated aldehydes can be achieved using N-heterocyclic carbenes as catalysts.143  
This can be achieved in high yields and with good enantioselectivity using the thiazolium 
salt 366 as a precatalyst (Scheme 96). 
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Scheme 96: Intermolecular Stetter reaction of unsaturated aldehydes  
 
5.2.1 Use of Metallated Enol Ethers 
 
Metallated enol ethers have been known since 1951.144 Schöllkopf145 and Baldwin146 were 
the first to realise the potential of these compounds as acyl anion equivalents.  Baldwin 
discovered that α-methoxyvinyllithium species were attractive substrates for use as acyl 
anion equivalents.  The reaction of α-methoxyvinyllithium species with an electrophile 
gives rise to a product containing a vinyl ether (Scheme 97).  This can easily be converted 
to the carbonyl compound by treatment with aqueous methanolic 0.02M HCl.  This acyl 
anion equivalent will react with many different electrophilic substrates.  Reaction with 
aldehydes and ketones affords hydroxy enol ethers and α-ketols.  Steric bulk is also 
tolerated with reaction of hindered carbonyl groups such as keto-steroids.146  
 
 
Scheme 97: α-Methoxyvinyllithium as an acetyl anion equivalent 
 
It is also possible to synthesise dicarbonyl compounds from reaction of an α-
methoxyvinyllithium species with nitriles.  If an ester undergoes reaction with 2 
equivalents of α-methyoxyvinyllithium species this provides high yields of substituted 
hydroxypentanediones 372 (Scheme 98).  It was noted by Baldwin that exclusively 1,2-
addition with α,β-unsaturated systems occurs with no conjugate addition found.147  
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Scheme 98: Synthesis of hydroxypentanediones 
 
It is accepted that the best approach for metallation of an enol ether is by reaction with t-
butyl lithium in tetrahydrofuran at -78 °C (Scheme 99).148  2-4 equivalents of t-butyl 
lithium are required as dependent on substitution more equivalents may be required to 
give quantitative conversion to the vinyl anion.  In order to overcome problems associated 
with the presence of excess t-butyl lithium the α-lithiated enol ether can be converted to a 
stannane which undergoes rapid Li-Sn exchange at low temperature.149  This can be 
purified by chromatography and undergo transmetallation with n-butyl lithium to give the 
desired α-lithiated enol ether. 
 
 
Scheme 99: Formation of the stannane from the enol ether 
 
Another method for the formation of stannanes is to proceed via a triflate e.g. 377 which 
can undergo a copper-mediated coupling to give the desired stannane 378.150  
 
Scheme 100: Copper-mediated coupling to give the desired stannane 
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Before this could only be achieved by the reaction of the enol triflates with Me3SnSnMe3 
in a Stille-type coupling but the tin reagent is very expensive and toxic.  The reaction does 
not facilitate the formation of five membered enol ethers.151  The Stille-type reaction 
gives a volatile tin by-product that is also extremely hazardous. 
 
Another alternative way to form an α-lithio enol ether is via the α-brominated enol ether 
(Scheme 101).  Yu and Lin have demonstrated the addition of HBr to alkynol ethers 
however, this does not work for cyclic systems.152  Kocienski has shown that it is possible 
to use Ni to catalyse the coupling of LiBr to give α-brominated compounds which can 
subsequently be transformed to the corresponding lithium derivative.153  The disadvantage 
here is the instability of the α-bromo enol ethers. 
 
 
Scheme 101: Triflate to lithiated enol conversion 
 
Kocienski has also shown that sulfoxide-lithium exchange is another possible 
transformation that can be employed to facilitate the preparation of metallated enol ethers 
(Scheme 102).154  This was achieved initially by a β-elimination reaction of a 
carbohydrate derivative 382 to give the sulfoxide 383. 
 
 
Scheme 102: Sulfoxide-lithium exchange 
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This has the advantage of being more environmentally friendly than the tin chemistry, and 
is efficient however the requirement of a β-elimination for the vinyl sulfoxide preparation 
reduces the substrate scope.   
 
To overcome the requirement for β-elimination Kocienski et al. have shown that starting 
from the lactone 385, preparing the enol triflate 386 or phosphate and then coupling this 
with sodium arene thiolate in the presence of nickel will give the thioether 387.155  
Subsequent slow addition of m-CPBA afforded the sulfoxide 388 (Scheme 103).  The 
sulfoxide was stable to column chromatography and can be stored for several months, 
unlike the sulfide.   
 
Scheme 103: Ni-catalysed coupling of enol triflate 386 derived from lactone 385 
 
2-Lithio-1,3-dithiane derivatives 390 are some of the most widely-used sulfur-stabilised 
acyl anion equivalents as demonstrated by Corey and Seebach (Scheme 104).156  
 
 
Scheme 104: Nucleophilic attack of a dithiane 
 
Recently Amos Smith et al. have achieved high chemoselectivity with vinyl epoxides by 
taking advantage of the steric properties of the dithiane.  It has been shown that the vinyl 
epoxide 393 will undergo attack at the allylic position A to give 394 if R’ is small (R = H) 
whereas if R’ is large (R = iPr) attack will occur at the terminal end of the alkene B to 
give 395 as outlined in Scheme 105.157 
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Scheme 105: Preferential attack of nucleophiles with differing steric properties 
 
5.2.2. Other α,β-unsaturated acyl anion equivalents 
 
It has been shown by Ito and Taguchi that allylic zirconium species can be used as α,β-
unsaturated acyl anion equivalents (Scheme 106).158  Preparation of γ,γ-dialkoxyallylic 
zirconium species 397 can be achieved by the reaction of triethyl orthoacrylate with a 
zirconocene equivalent.  The reaction proceeds via the formation of a 
zirconacyclopropane intermediate followed by the β-elimination of an alkoxy group.   
 
 
Scheme 106: Preparation of γ,γ-dialkoxyallylic zirconium species 
 
This reaction worked well with a range of aromatic aldehydes but with α,β-unsaturated 
aldehydes lower yields were obtained. 
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5.3 Uses of 4H-1,3-Dioxins in synthesis 
 
Substituted 4H-1,3-dioxins have recently been shown to be effective equivalents of α,β-
unsaturated carbonyl compounds as outlined by Funk.132  6-Bromomethyl-4H-1,3-dioxin 
400 was used as a masked equivalent of an unstable bromomethyl vinyl ketone 399 
(Scheme 107). 
 
 
Scheme 107: Masked vinyl ketone reacting with nucleophile 
 
The bromide 400 underwent the usual substitution reaction, permitting facile introduction 
of a basic nucleophile 401 (Scheme 108).  The remaining β-nucleophilic site could then 
be exposed simply by heating to facilitate the retrocycloaddition reaction, allowing for 
nucleophilic attack at the β-position to give the cyclic ketone 404. 
 
 
Scheme 108: Retro-cycloaddition to reveal desired ketone 
 
The acyl anion equivalent outlined in (Figure 12, page 79) cannot be easily synthesised 
from lithiation of the parent unsaturated system below.  Funk has shown that when dioxin 
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405 is reacted with sec-butyllithium, the metallated dioxin 406 is the sole product with no 
formation of 407 (Scheme 109).159 
 
 
Scheme 109: Lithiation of acyl dioxin 
 
Seebach has developed the use of 1,3-dioxanones in asymmetric synthesis from the 
alkylation of 3-hydroxy-carboxylic acids (Scheme 110).160  Previously, alkylation of 
carboxylic acids was achieved by utilising dilithio-alkoxide enolates.  The dioxanone 
method is superior as only 1 equivalent of strong base is required, the products are 
crystalline and facile preparation of both R and S configurations is possible. 
 
 
Scheme 110: Seebach’s self-reproduction of stereogenic centres 
  
The acid-catalysed reaction of (R)-3-hydroxy-butyric acid 408 with pivaldehyde gives 
409.  The lithium enolate that is generated from 409 is stable at -75 ˚C and does not 
undergo β-elimination.  The Michael addition of dialkyl cuprates gives only one product 
410.  The enantiopure hydroxy-acid product 411 is revealed by unmasking 410 using a 
mild acid. 
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Seebach has extended this work further by using readily available amino acids as starting 
materials to allow the preparation of brominated dioxanones (Scheme 111)161  Retentive 
nucleophilic substitution of serine followed by silylation leads to an intermediate 414.  
This undergoes TMS-triflate catalysed acetalisation of pivaldehyde to give a mixture of 
two diastereoisomers which are separable by column chromatography.  Catalytic 
hydrogenative debromination of the cis-isomer affords the enantiomerically pure 
derivative of 3-hydroxypropanoic acid 417. 
 
 
Scheme 111: Chiral β-Hydroxypropanoic-Acid Derivative from Serine 
 
We hope that the dioxinone 417 could be converted to an acyl anion intermediate by 
reduction of the lactone followed by elimination to give the unsaturated intermediate 418.   
 
5.4 Applications of Meldrum’s Acid to facilitate lactone formation    
 
It was envisaged that 423 (Scheme 112) could be synthesised from the commercially 
available Meldrum’s Acid 419.  The formation of formylated Meldrum’s Acid 421 was 
achieved by reacting Meldrum’s Acid 419 with triethylorthoformate to give the 
intermediate 420 which was then reacted with hydrochloric acid to give the formylated 
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Meldrum’s Acid 421.162, 163  This was reacted with tBuOH but did not yield the 
formylacetic ester 422.164  
 
Scheme 113: Attempted synthesis of a formylacetic ester 422 
 
The preparation of a tosylated Meldrum’s Acid 424 was attempted using conditions 
outlined by Tanabe et al. for effective preparation of β-ketoester enol tosylates (Scheme 
114).165  They report the formation of a highly reactive N-sulfonylammonium 
intermediate from tosylchloride and NMI.  Several variations of the reaction conditions 
were tested but to no avail.  This would have been beneficial as once the intermediate 424 
was formed it would have been potentially possible to do a conjugate reduction-
elimination with Stryker’s reagent.  A further reduction would afford the lactone 425 
which could be converted to the acyl anion equivalent as outlined in Scheme 90, (page 
81).  
 
 
Scheme 114: Attempts to prepare lactone 425 using Stryker’s reagent 
 
The tosylation of Meldrum’s acid 419 was attempted using various bases (triethylamine, 
2,6-lutidine and potassium tert-butoxide).  Tosyl chloride (1.1 to 1.5 equivalents) was 
used as the tosylating agent.  NMI was added in an effort to promote the tosylation and 
halogenated solvents (dichloromethane and chlorobenzene) were used.  The reaction was 
attempted at 0 °C and room temperature for varying times and no combination of reaction 
conditions yielded 424. 
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5.5 Cyclic ketones as a potential route to metallated dioxins 
  
The route below (Scheme 115) was then considered as a possible pathway to metallated 
dioxin 335.  Starting from the amine 431 oxidative cleavage would afford ketone 430.  
Sulfenylation of 430 would give 429 which would subsequently be reduced to yield 
intermediate 428.  This could be converted to the sulfonated moiety 427.  An elimination 
reaction would give 426 and with a metal-sulfoxide exchange would give the metallated 
dioxin 335.   
 
 
Scheme 115: Retrosynthetic analysis of metallated dioxin 335 
 
Yadav et al. report α-sulfenylation of cyclohexanone 432 in the presence of thiophenol 
433.166  However, in our hands, the reaction led only to the formation of a side product, 
diphenyl disulfide 435, therefore the reaction was not attempted with the cyclic ketone 
430 (Scheme 115). 
 
 
Scheme 116: Sulfenylation of cyclohexanone 432 
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Monteiro and Souza prepared β-keto-phenylsulfoxides from the corresponding ketone 
(Scheme 117).167  The reaction was attempted using the cyclic ketone 430 and methyl 
benzenesulfinate 438.  The starting material was consumed and there was no sign of 
product 439 by NMR analysis. 
 
 
Scheme 117: Attempted α-sulfinylation of cyclic ketone 430  
 
It was of interest to investigate the transformation of the cyclic ketone to the tosylate 440 
as this was considered a potential route to the dioxene 441 which could be converted to 
the metallated dioxin 445 as shown in Scheme 118.  This reaction was carried out by 
treatment of 430 with LiAlH4 to give the alcohol 439 which was subsequently reacted 
with p-toluenesulfonyl chloride and pyridine in the presence of a catalytic amount of 
DMAP to give 440.  If 441 had been formed reaction with dimethyldioxirane would have 
afforded the epoxide 442.  Ring opening of 442 with thiophenol would give 428.  The 
stannane 444 could have been prepared from the sulfone 443 by Ni-catalysis.   
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Scheme 118: Preparation of the tosylate 85 from the corresponding cyclic ketone 430 
 
5.5.1 Dioxene Chemistry 
 
It was envisaged that another potential route to lactone 449 could be achieved via a dioxin 
intermediate 448 (Scheme 119).168  Glycerol formal 446 was reacted with p-
toluenesulfonyl chloride and purification by crystallisation gave solely the 6-membered 
ring product 447.  This then underwent an elimination reaction to give the dioxin 448.  
Pyridinium chlorochromate proved ineffective for the oxidation of the dioxin 448 to yield 
449.169  This reaction was difficult to monitor as dioxene 448 has a low b.p. of 76 °C.  
The reaction was monitored by GC and there was no sign of a less volatile product being 
formed. 
 
Scheme 119: Potential route to lactone 449 
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The route below (Scheme 120) was attempted as Funk and Bolton have shown that 4H-
1,3-dioxins can undergo exclusive allylic deprotonation with sec-butyllithium.170  A range 
of sulfenylating agents were screened, diphenyl disulfide 436, phenylsulfenyl chloride 
and phenyl benzenethiosulfonate but all were unsuccessful.  
 
 
Scheme 120: Attempted preparation of sulfenylated 4H-1,3-dioxins 
 
Alkylation of the dioxin 448 (Scheme 121) was unsuccessful in the presence of methyl 
chloroformate.  However, alkylation using bromooctane was successful giving rise to a 
less volatile material.  This material was impossible to purify by column chromatography 
as the bromooctane and product co-elute on silica.  Vacuum distillation did not lead to the 
complete removal of bromooctane. 
 
 
Scheme 121: Attempts to alkylate dioxin 448 
 
It was envisaged that epoxidation of dioxin 448 followed by ring opening in the presence 
of a sulfenylating reagent would give rise to the sulfenylated intermediate 456 (Scheme 
122).  Epoxidation of dioxin 448 was attempted using dimethyldioxirane but this proved 
unsuccessful.171  This was again difficult to monitor as the starting material was volatile.  
Dioxene 448 could potentially undergo oxidative halogenation to give 454, followed by a 
bromide reduction to give lactone 449.  The oxidative halogenation of dioxin 448 looked 
promising by NMR of the crude reaction material (signal between 3-3.5 ppm).172  
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However, upon attempted purification by column chromatography no desired material 
was recovered. 
 
 
Scheme 122: Potential transformations of the dioxene 448 
 
Due to volatility of the dioxin 448, a limiting amount of N-bromosuccinimide was used so 
TLC analysis monitoring the consumption of NBS could be achieved.  Dihydropyran, 2,3-
dihydrofuran and dioxin 448 were all tested for their reactivity in the presence of NBS 
(0.9 equiv.).  The reaction was carried out in DMSO (0.5 M) at room temperature for 2-22 
hours.  The starting material was consumed in the case of the dioxin 448.  No diagnostic 
signal at 3-3.5ppm corresponding to an α-proton next to the bromine for 2,3-dihydrofuran 
was seen in the NMR.  Dihydropyran gave an unidentifiable mixture.  Due to these 
unpromising results it was decided to no longer attempt this transformation.   
 
5.6 Unsaturated Cyclic Acetal Formation 
 
A potential route to lactone 449 was undertaken starting from allyl bromide 460 (Scheme 
123).  Allyl bromide 460 was converted to allyl iodide 461 in a 77% yield.173  This was 
then converted to the cyclic acetal 462 in the presence of paraformaldehyde as outlined by 
Greshock and Funk.132  Initial attempts to form the exocyclic alkene 463 were 
unsuccessful and gave an inseparable mixture of starting material 462 and cyclic alkene 
463.  In the presence of PCC this did not afford lactone 449. 
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Scheme 123: Possible new route to lactone 449 
 
5.6.1 Lactone formation from furanones 
 
Another potential route that we investigated is outlined in Scheme 124, to form lactone 
467.  This would provide a less volatile lactone compared to 449.  It was necessary to 
alkylate the furanone 464 initially in order to avoid volatile intermediates that could have 
proved problematic to isolate.  Conjugate addition to the cyclic furanone 464 was first 
attempted using n-butyl magnesium chloride and CuBr.DMS.174  On a small scale (74 
mg) this gave a 34% yield.  This was not reproducible on a larger scale.  Smith et al. have 
shown that furanone 464 will undergo organocuprate addition to give 465, and this was 
achieved giving the desired product in a 65% yield.175  The cyclic ketone 465 underwent a 
Baeyer-Villiger oxidation to give the lactone 467 in a 34% yield.  Direct Baeyer-Villiger 
oxidation from the furanone 464 was attempted using the same conditions as employed 
for the oxidation of the saturated structure but this did not afford 466.  Instead an 
unidentifiable mixture was obtained. 
 
Scheme 124: Conjugate additions and Baeyer-Villiger oxidations of the cyclic enone 
464 and its derivatives.  
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As a control the lactone 467 was stirred in the presence of PCC for 2 hours and there were 
no signs of decomposition by NMR after this time.  The stability of the acetal group in 
467 to PCC and similar reagents was unknown.  This suggests lactone 449 (Scheme 119) 
would most likely be stable if formed.  
 
5.6.2 Attempted preparation of an acyl anion equivalent from commercially 
available 2,2,6-trimethyl-1,3-dioxin-4-one 468 
 
 
Figure 14: Possible acyl anion equivalent from 468 
 
Kocienski et al. have shown conversion of enol triflates to lithium enolates by the 
addition of Lipshutz mixed cuprate (Scheme 101, page 87).  We hoped to form enol 
triflate 469 from the commercially available 468.  If the triflate 469 was converted to the 
metallated compound 470 (Figure 14) this would give a novel acyl anion equivalent.   
 
Clive and Minaruzzaman176 converted a lactone to an enol triflate using KHMDS and 2-
[N,N-bis(trifluoromethylsulfonylamino]pyridine.  It was thought this methodology would 
be used to yield 469 (Scheme 125).  The triflate 469 could be transformed to the 
corresponding stannane and this would undergo a sulfoxide-lithium exchange to give a 
metallated dioxin similar to that outlined in Figure 14.  Unfortunately, these reaction 
conditions did not lead to trapping of 469.  Attempted silylation in the presence of LDA 
also gave no sign of 471.177 
 
Scheme 125: Attempted triflation of the commercially available dioxinone 469 
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Seebach and Zimmermann hydrogenated the substrate 472 with H2 (30 atm, PtO2).  The 
substrate 472 was synthesised and a PtO2 catalyst was used in the H-Cube.160  It seemed 
that the H-Cube being a flow reactor may not have been suitable for the hydrogenation 
due to low exposure times of the reactant with the catalyst.  Slower flow rates still 
produced only unreacted starting material 472. 
 
 
Scheme 126: Preparation of 472 and the subsequent attempted hydrogenation  
 
Hydrogenation of the commercially available dioxinone 468 was attempted (Scheme 
127).  Several different catalysts (Raney-Ni, Palladium on charcoal and palladium 
hydroxide on charcoal) were tested for the hydrogenation of dioxinone 468 using the H-
Cube hydrogenation flow reactor and the reaction conditions were also altered (50 bar-80 
bar and room temperature to 80 °C).  In each case starting material was recovered with no 
conversion observed at all.  It was considered that the two methyl groups in dioxinone 
468 may have caused steric difficulties in the interaction with the catalyst. 
 
 
Scheme 127: Hydrogenation attempts of dioxinone 468  
 
Another possible way to reduce the dioxinone 468 would be to employ Stryker’s reagent 
(Scheme 128).178  Stryker’s reagent ([(PPh3)CuH]6) is a mild source of hydride and is 
used in the reduction of enones, enol esters and related substrates.  Lipshutz et al. have 
shown that exposure of an enone to a catalytic quantity of Stryker’s reagent in the 
presence of a silane leads to conjugate reduction with concomitant formation of the 
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corresponding silyl enol ether.  Without isolation treatment of these intermediates with an 
activated fluoride source would give the reduced product.  When dioxinone 468 was 
treated with Stryker’s reagent overnight TLC showed starting material still present.  
TBAF was added to one test reaction and no reduction was observed.  It may be that the 
reduction conditions were too mild to facilitate the desired transformation.   
 
 
Scheme 128: Attempted reduction with Stryker’s Reagent 
 
5.6.3 Preparation of Dioxinones to test Dioxin Formation Methodology  
 
Seebach et al. have shown that dioxinones can be formed from 3-hydroxybutanoic acid 
479 (Scheme 129) and the corresponding aldehyde in the presence of pyridinium p-
toluenesulfonate.  The cyclic acetals 475 and 480 are of interest as they are structurally 
similar to the cyclic lactone 344 and would provide a means by which to test the 
methodology outlined in Scheme 90.   
 
Initially 3-hydroxybutanoic acid 479 was formed starting from ethyl acetoacetate 475 
undergoing a reduction to give 476 as shown by Padhi and Chadha179 followed by an ester 
hydrolysis.  The acid 479 was difficult to isolate from the aqueous work up due to the 
polarity of the material and column chromatography was not favourable on a large scale.  
Therefore 479 was synthesised from benzylacetoacetate 477 instead.  The benzyl ester 
was easier to isolate and required no further purification.  The hydrogenation of 478 to 
479 gave a purer sample of 479.   
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Scheme 129: Preparation of the cyclic acetals 473 and 480 
 
Initially 480 was synthesised from the acid 479 but purification was problematic as the 
product decomposes on silica and a dry-ice bath recrystallisation was necessary to isolate 
the product which is a liquid at room temperature.  It was decided that 473 would be 
synthesised as it was envisaged that recrystallisation would be more facile (m.p. 82°C).  
Recrystallisation of 473 proved much easier than 480 so work focussed on this substrate.  
 
With dioxinone 473 in hand we were able to attempt conversion to the acyl anion 
equivalent.  As a control reaction, the commercially available δ-valerolactone 481 was 
triflated to give 482 using the procedure of Kocienski (Scheme 130).  The intermediate 
could be identified by NMR (dd, 4.7 ppm) however purification of this material by 
column chromatography led to decomposition.   
 
 
Scheme 130: Sulfoxidation of δ-valerolactone 481 
 
The crude triflate 482 was therefore reacted on without purification to give the 
sulfenylated enol ether 483.  This was oxidised in the presence of m-CPBA.  This 
transformation of δ-valerolactone 481 to the corresponding sulfoxide 484 was of interest 
as it confirms that cyclic lactones are able to undergo triflation and subsequent 
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transformations and it was therefore anticipated that the cyclic acetal 473 would perhaps 
have similar reactivity to that shown for δ-valerolactone 481.   
 
 
Scheme 131: Attempted triflation of cyclic acetal 473 
 
Triflation of 473 was first attempted using KHMDS to form the potassium enolate 
intermediate and employing N-phenyl-bis(trifluoromethanesulfonimide) as the triflating 
agent (Scheme 131).  This was unsuccessful so LiHMDS/HMPA was used instead of 
KHMDS in the hope that the lithium enolate would be more stable and the desired 
product would be formed.  However this was not the case.  It was of interest to investigate 
this reaction further as it was unclear whether the enolate was being formed at all or if the 
starting material was just decomposing under these reaction conditions.  Alkylation of 
473 was achieved as outlined by Seebach and Zimmermann160 in Scheme 132.  It seems 
that the lithium enolate of 473 formed from reaction with LDA is stable.  It may be that a 
more reactive triflating reagent is required to produce the desired enol triflate.     
 
 
Scheme 132: Alkylation of 430 
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5.7 Conclusion and possible avenues for future investigation 
 
Sulfenylation of the cyclic ketone 430 (Scheme 133) was problematic as was the 
sulfenylation of the dioxene 448.  Aungst, Jr. and Funk have shown α-alkylation of the 
cyclic ketone 430, by first converting the ketone to an imine.180  This suggests that 
sulfenylation is probably not as straight forward as first anticipated.  Sulfenylation could 
be attempted following the alkylation methodology outlined by Funk et al. 
 
 
Scheme 133: Sulfenylation of cyclic lactone 430 
 
Although δ-valerolactone 481 can be converted to the corresponding sulfoxide 484 
(Scheme 130), the initial triflation of the cyclic acetal 473 was difficult.  Having two 
additional carbon-oxygen bonds in the acetal ring may lead to too much strain being 
incurred to allow for introduction of a triflate group in the formation of 485. 
 
Investigations could have been carried out to ascertain the stability of the lithium and 
potassium enolates of 473 and the ease of alkylation and triflation of these moieties.  
Successful triflation would have permitted the methodology outlined in Scheme 90 (page 
81) to be tested. 
 
However, as the viability of this method had not been demonstrated after approximately 
one year of investigation, the project was changed and the sulfamidate work was 
undertaken. 
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Chapter Six - Experimental  
 
6.1 General procedures 
1H NMR spectra were recorded on Bruker AV 300, DPX 400 and AV 400 
spectrometers at 300 and 400 MHz respectively and referenced to residual solvent. 13C 
NMR spectrum were recorded using the same spectrometers at 75 and 100 MHz 
respectively. Chemical shifts (δ
 
in ppm) were referenced to tetramethylsilane (TMS) 
or to residual solvent peaks (CDCl3 at δH 7.26). J values are given in Hz and s, d, dd, 
t, q and m abbreviations correspond to singlet, doublet, doublet of doublet, triplet, 
quartet and multiplet. Mass spectra were obtained at the EPSRC National Mass 
Spectrometry Service Centre in Swansea. Infrared spectra were obtained on Perkin-
Elmer Spectrum 100 FT-IR Universal ATR Sampling Accessory, deposited neat or as 
a chloroform solution to a diamond/ZnSe plate. 
 
Flash column chromatography was carried out using Matrix silica gel 60 from Fisher 
Chemicals and TLC was performed using Merck silica gel 60 F254 precoated sheets 
and visualised by UV (254 nm) or stained by the use of aqueous acidic KMnO4. 
Anhydrous dichloromethane (DCM) and anhydrous dichloroethane (DCE) was 
distilled from CaH2.  
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6.1.1 Experimental for Chapter 2 
 
Burgess reagent (119)92 
 
 
 
Anhydrous methanol (2.5 g, 3.1 mL) in benzene (30 mL) was added dropwise to a 
solution of chlorosulfonyl isocyanate (10 g, 71 mmol) in benzene (30 mL) dropwise over 
30 minutes.  The reaction mixture was concentrated in vacuo and the 
carbomethoxysulfamoyl chloride was dissolved in benzene (170 mL) and was added 
dropwise to a solution of triethylamine (18.0 g, 178 mmol) in benzene (80 mL).  After the 
addition was complete (1 hour), the mixture was filtered.  The filtrate was concentrated in 
vacuo to afford the title compound as a white solid (15.8 g, 67 mmol, 94%).  δH (300 
MHz, CDCl3) 3.70 (s, 3H), 3.47 (q, J = 7.3 Hz, 6H), 1.41 (t, J = 7.3 Hz, 9H); δC (75 MHz, 
CDCl3) 157.8 (C=O), 55.7 (CH2), 51.2 (CH3), 9.6 (CH3);  m.p. 76 °C (lit. m.p. 76-79 °C).  
 
(2S,3S,4S,5S)-1,6-dibromohexane-2,3,4,5-tetrayl tetraacetate (198)181 
 
 
 
D-mannitol 197 (20 g, 0.1 mol) was suspended in dry dioxane (150 mL).  Acetyl bromide 
(32.4 g, 19.5 mL, 0.3 mmol) was added slowly and stirred for 4 days at room temperature.  
The solution was heated to 40 °C and stirred for 4 hours.  The room temperature reaction 
mixture was concentrated in vacuo.  The residue was dissolved in dry pyridine (100 mL) 
and acetic anhydride (89.6 g, 82 mL, 0.9 mol) was added slowly.  The reaction mixture 
was stirred overnight, concentrated in vacuo and recrystallised using ethanol affording the 
title compound as a white solid (18.9 g, 39.6 mmol, 36%).  δH (300 MHz, CDCl3) 5.42 (d, 
J = 8.3 Hz, 2H), 5.18 – 5.04 (m, 2H), 3.55 (dd, J = 11.6, 3.6 Hz, 2H), 3.36 (dd, J = 11.6, 
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6.0 Hz, 2H), 2.12 (d, J = 3.2 Hz, 12H); δC (75 MHz, CDCl3) 169.8 (C=O), 169.7 (C=O), 
69.1 (CH), 68.9 (CH), 30.6 (CH2), 20.8 (CH3), 20.7 (CH3); νmax/cm-1 2976, 1746, 1428, 
1370, 1207, 1045; m.p. 77 °C (lit. m.p. 76-78 °C). 
 
Hexa-1,5-diene-3,4-diyl diacetate (199)93 
 
 
 
(2S,3S,4S,5S)-1,6-Dibromohexane-2,3,4,5-tetrayl tetraacetate 198 (7.0 g, 14.7 mmol) was 
dissolved in glacial acetic acid (70 mL).  Sodium acetate (4.4 g, 32.3 mmol) and zinc dust 
(3.9 g, 58.8 mmol) were added.  The mixture was heated to 110 °C until the evolution of 
gas ceased and the solution became clear (1 hour).  After cooling, the zinc dust was 
filtered off and the acetic acid removed under reduced pressure.  The residue was 
dissolved in water and extracted with diethyl ether (3 x 50 mL).  The combined organic 
layer was washed with saturated sodium bicarbonate solution, dried (MgSO4) and 
concentrated in vacuo affording the title compound as a yellow oil (2.9 g, 14.7 mmol, 
99%).  δH (300 MHz, CDCl3) 5.76 (ddd, J = 15.0, 10.5, 5.4 Hz, 2H), 5.44 – 5.22 (m, 6H), 
2.08 (s, 6H); δC (75 MHz, CDCl3) 169.8 (C=O), 132.1 (CH), 119.2 (CH2), 74.4 (CH), 
20.9 (CH3); b.p. 70 °C at 5 mbar (lit. b.p. 59-61°C at 0.8 mbar). 
 
2-Hydroxybut-3-en-1-yl 4-methylbenzenesulfonate (205)182 
 
 
 
3,4-Dihydroxy-1-butene 204 (1.5 g, 17.0 mmol) was dissolved in pyridine (90 mL).  At -
20 °C, tosyl chloride (3.9 g, 20.4 mmol) in pyridine (45 mL) was added dropwise over 40 
minutes.  The mixture was allowed to reach room temperature over 2 hours and stirred for 
20 hours.  The mixture was concentrated in vacuo and dissolved in ethyl acetate.  The 
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solution was washed with water, hydrochloric acid (1M), saturated sodium bicarbonate 
solution and brine.  The reaction mixture was dried (Na2SO4) and concentrated in vacuo.  
Purification by column chromatography (2:1 petroleum ether/ethyl acetate) afforded the 
title compound as a colourless liquid (2.9 g, 11.8 mmol, 69%).  δH (300 MHz, CDCl3) 
7.82 (d, J = 8.3 Hz, 2H), 7.38 (d, J = 8.4 Hz, 2H), 5.78 (ddd, J = 17.2, 10.6, 5.5 Hz, 1H), 
5.40 (dt, J = 17.3, 1.2 Hz, 1H), 5.27 (dd, J = 10.5, 1.2 Hz, 1H), 4.44 – 4.35 (m, 1H), 4.09 
(dd, J = 10.2, 3.4 Hz, 1H), 3.93 (dd, J = 10.3, 7.4 Hz, 1H), 2.47 (s, 3H); δC (400 MHz, 
CDCl3) 145.4 (C), 134.9 (C), 132.4 (CH), 128.9 (CH), 127.5 (CH), 117.9 (CH2), 72.7 
(CH), 70.0 (CH2), 21.6 (CH3); νmax/cm-1 2359, 1206, 1147, 758, 749. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
110 
 
6.1.2 Experimental for Chapter 3 
 
1-Cyclohexylpenta-3,4-dien-1-ol (215)183 
 
 
 
1-Cyclohexylbut-3-yn-1-ol 214 (1.2 g, 7.6 mmol), paraformaldehyde (522 mg) 
diisopropylamine (2.21 mL, 1.58 g, 15.66 mmol) and dry dioxane (20 mL) were placed in 
a round bottomed flask.  Copper(I) bromide (362 mg, 4.35 mmol) was added to the 
stirring solution and the solution refluxed for 5 hours.  The reaction mixture was filtered 
through silica with diethyl ether.  Purification by column chromatography (8:1 petroleum 
ether / ethyl acetate to ethyl acetate) giving the desired material as a yellow oil (210 mg, 
1.3 mmol, 15%).  δH (400 MHz, CDCl3) 5.18-5.12 (m, 1H), 4.75 – 4.67 (m, 2H), 3.49 – 
3.37 (m, 1H), 2.33 – 2.20 (m, 1H), 2.18 – 2.04 (m, 1H), 1.95 – 1.81 (m, 1H), 1.81 – 1.70 
(m, 1H), 1.70 – 1.60 (m, 2H), 1.46 – 1.32 (m, 2H), 1.32 – 0.97 (m, 6H); δC (75 MHz, 
CDCl3) 209.3 (C), 86.7 (CH), 75.3 (CH), 74.8 (CH2), 43.0 (CH), 33.6 (CH2), 29.1 (CH2), 
28.1 (CH2), 26.5 (CH2), 26.3 (CH2), 26.2 (CH2); νmax/cm-1 3380, 3052, 2923, 1949, 836. 
 
1-Cyclohexylpenta-3,4-dien-1-yl sulfamate (216) 
 
 
 
Under an inert atmosphere (nitrogen), formic acid (87 µmol, 2.3 mmol) was added drop 
wise to chlorosulfonyl isocyanate (0.2 mL, 2.3 mmol) with vigorous stirring at 0 °C.  
Acetonitrile (1.2 mL) was added and the reaction mixture warmed to room temperature 
111 
 
and stirred overnight.  The reaction mixture was cooled to 0 °C and a solution of 1-
cyclohexylpenta-3,4-dien-1-ol 215 (220 mg, 1.3 mmol) in dimethylacetamide (0.5 mL).  
The reaction mixture was stirred for 24 hours.  The reaction mixture was diluted using 
diethyl ether (2 mL) and quenched with saturated sodium chloride solution (1 mL).  This 
was added to a solution of diethyl ether (4 mL) and water (1.5 mL).  The separated 
aqueous phase was further extracted with diethyl ether (2 mL).  The combined organic 
phase was washed with saturated sodium chloride solution (2 x 1.5 mL), dried (Na2SO4) 
and concentrated in vacuo.  Purification by column chromatography (8:1 petroleum 
ether/ethyl acetate to 4:1 petroleum ether/ethyl acetate) afforded the title compound as a 
white solid (191 mg, 0.8 mmol, 60%).  δH (400 MHz, CDCl3) 5.20 – 5.13 (m, 1H), 4.79 – 
4.73 (m, 2H), 4.68 (s, 2H), 4.52 – 4.47 (m, 1H), 2.63 – 2.41 (m, 2H), 1.95 – 1.66 (m, 6H), 
1.37 – 1.03 (m, 5H); δC (75 MHz, CDCl3) 209.6 (C), 88.2 (CH), 85.0 (CH), 75.1 (CH2), 
40.4 (CH), 30.6 (CH2), 28.6 (CH2), 27.9 (CH2), 26.2 (CH2), 26.0 (CH2), 25.9 (CH2); 
νmax/cm-1 3277, 2927, 2854, 1645, 1408, 1361, 1175, 870; m/z (ESI+) 280 (M + Cl-, 
100%), 244 (70%); HRMS (ESI+) found 280.0774, C11H19O3NClS (M + Cl)- requires 
280.0780. 
 
6-Cyclohexyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (217) 
 
 
 
Under an inert atmosphere (nitrogen), 1-cyclohexylpenta-3,4-dien-1-yl sulfamate 216 (50 
mg, 0.20 mmol) was dissolved in dry dichloromethane (0.7 mL).  PPh3AuCl (5 mg, 10.2 
µmol) and AgOTf (2.6 mg, 10.2 µmol) was added and the reaction mixture was stirred for 
48 hours, then filtered through a plug of silica with diethyl ether and concentrated in 
vacuo.  Purification by column chromatography (2:1 hexane/dichloromethane to 1:2 
hexane/dichloromethane) afforded the title compound as separable diastereoisomers (37 
mg, 0.15 mmol, 74%, cis/trans 1.7:1).   
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cis-2: white solid; Rf 0.31 (2:1 dichloromethane/hexane); m.p. 91 °C; δH (400 MHz, 
CDCl3) 5.81 (ddd, J = 17.3, 10.6, 5.1 Hz, 1H), 5.38 - 5.18 (m, 2H), 4.56 (ddd, J = 11.9, 
6.4, 2.0 Hz, 1H), 4.31 - 4.17 (m, 1H), 3.98 (d, J = 10.3 Hz, 1H), 1.98 - 1.43 (m, 8H), 1.36 
- 0.96 (m, 5H); δC (101 MHz, CDCl3) 135.3 (CH), 117.3 (CH2), 88.3 (CH), 56.4 (CH), 
42.2 (CH), 32.5 (CH2), 28.3 (CH2), 28.0 (CH2), 26.3 (CH2), 25.9 (CH2), 25.7 (CH2); 
νmax/cm-1 3276, 2927, 2852, 1650, 1436, 1347, 1175;  m/z (ESI+) 263 (M + NH4+, 100%), 
246 (15%); HRMS (ESI+) found 263.1428, C11H23O3N2S (M + NH4)+ requires 263.1424.  
 
trans-2: colourless oil; Rf 0.15 (2:1 dichloromethane/hexane) δH (400 MHz, CDCl3) 6.18 
(ddd, J = 17.4, 10.7, 5.5 Hz, 1H), 5.28 (ddd, J = 10.7, 1.9, 0.7 Hz, 1H), 5.25 (ddd, J = 
17.4, 1.8, 0.7 Hz, 1H), 4.67 – 4.56 (m, 1H), 4.48 (d, J = 6.6 Hz, 1H), 4.29 - 4.13 (m, 1H), 
2.08 – 1.91 (m, 1H), 1.99 - 1.92 (m, 1H), 1.88 (ddd, J = 14.5, 3.9, 2.9 Hz, 1H), 1.83 - 1.61 
(m, 5H), 1.34 - 0.96 (m, 5H); δC (101 MHz, CDCl3) 136.0 (CH), 117.2 (CH2), 86.3 (CH), 
55.3 (CH), 41.7 (CH), 30.4 (CH2), 28.4 (CH2), 28.2 (CH2), 26.3 (CH2), 25.8 (CH2), 25.6 
(CH2); νmax/cm-1 3277, 2927, 2854, 1645, 1408, 1361, 1175, 870; m/z (ESI+) 263 (M + 
NH4+, 100%), 246 (15%), 149 (15%); HRMS (ESI+) found 263.1428, C11H23O3N2S (M + 
NH4)+ requires 263.1424. 
 
1-Cyclohexylbut-3-yn-1-ol (214)184   
 
 
 
Under an inert atmosphere (nitrogen), magnesium (1.3 g, 52.8 mmol) was dissolved in 
dry ether (10 mL).  Mercuric chloride (5 mg, 18.4 µmol) and propargyl bromide (80% wt 
in toluene) (0.2 mL, 0.2 g, 1.8 mmol) was added.  The reaction mixture was warmed with 
stirring until the reaction began, evidenced by the boiling of ether.  The reaction mixture 
was cooled to -25 °C.  A solution of cyclohexanecarboxaldehyde 218 (2.7 g, 2.9 mL, 23.8 
mmol) and propargyl bromide (80% wt in toluene) (3.3 mL, 4.4 g, 29.6 mmol) dissolved 
in dry diethyl ether (10 mL) was added dropwise to the flask over 2 hours.  The reaction 
mixture was warmed to room temperature and stirred overnight.  The reaction was 
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quenched by the addition of ice and saturated ammonium chloride solution.  The aqueous 
layer was separated and further extracted with diethyl ether (2 x 25 mL) and the combined 
organic phase dried (Na2SO4) and concentrated in vacuo.  Purification by column 
chromatography (8:1 petroleum ether/ethyl acetate) afforded the title compound (3.2 g, 
21.0 mmol, 88%). δH (400 MHz, CDCl3) 3.54-3.44 (m, 1H), 2.50 – 2.32 (m, 3H), 2.09 
(dd, J = 2.7, 2.7 Hz, 1H), 1.98 – 1.63 (m, 4H), 1.56 – 1.43 (m, 1H), 1.34 – 0.95 (m. 6H); 
δC  (75 MHz, CDCl3) 81.3 (C), 74.0 (CH), 70.7 (CH), 42.5 (CH), 29.0 (CH2), 28.2 (CH2), 
26.4 (CH2), 26.1 (CH2), 26.0 (CH2), 24.6 (CH2); νmax/cm-1 3309, 2925, 2853, 2250, 1450, 
906. 
 
(E)-1-Phenylhex-1-en-5-yn-3-ol (220)185 
 
 
 
Under an inert atmosphere (nitrogen), to a stirring solution of aluminium (183 mg, 6.8 
mmol) in dry tetrahydrofuran (3.5 mL) was added mercuric chloride (few crystals) 
followed by a solution of propargyl bromide (80% wt in toluene) (1.1 mL, 9.8 mmol) in 
dry tetrahydrofuran (1.5 mL).  The mixture was stirred at 40°C for 30 minutes.  Trans-
cinnamaldehyde 219 (1 g, 7.6 mmol) in dry tetrahydrofuran (1.5 mL) was added and 
stirred at 40 °C for 30 minutes.  The mixture was poured into ice-water (10 mL) and 
saturated ammonium chloride solution (10 mL) and extracted with diethyl ether (3 x 5 
mL).  The combined organic layer was washed with brine (10mL) and dried (MgSO4).  
Purification by column chromatography (6:1 petroleum ether/ethyl acetate) afforded the 
title compound as a yellow oil (1.1 g, 6.6 mmol, 87%).  δH (300 MHz, CDCl3) 7.45 – 7.19 
(m, 5H), 6.67 (dd, J = 15.9, 0.9 Hz, 1H), 6.29 (dd, J = 15.9, 6.3 Hz, 1H), 4.52 – 4.46 (m, 
1H), 2.68 – 2.45 (m, 2H), 2.12 (s, 1H), 2.09 (dd, J = 2.7, 2.7 Hz, 1H); δC (75 MHz, 
CDCl3) 135.3 (C), 130.3 (CH), 129.0 (CH), 127.6 (CH), 126.9 (CH), 125.6 (CH), 79.2 
(C), 70.1 (CH), 69.7 (CH), 27.8 (CH2); νmax/cm-1 3570, 3376, 3271, 2118, 1802, 1591, 
1484, 1072. 
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6-Methylhept-1-yn-4-ol (222)186  
 
 
 
Under an inert atmosphere (nitrogen), magnesium (1.3 g, 52.8 mmol) was dissolved in 
dry diethyl ether (10 mL).  Mercuric chloride (5.3 mg, 19.5 µmol) and propargyl bromide 
(80% wt in toluene (0.2 mL, 0.2 g, 1.8 mmol) was added.  The reaction mixture was 
warmed with stirring until the reaction began, evidenced by the boiling of ether.  The 
reaction mixture was cooled to -78 °C and a solution of isovaleraldehyde 221 (2.6 mL, 
2.1 g, 23.8 mmol) and propargyl bromide (80% wt in toluene) (3.3 mL, 4.4 g, 29.6 mmol) 
dissolved in dry diethyl ether (10 mL) was added dropwise and stirred for 2 hours before 
warming to room temperature and stirring for a further 1 hour.  The reaction was 
quenched by the addition of saturated ammonium chloride and the organic phase 
separated.  The aqueous phase was further extracted with diethyl ether (2 x 25 mL) and 
the combined organic phase dried (Na2SO4).  Purification by column chromatography 
(8:1 petroleum ether/ethyl acetate to 1:1 petroleum ether/ethyl acetate) affording the title 
compound as a yellow oil (1.7 g, 13.7 mmol, 58%).  δH (300 MHz, CDCl3) 3.85 (m, 1H), 
2.43 (ddd, J = 16.7, 4.6, 2.6 Hz, 1H), 2.30 (ddd, J = 16.7, 6.7, 2.7 Hz, 1H), 2.06 (dd, J = 
2.7, 2.7 Hz, 1H), 1.87 – 1.83 (m, 1H), 1.78 (m, 1H), 1.49 (m, 1H), 1.32 (m, 1H), 0.94 (d, 
J = 2.4 Hz, 3H), 0.92 (d, J = 2.3 Hz, 3H); δC (75 MHz, CDCl3) 80.9 (C), 70.8 (CH), 68.0 
(CH), 45.4 (CH2), 27.9 (CH2), 24.7 (CH), 23.3 (CH3), 22.1 (CH3). νmax/cm-1 3311, 2957, 
2927, 2869, 1726, 1468, 757. 
 
 
 
 
 
 
 
115 
 
2,2-Dimethylhex-5-yn-3-ol (224)187  
 
 
 
Under an inert atmosphere (nitrogen), magnesium (1.3 g, 52.8 mmol) was dissolved in 
dry diethyl ether (10 mL).  Mercuric chloride (5.3 mg, 19.5 µmol) and propargyl bromide 
(80% wt in toluene (0.2 mL, 0.2 g, 1.8 mmol) were added.  The reaction mixture was 
warmed with stirring until the reaction began, evidenced by the boiling of ether.  The 
reaction mixture was cooled to -25 °C and a solution of pivaldehyde 223 (2.6 mL, 2.1 g, 
23.8 mmol) and propargyl bromide (80% wt in toluene) (3.3 mL, 4.4 g, 29.6 mmol) 
dissolved in dry diethyl ether (10 mL) was added dropwise over a 2 hour period before 
warming to room temperature and stirring overnight.  The reaction was quenched by the 
pouring into an ice and saturated ammonium chloride solution.  The separated aqueous 
phase was further extracted with diethyl ether (2 x 25 mL) and the combined organic 
phase dried (Na2SO4).  Purification by column chromatography (8:1 petroleum ether/ethyl 
acetate to 1:1 petroleum ether/ethyl acetate) affording the title compound as a yellow oil 
(1.0 g, 7.9 mmol, 33%).  δH (300 MHz, CDCl3) 3.51 – 3.39 (m, 1H), 2.44 (m, 1H), 2.25 
(m, 1H), 2.12 – 2.01 (m, 2H), 0.92 (s, 9H); δH (75 MHz, CDCl3) 82.3 (CH), 77.3 (C), 70.2 
(CH), 34.4 (C), 25.4 (CH2), 20.1 (CH3); νmax/cm-1 3307, 2954, 2923, 2854, 1719, 1463. 
 
1-Phenylhex-5-yn-3-ol (226)188  
 
 
 
Magnesium (668 mg, 27.5 mmol) was dissolved in dry diethyl ether (5.5 mL) and 
mercuric chloride (2.9 mg, 10.7 µmol) was added followed by propargyl bromide (80% 
wt. in toluene) (0.2 g, 0.2 mL, 2.2 mmol).  The reaction was warmed with stirring until 
the reaction began, as evidenced by the boiling of ether.  The reaction mixture was cooled 
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to -25 °C.  A solution of hydrocinnamaldehyde 225 (2.3 g, 2.3 mL, 17.2 mmol) and 
propargyl bromide (80% wt in toluene) (3.1 g, 2.3 mL, 20.2 mmol) in diethyl ether (5.5 
mL) was added dropwise over 15 minutes.  After 2 hours the flask was warmed to room 
temperature and stirring continued overnight.  The reaction mixture was poured into ice-
water and sat ammonium chloride solution was added.  The separated aqueous layer was 
further extracted with diethyl ether (2 x 30 mL), the combined organic phase was dried 
(Na2SO4) and concentrated in vacuo.  Purification by column chromatography afforded 
the title compound as a yellow oil (2.9 g, 16.8 mmol, 98%).  δH (300 MHz, CDCl3) 7.39 – 
7.16 (m, 5H), 3.95 – 3.73 (m, 1H), 2.94 – 2.65 (m, 2H), 2.57 – 2.31 (m, 2H), 2.10 – 2.06 
(m, 1H), 1.99 (s, 1H), 1.94 – 1.87 (m, 2H); δc (75 MHz, CDCl3) 141.7 (C), 128.5 (CH), 
128.5 (CH), 126.0 (CH), 80.7 (C), 71.0 (C), 69.1 (CH), 37.8 (CH2), 31.9 (CH2), 27.5 
(CH2). νmax/cm-1 3386, 3293, 1496, 1455, 1051, 746, 698. 
 
(E)-1-Phenylhepta-1,5,6-trien-3-ol (227)189 
 
 
 
Under an inert atmosphere (nitrogen), (E)-1-phenylhex-1-en-5-yn-3-ol 220 (1.0 g, 5.8 
mmol), paraformaldehyde (348 mg) and diisopropylamine (1.5 mL, 1.1 g, 10.4 mmol) 
were dissolved in dry dioxane (13 mL).  Copper bromide (250 mg, 2.9 mmol) was added 
and the reaction mixture refluxed for 2 hours before being filtered through a plug of silica 
using diethyl ether.  Purification by column chromatography (4:1 petroleum ether/ethyl 
acetate) afforded the desired material as a yellow oil (401 mg, 2.2 mmol, 37%).  δH (300 
MHz, CDCl3) 7.44 – 7.20 (m, 5H), 6.63 (dd, J = 15.9, 1.0 Hz, 1H), 6.25 (dd, J = 15.9, 6.3 
Hz, 1H), 5.24 – 5.08 (m, 1H), 4.79 - 4.75 (m, 2H), 4.49 – 4.30 (m, 1H), 2.42 – 2.27 (m, 
2H); δc (75 MHz, CDCl3) 209.6 (C), 136.7 (C), 131.3 (CH), 130.6 (CH), 128.6 (CH), 
127.7 (CH), 126.5 (CH), 85.7 (CH), 72.1 (CH), 67.1 (CH2), 36.7 (CH2). νmax/cm-1 3374, 
3056, 1954, 1598, 1494, 967, 845, 747. 
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1-Phenylhepta-5,6-dien-3-ol (228)183 
 
 
 
Under an inert atmosphere (nitrogen), 1-phenylhex-5-yn-3-ol 226 (2.2 g, 12.4 mmol) 
paraformaldehyde (691 mg) and diisopropylamine were dissolved in dry dioxane (25 
mL).  Copper(I) bromide (831 mg, 5.8 mmol) was added and the reaction mixture 
refluxed for 5 hours before being filtered through a plug of silica using diethyl ether.  
Purification by column chromatography (8:1 petroleum ether/ethyl acetate to 4:1 
petroleum ether/ethyl acetate) afforded the desired material as a clear oil (1.0 g, 5.5 
mmol, 48%).  δH (300 MHz, CDCl3) 7.35 – 7.14 (m, 5H), 5.21 – 5.05 (m, 1H), 4.75 – 
4.71 (m, 2H), 3.84 – 3.60 (m, 1H), 2.90 – 2.61 (m, 2H), 2.33 – 2.07 (m, 2H), 1.89 – 1.74 
(m, 2H), 1.69 (s, 1H); δC (75 MHz, CDCl3) 209.4 (C), 142.0 (C), 128.3 (CH),127.8 (CH), 
125.7 (CH), 85.8 (CH), 75.3 (CH2), 70.2 (CH), 38.2 (CH2), 36.5 (CH2), 32.1 (CH2); 
νmax/cm-1 3384, 3056, 2947, 2855, 1952. 
 
(E)-non-5-en-1-yn-4-ol (229)190 
 
 
 
Under an inert atmosphere (nitrogen), to a stirring solution of aluminium (366 mg, 13.6 
mmol) in dry tetrahydrofuran (7.0 mL) was added mercuric chloride (44 mg) followed by 
a solution of propargyl bromide (80% wt in toluene) (1.7 mL, 15.1 mmol) in dry 
tetrahydrofuran (3.0 mL).  The mixture was stirred at 40 °C for 30 minutes.  Trans-2-
hexen-1-al (1.9 g, 19.7 mmol) in dry tetrahydrofuran (3.0 mL) was added and stirred at 40 
°C for 30 minutes.  The mixture was poured into ice-water (20 mL) and saturated 
ammonium chloride solution (20 mL) and extracted with diethyl ether (3 x 5 mL).  The 
combined organic layer was washed with brine (10mL) and dried (MgSO4).  Purification 
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by column chromatography (8:1 petroleum ether/ethyl acetate) afforded the title 
compound as a colourless oil (900 mg, 6.5 mmol, 43%).  δH (300 MHz, CDCl3) 5.77 (dtd, 
J = 15.4, 6.7, 0.9 Hz, 1H), 5.57 (ddt, J = 15.4, 6.6, 1.3 Hz, 1H), 4.51 – 4.19 (m, 1H), 2.58 
– 2.36 (m, 2H), 2.16 – 2.01 (m, 3H), 1.94 (d, J = 3.6 Hz, 1H), 1.53 – 1.35 (m, 2H), 0.93 
(t, J = 7.3 Hz, 3H); δC (75 MHz, CDCl3) 133.2 (CH), 130.8 (CH), 80.6 (CH), 77.2 (C), 
70.8 (CH), 34.2 (CH2), 27.7 (CH2), 22.2 (CH2), 13.6 (CH3); νmax/cm-1 3309, 2960, 2929, 
2874, 1722, 1458, 1380, 1248, 1098, 1034, 968; m/z (ESI+) 156 (M + NH4+, 70%), 138 
(M+, 100%); HRMS (ESI+) found 156.1384, C9H18ON (M + NH4)+ requires 156.1383. 
 
(E)-deca-1,2,6-trien-5-ol (230) 
 
 
 
Under an inert atmosphere (nitrogen), (E)-non-5-en-1-yn-4-ol 229 (759 mg, 5.5 mmol), 
paraformaldehyde (330 mg) and diisopropylamine (1.0 g, 1.4 mL, 9.9 mmol) were 
dissolved in dry dioxane (12 mL).  Copper(I) bromide (229 mg, 2.8 mmol) was added and 
the reaction mixture refluxed for 6 hours.  The reaction mixture was filtered through a 
plug of silica using diethyl ether and concentrated in vacuo.  Purification by column 
chromatography (8:1 petroleum ether/ethyl acetate) afforded the title compound as a clear 
oil (439 mg, 2.9 mmol, 52%).  δH (400 MHz, CDCl3) 5.69 (dtd, J = 15.4, 6.7, 1.1 Hz, 1H), 
5.49 (ddt, J = 15.4, 6.7, 1.4 Hz, 1H), 5.16 – 5.04 (m, 1H), 4.76 – 4.70 (m, 2H), 4.21 – 
4.11 (m, 1H), 2.30 – 2.19 (m, 2H), 2.07 – 1.96 (m, 2H), 1.47 – 1.33 (m, 2H), 0.90 (t, J = 
7.4 Hz, 3H); δC (100 MHz, CDCl3) 209.5 (C), 132.4 (CH), 132.0 (CH), 85.9 (CH), 74.8 
(CH2), 72.2 (CH), 36.7 (CH2), 34.3 (CH2), 22.3 (CH2), 13.6 (CH3); νmax/cm-1 3315, 2931, 
2864, 1948, 1714, 1458, 862; m/z (ESI+) 152 (M+, 100%), 135 (30%); HRMS (ESI+) 
found 170.1541, C10H20ON (M + NH4)+ requires 170.1539. 
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1-(Buta-2,3-dien-1-yl)cyclohexanol (232)191  
 
 
 
Under an inert atmosphere (nitrogen), 1-(prop-2-yn-1-yl)cyclohexanol 231 (1.2 g, 8.7 
mmol), paraformaldehyde (522 mg) and diisopropylamine (1.6 g, 2.2 mL, 15.7 mmol) 
were dissolved in dry dioxane (19 mL).  Copper(I) bromide (362 mg, 4.35 mmol) was 
added and the reaction mixture refluxed for 6 hours.  The reaction mixture was filtered 
through a plug of silica using diethyl ether and concentrated in vacuo.  Purification by 
column chromatography (8:1 petroleum ether/ethyl acetate) afforded the title compound 
as a white solid (443 mg, 2.9 mmol, 33%).  δH (400 MHz, CDCl3) 5.22 – 5.12 (m, 1H), 
4.72 - 4.68 (m, 2H), 2.17 (ddd, J = 8.0, 2.5, 2.5 Hz, 2H), 1.97 – 1.34 (m, 10H); δC (100 
MHz, CDCl3) 210.0 (C), 84.8 (CH), 73.9 (CH2), 71.4 (C), 41.6 (CH2), 37.2 (CH2), 25.8 
(CH2), 22.2 (CH2); vmax/cm-1 3365, 1953, 1145, 1054, 783, 734. 
 
2-Methylocta-6,7-dien-4-ol (233)192 
 
 
 
Under an inert atmosphere (nitrogen), 6-methylhept-1-yn-4-ol 222 (1.5 g, 11.9 mmol), 
paraformaldehyde (715 mg) and diisopropylamine (3.0 mL, 2.1 g, 21.4 mmol) were 
dissolved in dry dioxane (26 mL).  Copper bromide (860 mg, 6.0 mmol) was added to the 
stirring solution and the solution was refluxed for 5 hours before being filtered through a 
silica plug using diethyl ether.  Purification by column chromatography (8:1 petroleum 
ether/ethyl acetate to ethyl acetate) gave the desired material as a yellow oil (672 mg, 4.8 
mmol, 40%).  δH (400 MHz, CDCl3) 5.20 – 5.08 (m, 1H), 4.76 – 4.70 (m, 2H), 3.85 – 
3.71 (m, 1H), 2.28 – 2.04 (m, 2H), 1.87 – 1.72 (m, 1H), 1.46 – 1.42 (m, 1H), 1.30-1.25 
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(m, 1H), 0.96 (d, J = 4.6 Hz, 3H), 0.95 (d, J = 4.6 Hz, 3H); δC (75 MHz, CDCl3) 209.5 
(C), 86.3 (CH), 74.9 (CH2), 69.3 (CH), 46.0 (CH2), 37.1 (CH2), 22.2 (CH), 17.6 (CH3) 
17.3 (CH3); νmax/cm-1 3353, 2956, 2924, 1957, 1468, 1367, 840.8. 
 
2,2-Dimethylhepta-5,6-dien-3-ol (234)193 
 
 
 
Under an inert atmosphere (nitrogen), 2,2-dimethylhex-5-yn-3-ol (1.0 g, 7.9 mmol), 
paraformaldehyde (473 mg) and diispropylamine (2.0 mL, 1.4 g, 14.1 mmol) were 
dissolved in dry dioxane (17 mL).  Copper bromide (569 mg, 4.0 mmol) was added and 
the reaction mixture refluxed for 5 hours.  The reaction mixture was flushed through a 
plug of silica using diethyl ether.  Purification by column chromatography (8:1 petroleum 
ether/ethyl acetate to 2:1 petroleum/ethyl acetate) gave the desired material as a yellow oil 
(461 mg, 3.3 mmol, 42%).  δH (400 MHz, CDCl3) 5.24 – 5.12 (m, 1H), 4.78 – 4.69 (m, 
2H), 3.30 (ddd, J = 10.6, 3.7, 2.1 Hz, 1H), 2.36 – 2.20 (m, 1H), 2.05 – 1.92 (m, 1H), 0.93 
(s, 9H); δC (75 MHz, CDCl3) 208.7 (CH2), 87.8 (CH), 74.7 (C), 73.3 (CH), 35.7 (CH2), 
31.2 (C), 20.1 (CH3); νmax/cm-1 3377, 2959, 2873, 1726, 1657, 1479, 1467, 1366, 1175, 
1076. 
 
Hexa-4,5,dien-1-ol (236)194  
 
 
 
Under an inert atmosphere (nitrogen), 4-pentyn-1-ol 235 (1.0 g, 12.0 mmol), 
paraformaldehyde (714 mg) and diisopropylamine (3.0 mL, 2.2 g, 21.3 mmol) were 
dissolved in dioxane (23 mL).  Copper(I) bromide (500 mg, 6.0 mmol) was added and the 
reaction mixture refluxed for 6 hours.  The room temperature reaction mixture was 
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filtered through a plug of silica with diethyl ether and concentrated in vacuo. Purification 
by column chromatography (4:1 petroleum ether/ethyl acetate) afforded the title 
compound as a clear oil (556 mg, 5.7 mmol, 48%).  δH (300 MHz, CDCl3) 5.17 – 5.12 (m, 
1H), 4.74 – 4.62 (m, 2H), 3.71 – 3.67 (m, 2H), 2.18 – 2.02 (m, 2H), 1.78 – 1.62 (m, 2H), 
1.35 (s, 1H); δC (75 MHz, CDCl3) 208.5 (C), 89.4 (CH), 75.1 (CH2), 62.3 (CH2), 31.9 
(CH2), 24.5 (CH2); νmax/cm-1 3325, 2938, 1956, 1437, 1169, 1056, 977. 
 
4-Methylpent-2-yn-1-ol (238)195 
 
 
 
To a solution of 3-methyl-1-butyne 237 (2.5 g, 36.7 mmol, 3.8 mL) in tetrahydrofuran (47 
mL) at -78 °C was added a solution of n-butyllithium in hexanes (2.5 M; 14.7 mL) over 
10 minutes.  The reaction mixture was stirred at -78°C for 40 minutes and then 
paraformaldehyde (1.6 g) was added and the reaction mixture allowed to warm to room 
temperature and stirred for 18 hours.  The reaction mixture was quenched with saturated 
ammonium chloride solution (2 mL) followed by diethyl ether (57 mL).  The mixture was 
filtered through a plug of celite and dried (Na2SO4) affording the desired material as a 
yellow oil (15% tetrahydrofuran by NMR) (3.5 g, 35.2 mmol, 96% yield).  Reacted on 
crude. 
 
3-Phenylprop-2-yn-1-ol (240)196  
 
 
 
To a solution of phenylacetylene 239 (3.9 g, 4.1 mL, 38 mmol) in tetrahydrofuran (48 
mL) was added at -78 °C a solution of n-butyllithium in hexanes (2.5M; 15mL) dropwise 
over 10 minutes.  The reaction mixture was stirred at -78 °C for 40 minutes and then 
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paraformaldehyde (1.6 g) was added and the reaction mixture warmed to room 
temperature and stirred for 5 hours.  The reaction mixture was quenched with saturated 
ammonium chloride solution (2 mL) followed by diethyl ether (57 mL).  The separated 
aqueous phase was further extracted with diethyl ether and the combined organic phase 
dried (Na2SO4) and concentrated in vacuo.  Purification by column chromatography (4:1 
petroleum ether/ethyl acetate) afforded the title compound as a yellow oil (3.7 g, 27.7 
mmol, 73%). δH (300 MHz, CDCl3) 7.42 – 7.32 (m, 2H), 7.31 – 7.19 (m, 3H), 4.44 (d, J = 
6.2 Hz, 2H), 1.65 (t, J = 6.2 Hz, 1H); δC (75 MHz, CDCl3) 131.7 (CH), 128.5 (CH), 128.3 
(CH), 122.5 (C), 87.2 (C), 85.8 (C), 51.7 (CH2); νmax/cm-1 3311, 2913, 2866, 1489, 1442, 
1019.  
 
Hept-2-yn-1-ol (242)197 
 
 
 
Under an inert atmosphere (nitrogen), to a solution of 1-hexyne 241 (5.4 g, 66.2 mmol) in 
tetrahydrofuran (40 mL) was added at -78 °C n-butyllithium in hexanes (1.3 M; 50 mL) 
dropwise over 10 minutes.  The reaction mixture was stirred for 40 minutes at -78 °C and 
paraformaldehyde (2.7 g) was added.  The reaction mixture was allowed to reach room 
temperature and stirred for 16 hours.  The reaction mixture was quenched with saturated 
ammonium chloride solution and extracted with diethyl ether (2 x 40 mL) and the 
combined organic phase was washed with brine (2 x 15 mL) and dried (Na2SO4) and 
concentrated in vacuo affording the title compound as a clear oil (6.3 g, 56.2 mmol, 85%).  
δH (300 MHz, CDCl3) 4.31 – 4.19 (m, 2H), 2.28 – 2.10 (m, 2H), 1.57 – 1.19 (m, 4H), 0.90 
(t, J = 7.2 Hz, 3H); δC (75 MHz, CDCl3) 85.3 (C), 78.5 (C), 51.1 (CH2),31.2 (CH2), 21.5 
(CH2), 18.8 (CH2) 13.2 (CH3); νmax/cm-1 3313, 2958, 2933, 2864, 1137, 1009.  
 
 
 
123 
 
4-Cyclohexylbut-2-yn-1-ol (246)198  
 
 
 
Under an inert atmosphere (nitrogen), 3-cyclohexyl-1-propyne 245 (3.0 g, 3.6 mL, 24.5 
mmol) was dissolved in tetrahydrofuran (30 mL) and n-butyllithium in hexanes (2.0 M; 
12.3 mL) was added at -78 °C.  The reaction mixture was stirred for 1 hour and then 
paraformaldehyde (1.0 g) was added.  The reaction mixture was warmed to room 
temperature and stirred for a further 18 hours.  The reaction mixture was quenched with 
saturated ammonium chloride solution (30 mL) and extracted with diethyl ether (2 x 20 
mL) and the combined organic phase was washed with brine (2 x 10 mL) and dried 
(Na2SO4) and concentrated in vacuo.  Purification by column chromatography (8:1 
petroleum ether/ethyl acetate) afforded the title compound as a clear oil (3.2 g, 21.2 
mmol, 86%). δH (300 MHz, CDCl3) 4.24 (dt, J = 5.8, 2.1 Hz, 2H), 2.09 (dt, J = 6.7, 2.2 
Hz, 2H), 1.91 – 1.52 (m, 4H), 1.52 – 1.33 (m, 1H), 1.33 – 1.07 (m, 4H), 1.07 – 0.44 (m, 
2H); δC (75 MHz, CDCl3) 85.4 (C), 79.2 (C), 51.4 (CH2), 37.2 (CH), 32.7 (CH2), 26.6 
(CH2), 26.2 (CH2), 26.1 (CH3); νmax/cm-1 3332, 2921, 2851, 1448, 1136, 1006.   
 
3-Isopropylpenta-3,4-dien-1-ol (249) 
 
 
 
Under an inert atmosphere (nitrogen), 4-methylpent-2-yn-1-ol 238 (3.5 g, 35 mmol) was 
dissolved in triethyl orthoacetate (21 mL, 117 mmol) and propionic acid (0.7 mL, 9.5 
mmol) was added.  The reaction mixture was heated to reflux once fitted with a Dean-
Stark apparatus and refluxed for 5 hours.  Purification by distillation gave the desired 
allenoate (3.8 g, 22.9 mmol, 65%) b.p. 63-67 °C (@10 mmHg).  The allenoate (1.9 g, 
11.3 mmol) was dissolved in tetrahydrofuran (10 mL) and added dropwise to a solution of 
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lithium aluminium hydride (566 mg, 14.9 mmol) in tetrahydrofuran (10 mL) at 0 °C and 
warmed to room temperature and stirred for 2 hours.  Following a Fieser work up the 
reaction mixture was filtered through a plug of silica using diethyl ether and concentrated 
in vacuo.  Purification by column chromatography (4:1 petroleum ether/ethyl acetate) 
afforded the title compound as a clear oil (1.1 g, 8.3 mmol, 72% (over 2 steps).  δH (300 
MHz, CDCl3) 4.79 (dt, J = 6.1, 3.0 Hz, 2H), 3.77 – 3.73 (m, 2H), 2.30 – 2.16 (m, 2H), 
2.16 – 2.03 (m, 1H), 1.78 – 1.56 (m, 1H), 1.04 (d, J = 6.8 Hz, 6H); δC (75 MHz, CDCl3) 
204.3 (C), 106.7 (C), 77.6 (CH2), 61.1 (CH2), 33.3 (CH2), 30.7 (CH), 21.5 (CH3); νmax/cm-
1 3316, 2962, 2931, 2871, 1953, 1465, 1041, 844; m/z (ESI+) 127 (M + H+, 100%), 110 
(30%), 109 (35%); HRMS (ESI+) found 126.1038, C8H14O (M+) requires 126.1039. 
 
3-Vinylidenenonan-1-ol (251)64 
 
 
 
Non-2-yn-1-ol 250 (3.0 g, 21.4 mmol) was dissolved in triethyl orthoacetate (12.8 mL, 
71.2 mmol) and propionic acid (0.4 mL, 5.8 mmol) was added.  The reaction mixture was 
refluxed for 8 hours. Propionic acid (0.4 mL, 5.8 mmol) was added and the reaction 
mixture refluxed for a further 8 hours.  Propionic acid (0.4, 5.8 mmol) was added and the 
reaction mixture refluxed for a further 8 hours.  Purification by column chromatography 
(8:1 petroleum ether/ethyl acetate) afforded the crude allenoate (3.8 g).  The allenoate 
(3.8 g) was dissolved in dry tetrahydrofuran (18 mL) and this solution was added 
dropwise to lithium aluminium hydride (952 mg, 25.1 mmol) in tetrahydrofuran (10 mL) 
at 0 °C and stirred at room temperature for 23 hours.  Following a Fieser work up, 
filtration to remove lithium salts and purification by column chromatography (6:1 
petroleum ether/ethyl acetate) afforded the title compound as a colourless oil (1.4 g, 8.2 
mmol, 38%).  δH (300 MHz, CDCl3) 4.78 – 4.67 (m, 2H), 3.74 (t, J = 6.1 Hz, 2H), 2.20 
(tt, J = 6.3, 3.2 Hz, 2H), 2.15 – 1.91 (m, 2H), 1.71 (s, 1H), 1.48 – 1.03 (m, 8H), 0.87 (t, J 
= 6.8 Hz, 3H); δC (75 MHz, CDCl3) 205.5 (C), 100.3 (C), 76.2 (CH2), 60.8 (CH2), 35.3 
(CH2), 32.3 (CH2), 31.7 (CH2), 29.1 (CH2), 27.4 (CH2), 22.6 (CH2), 14.1(CH3); νmax/cm-1 
3336, 2956, 2925, 2857, 1957, 1045, 851, 724. 
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3-(Cyclohexylmethyl)penta-3,4-dien-1-ol (252)  
 
 
 
4-Cyclohexylbut-2-yn-1-ol 246 (2.6 g, 17.1 mmol) was dissolved in triethyl orthoacetate 
(10.0 mL, 56.4 mmol) and propionic acid (0.3 mL, 4.5 mmol) was added.  The reaction 
mixture was refluxed for 24 hours. Propionic acid (0.3 mL, 4.5 mL) was added and the 
reaction mixture refluxed for a further 24 hours.  Propionic acid (0.3 mL) was added and 
the reaction mixture refluxed for a further 36 hours.  Purification by column 
chromatography (8:1 petroleum ether/ethyl acetate) afforded the crude allenoate (3.6 g).  
The allenoate (3.6 g) was dissolved in dry tetrahydrofuran (16 mL) and this solution was 
added dropwise to lithium aluminium hydride (861 mg, 22.7 mmol) in tetrahydrofuran (9 
mL) at 0 °C and stirred at room temperature overnight.  Following a Fieser work up, 
filtration to remove lithium salts and purification by column chromatography (6:1 
petroleum ether/ethyl acetate) afforded the title compound as a clear oil (2.0 g, 11.3 
mmol, 66%).  δH (300 MHz, CDCl3) 4.75 – 4.69 (m, 2H), 3.74 (dd, J = 11.1, 5.6 Hz, 2H), 
2.25 – 2.12 (m, 2H), 1.90 – 1.71 (m, 2H), 1.70 – 1.58 (m, 4H), 1.53 – 1.32 (m, 1H), 1.31 
– 1.09 (m, 4H), 1.07 – 0.75 (m, 2H); νmax/cm-1 3326, 2920, 2850, 1957, 1448, 1045, 1015, 
842.  Further characterised by preparation of the 4-nitrobenzoate ester due to instability. 
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3-(Cyclohexylmethyl)penta-3,4-dien-1-yl 4-nitrobenzoate ester   
 
 
 
To a solution of 3-(cyclohexylmethyl)penta-3,4-dien-1-ol 252 (108 mg, 0.6 mmol) in 
dichloromethane (1 mL) was added triethylamine (85 mg, 0.8 mmol) and 
dimethylaminopyridine (6.8 mg, 56 µmol).  To the stirring solution at 0 °C was added p-
nitro benzoylchloride (128 mg, 0.7 mmol) in dichloromethane (1 mL) drop wise and 
stirred for 30 minutes.  The reaction mixture was stirred at room temperature for 18 hours.  
Water (10 mL) was added.  The separated organic layer was washed with hydrochloric 
acid (10%; 2 x 1 mL), water (5 mL) then brine (5 mL) and dried (Na2SO4) and 
concentrated in vacuo.  Purification by column chromatography (20:1 petroleum 
ether/ethyl acetate) afforded the title compound as a colourless oil (140 mg, 0.4 mmol, 
76%).  δH (300 MHz, CDCl3) 8.33 – 8.22 (m, 2H), 8.22 – 8.14 (m, 2H), 4.65 (p, J = 3.0 
Hz, 2H), 4.45 (t, J = 6.8 Hz, 2H), 2.39 (tt, J = 6.7, 3.2 Hz, 2H), 1.89 (dt, J = 6.7, 2.7 Hz, 
2H), 1.80 – 1.54 (m, 4H), 1.32 – 1.06 (m, 4H), 1.00 – 0.76 (m, 3H); δC (75 MHz, CDCl3) 
206.3 (C), 164.6 (C), 150.5 (C), 135.8 (C), 130.7 (CH), 123.5 (CH), 97.4 (C), 75.7 (CH2), 
64.1 (CH2), 40.5 (CH2), 35.9 (CH), 33.3 (CH2), 31.0 (CH2), 26.5 (CH2), 26.2 (CH2); 
νmax/cm-1 2922, 2850, 1957, 1724, 1527, 1347, 1268, 842; m/z (ESI+) 347 (M + NH4+, 
100%); HRMS (ESI+) found 347.1963, C19H27O4N2 (M + NH4)+ requires 347.1965. 
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3-Vinylidenehexan-1-ol (254)64 
 
 
 
Under an inert atmosphere (nitrogen), 2-hexyn-1-ol 253 (5 g, 51 mmol) was dissolved in 
triethyl orthoacetate (29.5 mL, 163 mmol) and propionic acid (0.9 mL) was added.  The 
mixture was heated to reflux once fitted with a Dean-Stark apparatus and refluxed for 21 
hours.  Propionic acid (0.9 mL) was added and the reaction mixture was heated at reflux 
for a further 19 hours.  Propionic acid (0.9 mL) was added and the reaction mixture 
heated to reflux for a further 24 hours.  The crude reaction mixture was filtered through a 
plug of silica using diethyl ether and concentrated in vacuo.  The crude allenoate was 
dissolved in tetrahydrofuran (40 mL) and this was added to lithium aluminium hydride 
(2.5 g, 66.3 mmol) in tetrahydrofuran (40 mL) at 0 °C.  The reaction mixture was stirred 
overnight and quenched with distilled water (7.5 mL) and stirred for 1 hour.  The lithium 
salts were filtered off and the solution concentrated in vacuo.  Purification by column 
chromatography (5:1 petroleum ether/ethyl acetate) afforded the title compound as a clear 
oil (2.6g, 20.3 mmol, 40%).  δH (300 MHz, CDCl3) 4.82 – 4.71 (m, 2H), 3.87 – 3.69 (m, 
2H), 2.26 – 2.22 (m, 2H), 1.99 – 1.95 (m, 2H), 1.59 – 1.40 (m, 2H), 0.95 (t, J = 7.3 Hz, 
3H); δC (75 MHz, CDCl3) 204.4 (C), 103.2 (C), 76.3 (CH2), 58.4 (CH2) 36.7 (CH2), 32.6 
(CH2), 23.1 (CH2), 14.3 (CH3); νmax/cm-1 3377, 2960, 2933, 2869, 1714, 1450, 1378, 
1182, 1042. 
 
(3-(2-(Benzyloxy)ethyl)penta-3,4-dien-1-ol (255) 
 
 
 
Under an inert atmosphere (nitrogen), at -78 °C, to a solution of ((but-3-yn-1-
yloxy)methyl)benzene (10.5 g, 65.5 mmol) in dry tetrahydrofuran (83 mL) was added n-
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butyllithium in hexanes (1.9 M, 34.5 mL, 65.5 mmol) over 10 minutes.  The mixture was 
stirred for a further 30 minutes.  Paraformaldehyde (2.8 g) was added and the reaction 
mixture was allowed to warm to room temperature and stirred for 19 hours.  Saturated 
ammonium chloride solution (6 mL) was added folowed by diethyl ether (50 mL).  The 
reaction mixture was filtered through a plug of silica with ether.  The separated aqueous 
layer was further extracted with diethyl ether and the combined organic phases were 
washed with brine and dried (Na2SO4) and concentrated in vacuo.  Purification by column 
chromatography (7:3 petroleum ether/ethyl acetate) gave 5-(benzyloxy)pent-2-yn-1-ol 
248 as a colourless oil (6.2 g, 32.4 mmol, 50%). This was reacted on below. 
 
5-(Benzyloxy)pent-2-yn-1-ol 248 (5.0 g, 26.0 mmol) was dissolved in triethyl 
orthoacetate (15 mL) and propionic acid (0.5 mL) and the reaction mixture refluxed under 
Dean-Stark conditions for 17 hours.  Propionic acid (0.5 mL) was added and refluxed for 
a further 17 hours.  Propionic acid (0.5 mL) was added and the reaction mixture refluxed 
for a further 17 hours.  Purification by column chromatography (16:1 petroleum 
ether/ethyl acetate to 6:1 petroleum ether/ethyl acetate) afforded the crude allenoate.  The 
allenoate (3.6 g) was dissolved in dry tetrahydrofuran (13 mL) and added dropwise to a 
solution of lithium aluminium hydride (686 mg, 18.0 mmol) in dry tetrahydrofuran (6 
mL) at 0 °C and warmed to room temperature and stirred for 27 hours.  Following a 
Fieser work up the reaction mixture was filtered.  The separated aqueous phase was 
extracted with diethyl ether, dried (Na2SO4) and concentrated in vacuo.  Purification by 
column chromatography (3:1 petroleum ether/ethyl acetate) afforded the title compound 
as a colourless oil (2.4 g, 11 mmol, 42% (over 2 steps)).  δH (300 MHz, CDCl3) 7.39 – 
7.25 (m, 5H), 4.79 – 4.74(m, 2H), 4.52 (s, 2H), 3.78 – 3.72 (m, 2H), 3.60 (t, J = 6.6 Hz, 
2H), 2.30 (td, J = 6.6 Hz, 3.3 Hz, 2H), 2.24 (td, J = 6.1, 3.0 Hz); δC (75 MHz, CDCl3) 
206.0 (C), 134.6 (C), 129.1 (CH), 128.5 (CH), 127.9 (CH), 97.5 (C), 77.4 (CH2), 73.2 
(CH2), 68.7 (CH2), 60.8 (CH2), 35.7 (CH2), 32.3 (CH2); νmax/cm-1 3406, 2927, 2881, 1715, 
1453,1273, 713; m/z (ESI+) 219 (M + H+, 30%), 213 (100%), 197 (50%), 195 (95%); 
HRMS (ESI+) found 437.2683, C28H37O4 (2M + H)+ requires 437.2686. 
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4-Cyclohexylidenebut-3-en-1-ol (257)199 
 
 
 
Under an inert atmosphere, 1-ethynylcyclohexanol 256 (5.65 mL, 43 mmol) was 
dissolved in triethyl orthoacetate (25 mL, 14 mmol) and propionic acid (1.0 mL, 13 
mmol) was added.  The reaction mixture was refluxed overnight with Dean-Stark 
apparatus.  Propionic acid (1.0 mL, 13 mmol) was added and the reaction refluxed for a 
further 2 days and concentrated in vacuo.  Purification by column chromatography (98:2 
petroleum ether/ethyl acetate) afforded the crude allenoate (2.3 g, 11.8 mmol, 27%).  
Under an inert atmosphere (nitrogen), the allenoate (1.0 g, 5.2 mmol) dissolved in dry 
tetrahydrofuran (5 mL) was added dropwise to a solution of lithium aluminium hydride 
(254 mg, 6.7 mmol) in tetrahydrofuran (5 mL) and the reaction mixture was stirred for 2 
hours.  The reaction was quenched with water and then diethyl ether was added.  The 
solution was filtered and the phases separated.  The organic layer was washed with water 
then brine and dried (Na2SO4) and concentrated in vacuo to afford the title compound as a 
colourless oil (600 mg, 3.9 mmol, 21% (over 2 steps)).  δH (300 MHz, CDCl3) 5.04 – 4.89 
(m, 1H), 3.77 – 3.45 (m, 2H), 2.25 – 2.21 (m, 2H), 2.17 – 2.06 (m, 4H), 1.89 – 1.27 (m, 
6H); δC (75 MHz, CDCl3) 198.6 (C), 103.0 (C), 84.2 (CH), 61.8 (CH2), 32.5 (CH2), 31.4 
(CH2), 27.2 (CH2), 25.8 (CH2); νmax/cm-1 3342, 2923, 2850, 1961, 1445, 1339, 1174. 
 
 
 
 
 
 
 
130 
 
2-Methyl-3-phenylpenta-3,4-dien-1-ol (258)108 
 
 
 
3-Phenylprop-2-yn-1-ol 240 (2.5 g, 18.9 mmol) was dissolved in triethyl orthopropionate 
(14 mL, 70 mmol) and propionic acid (0.23 mL) was added.  The reaction mixture was 
stirred at 140 °C for 7 hours fitted with a Dean-Stark apparatus.  The reaction mixture was 
filtered through a plug of silica using a 2:1 mixture of petroleum ether/ethyl acetate 
giving the crude allenoate (2.6 g).  The crude allenoate was added to DIBAL in 
tetrahydrofuran (1 M; 22.8 mL) at -78 °C whilst stirring and the reaction mixture warmed 
to room temperature and stirred overnight.  Following a Fieser work up, the reaction 
mixture was diluted with diethyl ether.  The separated aqueous phase was further 
extracted with diethyl ether and the combined organic phase was washed with brine, dried 
(Na2SO4) and concentrated in vacuo.  Purification by column chromatography (4:1 
petroleum ether/ethyl acetate) afforded the title compound as a clear oil (1.6 g, 9.2 mmol, 
48% (over 2 steps)).  δH (300 MHz, CDCl3) 7.50 – 7.09 (m, 5H), 5.27 – 5.10 (m, 2H), 
3.76 (dd, J = 10.8, 6.2 Hz, 1H), 3.64 (dd, J = 10.8, 5.8 Hz, 1H), 3.28 – 2.86 (m, 1H), 1.60 
(s, 1H), 1.21 (d, J = 6.8 Hz, 3H); δC (75 MHz, CDCl3) 207.7 (C), 135.8 (C), 128.5 (CH), 
126.9 (CH), 126.4 (CH), 108.0 (C), 79.7 (CH2), 66.8 (CH2), 35.8 (CH), 16.8 (CH3); 
νmax/cm-1 3437, 2971, 2933, 2877, 1732, 1683, 1449, 1240, 1215, 699. 
 
2-Methylpenta-3,4-dien-1-ol (260)200 
 
 
 
Propargyl alcohol 259 (4.9 mL, 4.7 g, 83.7 mmol) was dissolved in triethyl 
orthopropionate (30 mL, 150 mmol).  The flask was fitted with a Dean-Stark apparatus.  
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Propionic acid (0.75 mL) was added and the reaction mixture heated at 140 °C for 24 
hours and cooled to room temperature.  The crude mixture was flushed through a silica 
plug with diethyl ether and and concentrated in vacuo.  Purification by column 
chromatography (16:1 petroleum ether/ethyl acetate) afforded the crude allenoate.  The 
crude allenoate (9.7 g) was dissolved in tetrahydrofuran (30 mL) and this was added 
dropwise to a suspension of lithium aluminium hydride (3.4 g, 1.3eq) in tetrahydrofuran 
(10 mL) at 0 °C and warmed to room temperature and stirred for 14 hours.  Fieser work 
up, followed by filtration to remove lithium salts.  The reaction mixture was extracted 
with diethyl ether and dried (Na2SO4) and concentrated in vacuo.  Purification by column 
chromatography (4:1 petroleum ether/ethyl acetate) afforded the desired material as a 
clear oil (3.9 g, 40.0 mmol, 47%).  δH (300 MHz, CDCl3) 5.20 – 5.07 (m, 1H), 4.84 – 4.74 
(m, 2H), 3.63 – 3.26 (m, 2H), 2.51 – 2.12 (m, 1H), 1.04 (d, J = 6.9 Hz, 3H); δC (75MHz, 
CDCl3) 207.5 (C), 99.0 (CH), 74.2 (CH2), 64.8 (CH2), 38.3 (CH), 13.3 (CH3); νmax/cm-1 
3344, 1950, 1472, 1146, 1029.  
 
Deca-3,4-dien-1-yl sulfamate (263) 
 
 
 
Under an inert atmosphere (nitrogen), formic acid (75 µL, 2.0 mmol) was added dropwise 
to neat chlorosulfonyl isocyanate (0.2 mL, 2.0 mmol) at 0 °C with rapid stirring.  The 
resulting suspension was stirred at room temperature for 18 hours.  The reaction mixture 
was cooled to 0 °C and dimethylacetamide (0.4 mL) was added and the solution was 
stirred for 5 minutes.  A solution of deca-3,4-dien-1-ol 262 (200 mg, 1.3 mmol) in 
dimethylacetamide (0.7 mL) was added dropwise and the resulting solution allowed to 
reach room temperature and stirring was continued for 4 hours.  The reaction was 
quenched by the addition of ethyl acetate (1.8 mL) and brine (1 mL).  The reaction 
mixture was poured into ethyl acetate (3.5 mL) and water (1.5 mL).  The separated 
aqueous phase was further extracted with ethyl acetate (5 mL).  The combined organic 
extracts were washed with brine (2 x 5 mL), dried (Na2SO4) and concentrated in vacuo.  
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Purification by column chromatography (7:3 petroleum ether/ethyl acetate) afforded the 
title compound as a colourless oil (195 mg, 0.8 mmol, 62%).  δH (300 MHz, CDCl3) 5.25 
– 5.00 (m, 2H), 4.71 (s, 2H), 4.26 (t, J = 6.9 Hz, 2H), 2.48 – 2.42 (m, 2H), 2.01 – 1.93 (m, 
2H), 1.58 – 1.21 (m, 6H), 0.89 (t, J = 6.8 Hz, 3H); δC (75 MHz, CDCl3) 204.7 (C), 92.5 
(CH), 85.5 (CH), 70.5 (CH2), 31.3 (CH2), 28.7 (CH2), 28.6 (CH2), 28.5 (CH2), 22.5 
(CH2), 14.1 (CH3); m/z (ESI+) 256 (M + Na+, 80%), 251 (M + NH4+, 100%); HRMS 
(ESI+) found 251.1429, C10H23O3N2S (M + NH4)+ requires 251.1424. 
 
3-Vinylidenehexyl sulfamate (264)79 
 
 
 
Formic acid (0.8 mL, 20.0 mmol) was added dropwise to chlorosulfonyl isocyanate (1.8 
mL, 20.0 mmol) at 0 °C with vigorous stirring.  Acetonitrile (3.6 mL) was added and the 
reaction mixture stirred overnight.  A solution of 3-vinylidenehexan-1-ol 254 (1.0 g, 8.0 
mmol) in dimethylacetamide (3 mL) was added dropwise at 0 °C and stirred for 20 hours.  
The reaction mixture was quenched with ethyl acetate (7 mL) and brine (3.5 mL) before 
being poured onto ethyl acetate (14 mL) and water (5 mL).  The separated aqueous layer 
was extracted with ethyl acetate (10 mL) and the combined organic phase washed with 
brine (2 x 5 mL), dried (Na2SO4) and concentrated in vacuo.  Purification by column 
chromatography (4:1 petroleum ether/ethyl acetate) afforded the title compound as a 
yellow oil (701 mg, 3.4 mmol, 43%).  δH (300 MHz, CDCl3) 4.75 (p, J = 3.3 Hz, 2H), 
4.67 (br s, 2H), 4.30 (t, J = 7.1 Hz, 2H), 2.45 – 2.32 (m, 2H), 2.02 – 1.88 (m, 2H), 1.55 – 
1.36 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H); δC 75 MHz, CDCl3) 205.3 (C), 98.4 (C), 77.6 
(CH2), 68.8 (CH2), 33.1 (CH2), 31.6 (CH2), 29.6 (CH2), 14.7 (CH3); νmax/cm-1 3286, 2956, 
1959, 1359, 1126. 
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3-Vinylidenenonyl sulfamate (265)  
 
 
 
Under an inert atmosphere (nitrogen), formic acid (0.7 mL, 17.9 mmol) was added drop 
wise to neat chlorosulfonyl isocyanate (1.6 mL, 17.9 mmol) at 0 °C with vigorous 
stirring.  Acetonitrile (10 mL) was added and the reaction mixture stirred for 18 hours. 3-
vinylidenenonan-1-ol 251 (1.3 g, 7.8 mmol) in dimethylacetamide (5 mL) was added drop 
wise at 0 °C and stirred for 36 hours.  The reaction mixture was diluted using ethyl 
acetate (28 mL) and quenched with brine (14 mL).  The mixture was poured into a 
solution of ethyl acetate (28 mL) and water (10 mL).  The separated aqueous phase was 
further extracted with ethyl acetate (20 mL).  The combined organic phase was washed 
with brine (2 x 5 mL), dried (Na2SO4) and concentrated in vacuo.  Purification by column 
chromatography (3:1 petroleum ether/ethyl acetate) afforded the title compound as a 
colourless oil (1.3 g, 5.1 mmol, 43%).  δH (300 MHz, CDCl3) 4.86 – 4.64 (m, 2H), 4.75 
(s, 2H), 4.30 (t, J = 7.1 Hz, 2H), 2.38 (tt, J = 6.9, 3.3 Hz, 2H), 2.03 – 1.89 (m, 2H), 1.70 – 
1.19 (m, 8H), 0.91 (t, J = 4.7 Hz, 3H); δC (75 MHz, CDCl3) 205.5 (C), 98.7 (C), 77.2 
(CH2), 69.5 (CH2), 32.3 (CH2), 31.7 (CH2), 31.0 (CH2), 28.9 (CH2), 27.3 (CH2), 22.6 
(CH2), 14.1 (CH3); νmax/cm-1 3283, 2957, 2927, 2858, 1958, 1724, 1361, 1125; m/z (ESI+) 
265 (M + NH4+, 100%), 255 (15%); HRMS (ESI+) found 265.1584, C11H25O3N2S (M + 
NH4)+ requires 265.1580. 
 
3-(2-(Benzyloxy)ethyl)penta-3,4-dien-1-yl sulfamate (266)  
 
 
 
Under an inert atmosphere (nitrogen), formic acid (0.4 mL, 11.5 mmol) was added drop 
wise to neat chlorosulfonyl isocyanate (1.0 mL, 11.5 mmol) at 0 °C with vigorous 
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stirring.  Acetonitrile (3.6 mL) was added and the reaction mixture stirred for 17 hours.  A 
solution of (3-(2-(benzyloxy)ethyl)penta-3,4-dien-1-ol 255 (1.0 g, 4.6 mmol) in 
dimethylacetamide (9 mL) was added drop wise at 0 °C and the reaction mixture allowed 
to reach room temperature and the reaction mixture stirred for 24 hours.  The reaction 
mixture was quenched by the addition of diethyl ether (7 mL) and brine (4 mL).  The 
reaction mixture was poured into diethyl ether (10 mL) and water (7 mL).  The separated 
aqueous layer was further extracted with diethyl ether (10 mL) and the combined organic 
layer was washed with brine (2 x 5 mL), dried (Na2SO4) and concentrated in vacuo.  
Purification by column chromatography (19:1 dichloromethane/ethyl acetate) afforded the 
title compound as a white solid (609 mg, 2.0 mmol, 45%).  δH (300 MHz, CDCl3) 7.44 – 
7.20 (m, 5H), 4.93 – 4.63 (m, 4H), 4.53 (s, 2H), 4.33 (t, J = 6.8 Hz, 2H), 3.63 (t, J = 6.4 
Hz, 2H), 2.44 (tt, J = 6.6, 3.2 Hz, 2H), 2.33 (tt, J = 6.4, 3.2 Hz, 2H); δC (100 MHz, 
CDCl3) 205.6 (C), 161.0 (C), 129.6 (CH), 128.4 (CH), 127.7 (CH), 127.6 (CH), 77.2 
(CH2), 73.0 (CH2), 68.5 (CH2), 62.1 (CH2), 32.4 (CH2), 31.1 (CH2); νmax/cm-1 3280, 2866, 
1958, 1716, 1363, 1176; m/z (ESI+) 315 (M + NH4+, 100%), 298 (M + H+, 35%); HRMS 
(ESI+) found 298.1115, C14H20O4NS (M + H)+ requires 298.1108. 
 
4-Cyclohexylidene-3-en-1-yl sulfamate (267) 
 
 
 
Under an inert atmosphere (nitrogen), formic acid (0.2 mL, 6.1 mmol) was added 
dropwise to neat chlorosulfonyl isocyanate (0.5 mL, 0.9 g, 6.1 mmol) at 0 °C with rapid 
stirring.  The resulting suspension was stirred at room temperature for 18 hours.  The 
reaction mixture was cooled to 0 °C and dimethylacetamide (1.1 mL) was added and the 
solution stirred for 5 minutes.  A solution of 4-cyclohexylidenebut-3-en-1-ol 257 (500 
mg, 3.3 mmol) in dimethylacetamide (2.2 mL) was added dropwise was added to the 
reaction mixture and stirring continued for 5 hours.  The reaction mixture was quenched 
by the addition of ethyl acetate (10 mL) and brine (10 mL).  The mixture was poured into 
ethyl acetate (5 mL) and water (5 mL).  The combined organic phase was washed with 
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brine (2 x 5 mL) and dried Na2SO4 and concentrated in vacuo giving the desired material 
as a clear oil (429 mg, 1.9 mmol, 58%).  δH (300 MHz, CDCl3) 5.10 – 4.85 (m, 1H), 4.68 
(s, 2H), 4.25 (t, J = 6.9 Hz, 2H), 2.41 (dd, J = 13.3, 6.9 Hz, 2H), 2.17 – 2.05 (m, 4H), 1.69 
– 1.35 (m, 6H); δC (75 MHz, CDCl3) 199.3 (C), 104.0 (C), 83.2 (CH), 70.8 (CH2), 31.5 
(CH2), 28.9 (CH2), 27.3 (CH2), 26.0 (CH2); νmax/cm-1 3385, 3282, 2925, 2853, 1966, 
1554, 1446, 1359, 1266, 1239, 1175, 978, 924, 851, 825, 797, 739; m/z (ESI+) 249 (M + 
NH4+, 100%), 232 (M + H+, 40%); HRMS (ESI+) found 232.1004, C10H18O3NS (M + H)+ 
requires 232.1002. 
 
Hexa-4,5-dien-1-yl sulfamate (272) 
 
 
 
Formic acid was (0.3 mL, 7.8 mmol) was added dropwise to neat chlorosulfonyl 
isocyanate (0.7 mL, 7.8 mmol) at 0 °C with rapid stirring.  The resulting suspension was 
stirred at room temperature for 18 hours.  The reaction mixture was cooled to 0 °C and 
dimethylacetamide (1.4 mL) was added and the solution stirred for 5 minutes.  A solution 
of hexa-4,5-dien-1-ol 236 (510 mg, 5.2 mmol) in dimethylacetamide (1.4 mL) was added 
and the resulting solution was warmed to room temperature and stirring continued for 4 
hours.  The reaction mixture was quenched by the addition of ethyl acetate (7.5 mL) and 
brine (5 mL).  This was poured into ethyl acetate (25 mL) and water (10 mL).  The 
separated aqueous phase was further extracted with ethyl acetate (2 x 25 mL.)  The 
combined organic phase was washed with brine (2 x 5 mL) and dried (Na2SO4) and 
concentrated in vacuo.  Purification by column chromatography (4:1 petroleum 
ether/ethyl acetate) afforded the title compound as a clear oil (445 mg, 2.5 mmol, 48%).  
δH (300 MHz, CDCl3) 5.16 – 5.12 (m, 1H), 4.92 – 4.66 (m, 4H), 4.26 (t, J = 6.4 Hz, 2H), 
2.22 – 2.06 (m, 2H), 1.97 – 1.81 (m, 2H); δC (75 MHz, CDCl3) 208.6 (C), 88.5 (CH), 75.7 
(CH2), 70.7 (CH2), 27.9 (CH2), 23.9 (CH2); νmax/cm-1 3391, 3291, 2939, 1958, 1539, 
1455, 1344, 1169, 895; m/z (ESI+) 178 (M + H+, 100%), 154 (10%), 115 (10%); HRMS 
(ESI+) found 178.0533, C6H12O3NS (M + H)+ requires 178.0533.  
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1-(Buta-2,3-dien-1-yl)cyclohexyl sulfamate (274)  
 
 
 
Under an inert atmosphere (nitrogen), formic acid (0.33 mL, 4.0 mmol) was added 
dropwise to a neat chlorosulfonyl isocyanate (0.74 mL, 4.0 mmol) at 0 oC with rapid 
stirring.  The resulting suspension was stirred at room temperature for 16 hr.  The reaction 
mixture was cooled to 0 oC and DMA (1.4 mL) was added and the solution stirred for 5 
minutes.  Half of this solution was placed in a dry flask and a solution of 1-(buta-2,3-
dien-1-yl)cyclohexanol 232 (274 mg, 1.80 mmol) in DMA (0.7 mL) was added dropwise 
at 0 oC to the stirring solution.  The reaction mixture was stirred at room temperature for 5 
hours.  The reaction mixture was quenched by the addition of ethyl acetate (1 mL) and 
brine (1 mL).  This was poured into ethyl acetate (3 mL) and water (1 mL).  The 
separated aqueous phase was further extracted with ethyl acetate (2 x 5 mL) and the 
combined organic phase washed with brine (2 x 2.5 mL), dried Na2SO4 and concentrated 
in vacuo.  Purification by column chromatography (petroleum ether) gave the desired 
material as a clear oil (123 mg, 0.53 mmol, 29%).  δH (300 MHz, CDCl3) 5.48 (ddd, J = 
5.1, 3.5, 1.4 Hz, 1H), 5.16 – 4.99 (m, 1H), 4.66 (dt, J = 6.6, 2.8 Hz, 2H), 2.64 (d, J = 8.6 
Hz, 2H), 1.98 (dt, J = 12.9, 4.7 Hz, 4H), 1.71 – 1.47 (m, 5H); δC (75 MHz, CDCl3) 208.9 
(C), 136.3 (C), 121.9 (CH), 88.4 (CH2), 74.3 (CH2), 37.4 (CH2), 28.2 (CH2), 25.2 (CH2), 
22.9 (CH2), 22.5 (CH2); νmax/cm-1 3277, 2927, 2854, 1645, 1408, 1361, 1175, 870; m/z 
(ESI+) 249 (M+NH4+, 100%), 244 (70%); HRMS (ESI+) found 249.0774, C10H21O3N2S 
(M+) requires 249.0779. 
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2-Methylocta-6,7-dien-4-yl sulfamate (275) 
 
 
 
Under an inert atmosphere (nitrogen), formic acid (0.26 mL) was added dropwise to 
chlorosulfonyl isocyanate (0.6 mL, 6.8 mmol) with vigorous stirring at 0 °C.  Acetonitrile 
(1.2 mL) was added and the reaction mixture stirred overnight. 2-methylocta-6,7-dien-4-
ol 233 (378 mg, 2.7 mmol) was added in dimethylacetamide (1.2 mL) and the reaction 
mixture stirred at room temperature for 24 hours.  The reaction mixture was diluted with 
diethyl ether (4 mL) and quenched with saturated sodium chloride solution (2 mL).  This 
was added to a mixture of diethyl ether (4 mL) and water (3 mL).  The separated aqueous 
phase was further extracted with diethyl ether (3 mL).  The combined organic phase 
washed with saturated sodium chloride solution (2 x 1.5 mL), dried Na2SO4 and 
concentrated in vacuo.  Purification by column chromatography (6:1 petroleum 
ether/ethyl acetate) afforded the title compound as a yellow oil (421 mg, 1.9 mmol, 71%).  
δH (300 MHz, CDCl3) 5.16 – 5.10 (m, 1H), 4.86 – 4.39 (m, 4H), 2.58 – 2.42 (m, 2H), 1.88 
– 1.66 (m, 2H), 1.61 – 1.38 (m, 1H), 0.96 (d, J = 6.2 Hz, 3H), 0.94 (d, J = 6.3 Hz, 3H); δC 
(75 MHz, CDCl3) 209.7 (C), 84.6 (CH2), 82.7 (CH2), 75.3 (CH), 42.8 (CH), 33.8 (CH), 
24.3 (CH2), 22.9 (CH3), 22.2 (CH3); νmax/cm-1 3362, 3283, 2951, 2935, 1957, 1539, 1351, 
1329, 1178; m/z (ESI+) 218 (M - H+, 100%); HRMS (ESI+) found 218.0852, C9H16O3NS 
(M - H)+ requires 218.0856. 
 
2,2-Dimethylhepta-5,6-dien-3-yl sulfamate (276) 
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Under an inert atmosphere (nitrogen), formic acid (0.26 mL) was added dropwise to 
chlorosulfonyl isocyanate (0.6 mL, 6.8 mmol) with vigorous stirring at 0 °C.  Acetonitrile 
(1.2 mL) was added and the reaction mixture stirred overnight.  2,2-dimethylhepta-5,6-
dien-3-ol 234 (415 mg, 2.9 mmol) was added in dimethylacetamide (1.2 mL) and the 
reaction mixture stirred at room temperature for 24 hours.  The reaction mixture was 
diluted with diethyl ether (4 mL) and quenched with saturated sodium chloride solution (2 
mL).  This was added to a mixture of diethyl ether (4 mL) and water (3 mL).  The 
separated aqueous phase was further extracted with diethyl ether (3 mL).  The combined 
organic phase washed with saturated sodium chloride solution (2 x 1.5 mL), dried Na2SO4 
and concentrated in vacuo.  Purification by column chromatography (8:1 petroleum 
ether/ethyl acetate to 2:1 petroleum ether/ ethyl acetate) afforded the title compound as a 
yellow oil (257 mg, 1.2 mmol, 41%).  δH (300 MHz, CDCl3) 5.32 – 5.26 (m, 1H), 4.86 – 
4.62 (m, 2H), 4.47 – 4.43 (m, 1H), 2.62 – 2.31 (m, 2H), 1.03 (s, 9H); δC (75 MHz, CDCl3) 
209.2 (C), 92.6 (CH), 87.4 (CH), 75.6 (CH2), 35.4 (C), 30.4 (CH2), 26.1 (CH3); νmax/cm-1 
3381, 2964, 2881, 1957, 1365, 1176, 907; m/z (ESI+) 220 (M+H+, 100%), HRMS (ESI+) 
found 220.0853, C9H17O3NS (M + H)+ requires 220.0856. 
 
1-Phenylhepta-5,6-dien-3-yl sulfamate (277) 
 
 
 
Under an inert atmosphere (nitrogen), formic acid (0.2 mL, 4.0 mmol) was added to neat 
chlorosulfonyl isocyanate (0.4 mL, 4.0 mmol) at 0 °C with vigorous stirring.  After 10 
minutes acetonitrile (2 mL) was added and the reaction mixture stirred at room 
temperature overnight.  A solution of 1-phenylhepta-5,6-dien-3-ol 228 (500 mg, 2.7 
mmol) in dimethylacetamide (5 mL) was added drop wise and the reaction mixture stirred 
for 5 hours.  The reaction mixture was quenched by the addition of diethyl ether (4 mL) 
and brine (2 mL).  The reaction mixture was poured into diethyl ether (4 mL) and water 
(3 mL).  The separated aqueous phase was further extracted with diethyl ether (3 mL) and 
the combined organic phase washed with brine (2 x 1.5 mL), dried (Na2SO4) and 
concentrated in vacuo.  Purification by column chromatography (6:1 petroleum ether/ 
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ethyl acetate) afforded the title compound as a yellow oil (421 mg, 1.9 mmol, 71%).  δH 
(300 MHz, CDCl3) 7.36 – 7.14 (m, 5H), 5.19 – 5.03 (m, 1H), 4.70 (m, 5H), 2.88 – 2.66 
(m, 2H), 2.55 – 2.49 (m, 2H), 2.15 – 2.02 (m, 2H); δC (75 MHz, CDCl3) 209.7 (C), 141.0 
(C), 128.6 (CH), 128.4 (CH), 126.2 (CH), 84.4 (CH), 83.3 (CH2), 75.4 (CH), 35.2 (CH2), 
33.4 (CH2), 31.2 (CH2); νmax/cm-1 3379, 3281, 2928, 1956, 1355, 1177, 912; m/z (ESI+) 
268 (M + H+, 100%), 204 (45%), 163 (30%); HRMS (ESI+) found 268.1272, C13H18O3NS 
(M + H)+ requires 268.1267. 
 
3-Isopropylpenta-3,4-dien-1-yl sulfamate (278)  
 
 
 
Under an inert atmosphere (nitrogen), formic acid (0.2 mL, 6.0 mmol) was added 
dropwise to chlorosulfonyl isocyanate (0.5 mL, 6.0 mmol) with vigorous stirring at 0 °C.  
Acetonitrile (3.6 mL) was added and the reaction mixture warmed to room temperature 
and stirred overnight.  The reaction mixture was cooled to 0 °C, and a solution of 3-
isopropylpenta-3,4-dien-1-ol 249 (500 mg, 4.0 mmol) in dimethylacetamide (7.6 mL) was 
added dropwise and stirred for 30 hours.  The reaction was quenched by the addition of 
ethyl acetate (7 mL) and brine (3.5 mL).  The mixture was poured into ethyl acetate (14 
mL) and water (5 mL).  The separated aqueous phase was further extracted with ethyl 
acetate (5 mL).  The combined organic phase was washed with brine (2 x 5 mL), dried 
(Na2SO4) and concentrated in vacuo.  Purification by column chromatography (1:1 
petroleum ether/ethyl acetate) afforded the title compound as a clear oil (581 mg, 2.8 
mmol, 54%).  δH (300 MHz, CDCl3) 4.91 – 4.75 (m, 2H), 4.71 (s, 2H), 4.30 (t, J = 7.2 Hz, 
2H), 2.45 – 2.39 (m, 2H), 2.24 – 2.04 (m, 1H), 1.04 (d, J = 6.8 Hz, 6H); δC (75 MHz, 
CDCl3) 204.3 (C), 104.9 (C), 78.3 (CH2), 69.8 (CH2), 30.7 (CH), 29.1 (CH2), 21.3 (CH3); 
νmax/cm-1 3378, 3283, 2964, 2932, 2872, 1361, 1176, 971, 918.6; m/z (ESI+) 223 (M + H+, 
100%), 142 (35%); HRMS (ESI+) found 206.0840, C8H16O3NS (M + H)+ requires 
206.0845. 
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3-(Cyclohexylmethyl)penta-3,4-dien-1-yl sulfamate (279) 
 
 
 
Under an inert atmosphere (nitrogen), formic acid (0.3 mL, 8.3 mmol) was added drop 
wise to neat chlorosulfonyl isocyanate (0.7 mL, 8.3 mmol) with vigorous stirring at 0 °C.  
Acetonitrile (4.5 mL) was added and stirred overnight at room temperature.  A solution of 
3-(cyclohexylmethyl)penta-3,4-dien-1-ol 252 (1.0 g, 5.6 mmol) in dimethylacetamide (2.5 
mL) was added drop wise at 0 °C and stirred for 20 hours.  The reaction mixture was 
quenched by the addition of ethyl acetate (7 mL) and brine (3.5 mL).  The mixture was 
poured into ethyl acetate (14 mL) and water (5 mL).  The separated aqueous phase was 
further extracted with ethyl acetate (10 mL) and the combined organic phase washed with 
brine (2 x 5 mL) and dried (Na2SO4) and concentrated in vacuo.  Purification by column 
chromatography (3:1 petroleum ether/ethyl acetate) afforded the desired material as a 
clear oil (1.1 g, 4.2 mmol, 76%).  δH (300 MHz, CDCl3) 4.79 – 4.50 (m, 4H), 4.29 (t, J = 
7.1 Hz, 2H), 2.36 (tt, J = 7.0, 3.4 Hz, 2H), 1.91 – 1.82 (m, 2H), 1.82 – 1.57 (m, 4H), 1.51 
– 1.32 (m, 1H), 1.31 – 0.99 (m, 4H), 0.99 – 0.73 (m, 2H); δC (75 MHz, CDCl3) 206.0 (C), 
96.9 (C), 76.4 (CH2), 69.5 (CH2), 40.5 (CH2), 35.8 (CH), 33.3 (CH2), 31.0 (CH2), 26.5 
(CH2), 26.2 (CH2); νmax/cm-1 3274, 2921, 2851, 1959, 1709, 1561, 1448, 1363, 1176.  
This compound decomposed rapidly; good MS/HRMS data could not be obtained. 
 
2-Methyl-3-phenylpenta-3,4-dien-1-yl sulfamate (280)  
 
 
 
Under an inert atmosphere (nitrogen), formic acid (0.2 mL, 6.0 mmol) was added 
dropwise to neat chlorosulfonyl isocyanate (0.5 mL, 6.0 mmol) with vigorous stirring at 0 
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°C.  Acetonitrile (3.6 mL) was added and the reaction mixture allowed to warm to room 
temperature and stirred overnight.  The reaction mixture was cooled to 0 °C and 2-
methyl-3-phenylpenta-3,4-dien-1-ol 258 (686 mg, 4.0 mmol) in dimethylacetamide (7.6 
mL) was added and the reaction mixture stirred for 36 hours.  The reaction was quenched 
by the addition of ethyl acetate (7 mL) and brine (3.5 mL).  The reaction mixture was 
poured into a mixture of ethyl acetate (14 mL) and water (5 mL).  The separated aqueous 
phase was further extracted with ethyl acetate (5 mL).  The combined organic phase was 
washed with brine (2 x 5 mL), dried (Na2SO4) and concentrated in vacuo.  Purification by 
column chromatography (4:1 petroleum ether/ethyl acetate to 2:1 petroleum ether/ethyl 
acetate) afforded the title compound as a white solid (655 mg, 2.6 mmol, 65%).  δH (300 
MHz, CDCl3) 7.44 – 7.16 (m, 5H), 5.27 – 5.11 (m, 2H), 4.62 (s, 2H), 4.34 (dd, J = 9.6, 
5.3 Hz, 1H), 4.06 (dd, J = 9.5, 8.1 Hz, 1H), 3.23 – 3.01 (m, 1H), 1.27 (d, J = 6.8 Hz, 3H); 
δC (75 MHz, CDCl3) 207.9 (C), 135.1 (C), 128.7 (CH), 127.2 (CH), 126.3 (CH), 106.7 
(C), 80.4 (CH2), 74.5 (CH2), 32.6 (CH), 17.0 (CH3); νmax/cm-1 3416, 3310, 2982, 2970, 
1933, 1542, 1464, 1330, 1170; m/z (ESI+) 271 (M + NH4+, 100%), 157 (60%); HRMS 
(ESI+) found 271.1115, C12H19O3N2S (M + NH4)+ requires 271.1111. 
 
2-Methylpenta-3,4-dien-1-yl sulfamate (281) 
 
 
 
Formic acid (0.3 mL, 7.7 mmol) was added dropwise to chlorosulfonyl isocyanate (0.7 
mL, 7.7 mmol) at 0 °C with rapid stirring.  Acetonitrile (4.6 mL) was added and the 
mixture stirred overnight.  A solution of 2-methylpenta-3,4-dien-1-ol 260 (500 mg, 5.1 
mmol) in dimethylacetamide (10 mL) was added dropwise at 0 °C and the reaction 
mixture stirred overnight.  The reaction was quenched by the addition of ethyl acetate (10 
mL) and brine (5 mL).  The mixture was poured into ethyl acetate (20 mL) and water (7.5 
mL).  The separated aqueous phase was further extracted with ethyl acetate (7mL).  The 
combined organic layer was washed with brine (2 x 5 mL), dried (Na2SO4) and 
concentrated in vacuo.  Purification by column chromatography (4:1 petroleum 
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ether/ethyl acetate) afforded the title compound as a clear oil (601 mg, 3.4 mmol, 67%).  
δH (300 MHz, CDCl3) 5.14 (dd, J = 13.1, 6.5 Hz, 1H), 4.85 – 4.77 (m, 2H), 4.76 (s, 2H), 
4.14 (dd, J = 9.4, 6.3 Hz, 1H), 4.04 (dd, J = 9.4, 7.0 Hz, 1H), 2.72 – 2.52 (m, 1H), 1.12 (d, 
J = 6.9 Hz, 3H); δC (75 MHz, CDCl3) 208.0 (C), 91.2 (CH), 77.2 (CH2), 75.0 (CH2), 32.2 
(CH), 16.5 (CH3); νmax/cm-1 3376, 3283, 2974, 1956, 1357, 1175, 972, 919; m/z (ESI+) 
250 (M + OAc+, 100%), 236 (15%); HRMS (ESI+) found 178.0529, C6H11O3NS (M + 
H)+ requires 178.0532. 
 
2-Methyl-3-vinylideneheptyl sulfamate (282) 
 
  
 
Hept-2-yn-1-ol (2.0 g, 17.9 mmol) was dissolved in triethyl orthopropionate (6.4 mL, 
32.0 mmol) and propionic acid (0.2 mL) was added.  The flask was fitted with a Dean-
Stark apparatus and heated to 150 °C.  After stirring for 28 hours propionic acid (0.5 mL) 
was added and the reaction mixture stirred for a further 10 hours.  Purification by column 
chromatography (16:1 petroleum ether/ethyl acetate) afforded the crude allenoate (2.4 g).  
The allenoate was dissolved in dry tetrahydrofuran (16 mL) and was added dropwise to a 
solution of lithium aluminium hydride (846 mg, 22.2 mmol) in dry tetrahydrofuran (8 
mL) at 0 °C and warmed to room temperature and stirred for 2 hours.  Following a Fieser 
work up the reaction mixture was filtered through a plug of silica using diethyl ether and 
concentrated in vacuo.  Purification by column chromatography (4:1 petroleum 
ether/ethyl acetate) afforded 2-methyl-3-vinylideneheptan-1-ol 261108 as a clear oil (1.3 g, 
8.6 mmol, 48% (over 2 steps)).  δH (300 MHz, CDCl3) 4.81 – 4.71 (m, 2H), 3.69 – 3.49 
(m, 2H), 2.34 – 2.00 (m, 1H), 2.00 – 1.89 (m, 2H), 1.56 ( br s, 1H), 1.46 – 1.30 (m, 1H), 
1.30 – 1.15 (m, 4H), 1.04 (d, J = 6.9 Hz, 3H), 0.90 (t, J = 7.1 Hz, 3H). This was reacted 
on below. 
 
Formic acid (0.3 mL, 7.7 mmol) was added dropwise to chlorosulfonyl isocyanate (0.7 
mL, 7.7 mmol) at 0 °C with rapid stirring.  Acetonitrile (4.6 mL) was added and the 
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mixture stirred overnight.  A solution of 2-methyl-3-vinylideneheptan-1-ol 261 (785 mg, 
5.1 mmol) in dimethylacetamide (10 mL) was added dropwise at 0 °C and the reaction 
mixture stirred overnight.  The reaction was quenched by the addition of ethyl acetate (10 
mL) and brine (5 mL). The mixture was poured into ethyl acetate (20 mL) and water (7.5 
mL).  The separated aqueous phase was further extracted with ethyl acetate (7mL).  The 
combined organic layer was washed with brine (2 x 5 mL), dried (Na2SO4) and 
concentrated in vacuo.  Purification by column chromatography (8:1 petroleum 
ether/ethyl acetate to 4:1 petroleum ether/ethyl acetate) afforded the title compound as a 
clear oil (925 mg, 4.0 mmol, 78%).  δH (300 MHz, CDCl3) 4.84 – 4.60 (m, 3H), 4.23 (dd, 
J = 9.4, 5.7 Hz, 1H), 3.98 (dd, J = 9.4, 8.0 Hz, 1H), 2.50 – 2.27 (m, 1H), 2.11 – 1.90 (m, J 
= 11.6, 3.4 Hz, 2H), 1.50 – 1.15 (m, 5H), 1.13 (d, J = 6.8 Hz, 3H), 0.90 (t, J = 7.1 Hz, 
3H); δC (75 MHz, CDCl3) 205.1 (C), 104.3 (C), 78.0 (CH2), 74.5 (CH2), 35.3 (CH), 30.5 
(CH2), 29.7 (CH2), 22.4 (CH2), 16.5 (CH3), 13.9 (CH3); νmax/cm-1 3286, 2958, 2931, 2874, 
1954, 1363, 1181, 908; m/z (ESI+) 273 (M + NH4+, 100%), 241 (15%), 154 (15%), 137 
(70%); HRMS (ESI+) found 251.1423, C10H23O3N2S (M + NH4)+ requires 251.1424. 
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6.1.3 Experimental for Chapter 4 
 
6-Cyclohexyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (217)   
 
 
 
Under an inert atmosphere (nitrogen), 1-cyclohexylpenta-3,4-dien-1-yl sulfamate 216 (60 
mg, 0.24 mmol) was dissolved in dry dichloromethane (0.7 mL) and PPh3AuNTf2 (8.0 
mg, 10.2 µmol) was added.  The reaction mixture was stirred for 5 days, then filtered 
through a plug of silica with diethyl ether and concentrated in vacuo.  Purification by 
column chromatography (2:1 hexane/dichloromethane to 1:2 hexane/dichloromethane) 
afforded the title compound as separable diastereoisomers (60 mg, 0.24 mmol, 99%, 
cis/trans = 1.2:1).   
 
cis-217: white solid (33 mg, 0.13 mmol); Rf 0.31 (2:1 dichloromethane/hexane); m.p. 91 
°C; δH (400 MHz, CDCl3) 5.81 (ddd, J = 17.3, 10.6, 5.1 Hz, 1H), 5.38 - 5.18 (m, 2H), 
4.56 (ddd, J = 11.9, 6.4, 2.0 Hz, 1H), 4.31 - 4.17 (m, 1H), 3.98 (d, J = 10.3 Hz, 1H), 1.98 
- 1.43 (m, 8H), 1.36 - 0.96 (m, 5H); δC (101 MHz, CDCl3) 135.3 (CH), 117.3 (CH2), 88.3 
(CH), 56.4 (CH), 42.2 (CH), 32.5 (CH2), 28.3 (CH2), 28.0 (CH2), 26.3 (CH2), 25.9 (CH2), 
25.7 (CH2); νmax/cm-1 3276, 2927, 2852, 1650, 1436, 1347, 1175; m/z (ESI+) 263 (M + 
NH4+, 100%), 246 (15%); HRMS (ESI+) found 263.1428, C11H23O3N2S (M + NH4)+ 
requires 263.1424.  
 
trans-217: colourless oil (27 mg, 0.11 mmol); Rf 0.15 (2:1 dichloromethane/hexane) δH 
(400
 
MHz, CDCl3) 6.18 (ddd, J = 17.4, 10.7, 5.5 Hz, 1H), 5.28 (ddd, J = 10.7, 1.9, 0.7 Hz, 
1H), 5.25 (ddd, J = 17.4, 1.8, 0.7 Hz, 1H), 4.67 – 4.56 (m, 1H), 4.48 (d, J = 6.6 Hz, 1H), 
4.29 - 4.13 (m, 1H), 2.08 – 1.91 (m, 1H), 1.99 - 1.92 (m, 1H), 1.88 (ddd, J = 14.5, 3.9, 2.9 
Hz, 1H), 1.83 - 1.61 (m, 5H), 1.34 - 0.96 (m, 5H); δC (101 MHz, CDCl3) 136.0 (CH), 
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117.2 (CH2), 86.3 (CH), 55.3 (CH), 41.7 (CH), 30.4 (CH2), 28.4 (CH2), 28.2 (CH2), 26.3 
(CH2), 25.8 (CH2), 25.6 (CH2); νmax/cm-1 3277, 2927, 2854, 1645, 1408, 1361, 1175, 870; 
m/z (ESI+) 263 (M + NH4+, 100%), 246 (15%), 149 (15%); HRMS (ESI+) found 
263.1428, C11H23O3N2S (M + NH4)+ requires 263.1424. 
 
(E)-4-(hept-1-en-1-yl)-1,2,3-oxathiazinane 2,2-dioxide (292) 
 
 
 
Under an inert atmosphere (nitrogen), deca-3,4-dien-1-yl sulfamate 263 (45 mg, 0.19 
mmol) was dissolved in dry dichloromethane (0.7 mL) and PPh3AuNTf2 287 (8.3 mg, 
10.6 µmol) was added. The reaction mixture was stirred for 24h, then filtered through a 
plug of silica with diethyl ether and concentrated in vacuo, affording the title compound 
as a colourless oil (42 mg, 0.18 mmol, 94%).  Rf 0.49 (7:3 petroleum ether/ethyl acetate); 
δH (300 MHz, CDCl3) 5.81 - 5.68 (m, 1H), 5.44 - 5.33 (m, 1H), 4.73 (td, J = 11.9, 3.1 Hz, 
1H), 4.58 - 4.48 (m, 1H), 4.32 - 4.16 (m, 2H), 2.09 - 1.96 (m, 2H), 1.95 - 1.72 (m, 2H), 
1.42 - 1.16 (m, 6H), 0.87 (t, J = 6.8 Hz, 3H); δC (75.5 MHz, CDCl3) 134.9 (CH), 126.8 
(CH), 71.8 (CH2), 56.9 (CH), 32.3 (CH2), 31.4 (CH2), 29.9 (CH2), 28.7 (CH2), 22.6 
(CH2), 14.1 (CH3); νmax/cm-1 3245, 2926, 1433, 1346, 1190, 1170; m/z (ESI+) 251 (M + 
NH4+, 100%), 216 (6%), 156 (6%); HRMS (ESI+) found 251.1428, C10H23O3N2S (M + 
NH4)+ requires 251.1424. 
 
4-(Cyclohexylidenemethyl)-1,2,3-oxathiazinane 2,2-dioxide (293) 
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Under an inert atmosphere (nitrogen), 4-cyclohexylidenebut-3-en-1-yl sulfamate 267 (50 
mg, 0.22 mmol) was dissolved in dry dichloromethane (0.7 mL).  PPh3AuCl (5.4 mg, 10.8 
µmol) and AgOTf (2.8 mg, 10.8 µmol) were added.  The reaction mixture was stirred for 
24 h, then filtered through a plug of silica using diethyl ether as eluent and concentrated 
in vacuo, affording the title compound as a colourless oil (33 mg, 0.14 mmol, 66%).  Rf 
0.51 (1:1 petroleum ether/ethyl acetate); δH (400 MHz, CDCl3) 5.56 - 5.42 (m, 1H), 4.78 - 
4.66 (m, 1H), 4.59 - 4.49 (m, 1H), 4.05 - 3.71 (m, 2H), 2.17 (d, J = 6.7 Hz, 2H), 2.06 - 
1.50 (m, 9H); δC (101 MHz, CDCl3) 132.1 (C), 126.5 (CH), 72.2 (CH2), 53.8 (CH), 44.2 
(CH2), 30.2 (CH2), 28.5 (CH2), 25.4 (CH2), 22.8 (CH2), 22.2 (CH2); νmax/cm-1 3246, 2922, 
1421, 1347, 1187; m/z (ESI+) 440 (M + NH4+, 100%), 232 (43%), 199 (20%), 149 (27%); 
HRMS (ESI+) found 249.1271, C10H21O3N2S (M + NH4)+ requires 249.1267. 
 
6-Isobutyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (294) 
 
 
 
Under an inert atmosphere (nitrogen), 2-methylocta-6,7-dien-4-yl sulfamate 275 (52 mg, 
0.24 mmol) was dissolved in dry dichloroethane (0.7 mL) and PPh3AuNTf2 287 (10.0 mg, 
12.7 µmol) was added.  The reaction mixture was stirred at 40 oC for 5 days, then filtered 
through a plug of silica with diethyl ether and concentrated in vacuo.  Purification by 
column chromatography (4:1 petroleum ether/ethyl acetate) afforded the title compound 
as an inseparable mixture of diastereoisomers, colourless oil (49 mg, 0.18 mmol, 95%, 
cis/trans 1.8:1).  Rf 0.52 (4:1 petroleum ether/ethyl acetate); δH (300 MHz, CDCl3) cis-
isomer: 5.81 (ddd, J = 17.3, 10.6, 5.0 Hz, 1H), 5.37 - 5.22 (m, 2H), 4.90 - 4.79 (m, 2H), 
3.90 (d, J = 10.2 Hz, 1H), 1.96 - 1.80 (m, 2H), 1.80-1.66 (m, 1H), 1.60 - 1.45 (2H), 1.00 - 
0.87 (m, 6H) trans-isomer: 6.18 (ddd, J = 17.3, 10.7, 5.5 Hz, 1H), 5.37 - 5.22 (m, 2H), 
5.00 - 4.91 (m, 2H), 4.44 (d, J = 7.1 Hz, 1H), 1.96 - 1.80 (m, 2H), 1.80 - 1.66 (m, 1H), 
1.44 - 1.32 (m, 2H), 1.00 - 0.87 (m, 6H); δC (75 MHz, CDCl3) cis-isomer: 135.1 (CH), 
117.4 (CH2), 82.7 (CH), 56.3 (CH), 44.3 (CH2), 35.6 (CH), 23.8 (CH2), 23.0 (CH3), 22.0 
(CH3) trans-isomer: 135.9 (CH), 117.4 (CH2), 81.1 (CH), 55.2 (CH), 43.6 (CH2), 33.5 
(CH), 24.1 (CH2), 23.0 (CH3), 21.9 (CH3); νmax/cm-1 3245, 2960, 2874, 1650, 1413, 1356, 
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1185; m/z (ESI+) 237 (M+NH4+, 100%), HRMS (ESI+) found 237.1270, C9H21O3N2S (M 
+ NH4)+ requires 237.1267. 
 
6-(tert-Butyl)-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (295) 
 
 
 
Under an inert atmosphere (nitrogen), 2,2-dimethylhepta-5,6-dien-3-yl sulfamate 276 (57 
mg, 0.24 mmol) was dissolved in dry dichloroethane (0.7 mL) and PPh3AuNTf2 287 (10.0 
mg, 12.7 µmol) was added.  The reaction mixture was stirred at 40 oC for 4 days, then 
filtered through a plug of silica with diethyl ether and concentrated in vacuo.  Purification 
by column chromatography (petroleum ether to 2:1 petroleum ether/ethyl acetate) 
afforded the title compound as an inseparable mixture of diastereoisomers, colourless oil 
(53 mg, 0.22 mmol, 93%, cis/trans 2:1).  Rf 0.44 (4:1 petrol ether/ethyl acetate); δH (300 
MHz, CDCl3) cis-isomer: 5.82 (ddd, J = 17.3, 10.6, 5.0 Hz, 1H), 5.42 - 5.15 (m, 2H), 4.58 
- 4.39 (m, 1H), 4.28 - 4.15 (m, 2H), 1.95 – 1.82 (m, 1H), 1.65 – 1.46 (1H, m), 0.98 (s, 9H) 
trans-isomer: 6.20 (ddd, J = 17.4, 10.7, 5.4 Hz, 1H), 5.42 - 5.15 (m, 2H), 4.58 – 4.39 (m, 
1H), 4.30 - 4.01 (m, 2H), 2.10 - 1.97 (m, 1H), 1.95 – 1.82 (m, 1H), 0.98 (s, 9H); δC (75 
MHz, CDCl3) cis-isomer 135.2 (CH), 117.3 (CH2), 91.3 (CH), 56.3 (CH), 34.5 (CH2), 
29.9 (C), 25.4 (CH3) trans-isomer 135.9 (CH), 117.1 (CH2), 88.5 (CH), 55.2 (CH), 34.4 
(C), 27.8 (CH2), 25.2 (CH3); νmax/cm-1 3252, 2962, 2877, 1650, 1413, 1346, 1183; m/z 
(ESI+) 237 (M + NH4+, 100%) HRMS (ESI+) found 237.1269, C9H21O3N2S (M + NH4)+ 
requires 237.1267. 
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6-Phenethyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (296) 
 
 
 
Under an inert atmosphere (nitrogen), 1-phenylhepta-5,6-dien-3-yl sulfamate 277 (50 mg, 
0.19 mmol) was dissolved in dry dichloromethane (0.7 mL) and PPh3AuNTf2 287 (7.3 
mg, 9.3 µmol) was added.  The reaction mixture was stirred at room temperature for 5 
days then filtered through a plug of silica with diethyl ether and concentrated in vacuo.  
Purification by column chromatography (6:1 pentane/ethyl acetate to 4:1 pentane/ethyl 
acetate) afforded the title compound as an inseparable mixture of diastereoisomers, 
colourless oil (48 mg, 0.18 mmol, 95%, cis/trans 1.8:1).  δH (400 MHz, CDCl3) cis-
isomer: 7.42 - 7.19 (m, 5H), 5.85 (ddd, J = 17.3, 10.6, 5.0 Hz, 1H), 5.41 - 5.25 (m, 2H), 
4.86 - 4.76 (m, 1H), 4.37 - 4.24 (m, 1H), 4.04 (d, J = 10.4 Hz, 1H), 3.00 - 2.71 (m, 2H), 
2.22 - 2.04 (m, 1H), 2.03 - 1.86 (m, 2H), 1.63 (dt, J = 14.3, 11.9 Hz, 1H) trans-isomer: 
7.42 – 7.19 (m, 5H), 6.16 (ddd, J = 17.2, 10.7, 5.5 Hz, 1H), 5.41 - 5.25 (m, 2H), 4.91 (m, 
1H), 4.54 (d, J = 6.8 Hz, 1H), 4.37 - 4.24 (m, 1H), 3.00 - 2.71 (m, 2H), 2.36 (dtd, J = 
14.4, 9.2, 5.3 Hz, 1H), 2.03 - 1.86 (m, 3H); δC (75 MHz, CDCl3) cis-isomer: 140.4 (C), 
135.0 (CH), 128.8 (CH), 128.6 (CH), 126.5 (CH), 117.5 (CH2), 83.1 (CH), 56.3 (CH), 
37.1 (CH2), 35.2 (CH2), 30.7 (CH2) trans-isomer: 140.5 (C), 135.6 (CH), 128.7 (CH), 
128.6 (CH), 126.4 (CH), 117.5 (CH2), 81.9 (CH), 55.0 (CH), 36.5 (CH2), 33.1 (CH2), 31.1 
(CH2); νmax/cm-1 3263, 3028, 2931, 1603, 1497, 1416, 1360, 1183; m/z (ESI+) 285 (M + 
NH4+, 100%), 214 (60%); HRMS (ESI+) found 285.1272, C13H21O3N2S (M + NH4)+ 
requires 285.1267. 
 
 
 
 
 
149 
 
5-Methyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (297) 
 
 
 
Under an inert atmosphere (nitrogen), 2-methylpenta-3,4-dien-1-yl sulfamate 281 (50 mg, 
0.28 mmol) was dissolved in dry dichloromethane (0.7 mL) and PPh3AuNTf2 287 (13 mg, 
16.5 µmol) was added.  The reaction mixture was stirred for 3 days at room temperature 
and flushed through a plug of silica with diethyl ether and concentrated in vacuo.  
Purification by column chromatography (dichloromethane to 1% methanol in 
dichloromethane) afforded the title compound as a colourless oil (36 mg, 0.23 mmol, 
75%, major/minor 3:1);  δH (400 MHz, CDCl3) major-isomer: 5.81 - 5.66 (m, 1H), 5.42 - 
5.23 (m, 2H), 4.84 (dd, J = 11.1, 2.5 Hz, 1H), 4.58 - 4.42 (m, 2H), 4.33 (dd, J = 11.5, 1.9 
Hz, 1H), 2.00 - 1.79 (m, 1H), 1.08 (d, J = 7.2 Hz, 3H) minor-isomer: 5.81 – 5.66 (m, 1H), 
5.42 – 5.23 (m, 2H), 4.42 – 4.35 (m, 2H), 3.87 (dd, J = 17.6, 9.8 Hz, 1H), 2.00-1.79 (m, 
1H), 0.89 (d, J = 6.8 Hz, 3H); δC (101 MHz, CDCl3) major-isomer: 133.9 (CH), 117.0 
(CH2), 77.7 (CH2), 59.8 (CH), 30.8 (CH), 9.7 (CH3) minor-isomer: 133.7 (CH), 120.1 
(CH2), 76.4 (CH2), 63.4 (CH), 33.3 (CH), 12.0 (CH3); νmax/cm-1 3266, 2977, 1647, 1423, 
1358, 1185, 919; m/z (ESI+) 195 (M + NH4+, 100%), 187 (10%); HRMS (ESI+) found 
195.0794, C6H15O3N2S (M + NH4)+ requires 195.0798.  
 
tert-Butyl 5-methyl-4-vinyl-1,2,3-oxathiazinane-3-carboxylate 2,2-dioxide (299)  
 
 
 
5-Methyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide 297 (188 mg, 1.0 mmol) was dissolved 
in dry dichloromethane (10 mL) and di-tert-butyl dicarbonate (255 mg, 1.2 mmol) was 
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added followed by pyridine (94 µL, 1.2 mmol) and dimethylaminopyridine (13 mg, 0.1 
mmol).  The reaction mixture was stirred for 18 hours.  The reaction mixture was poured 
into brine (10 mL) and extracted with dichloromethane (3 x 10 mL), dried (Na2SO4) and 
concentrated in vacuo.  Purification by column chromatography (1:1 
dichloromethane/hexane to dichloromethane) afforded the title compound as a colourless 
oil (146 mg, 0.5 mmol, 50%).  δH (300 MHz, CDCl3) 6.02 (ddd, J = 17.2, 10.0, 8.4 Hz, 
1H), 5.46 – 5.27 (m, 2H), 4.75 (ddd, J = 8.4, 4.5, 0.6 Hz, 1H), 4.55 (ddd, J = 10.9, 6.5, 
0.9, 1H), 4.30 – 4.16 (m, 1H), 2.95 – 2.73 (m, 1H), 1.53 (s, 9H), 0.98 (d, J = 7.0 Hz, 3H); 
δC (75 MHz, CDCl3) 150.4 (C), 130.0 (CH), 121.5 (CH2), 85.2 (C), 74.5 (CH2), 64.7 
(CH), 31.5 (CH), 28.0 (CH3), 13.4 (CH3); νmax/cm-1 3266, 2976, 1647, 1424, 1360, 1187, 
920; m/z (ESI+) 295 (M + NH4+, 100%), 222 (30%); HRMS (ESI+) found 295.1326, 
C11H23O5N2S (M + NH4)+ requires 295.1322. 
 
(4S,5R)-5-methyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (300) 
 
 
 
tert-Butyl 5-methyl-4-vinyl-1,2,3-oxathiazinane-3-carboxylate 2,2-dioxide 299 (100 mg, 
0.4 mmol) was dissolved in acetonitrile (4 mL) and water (3 mL) and was stirred at 75 °C 
for 24 hours.  After cooling to room temperature aqueous hydrochloric acid (1M; 2 mL) 
and ethyl acetate (2 mL) were added and the reaction mixture stirred for 1 hour, then 
basified with aqueous sodium hydroxide (1M).  The biphasic mixture was extracted with 
ethyl acetate (3 times).  The combined organic layer washed with brine, dried (MgSO4) 
and concentrated in vacuo affording the title compound as a yellow oil (46mg, 0.26 
mmol, 72%).  δH (300 MHz, CDCl3) 5.76 (ddd, J = 17.2, 10.8, 4.3 Hz, 1H), 5.30 (ddd, J = 
15.6, 10.1, 1.9 Hz, 2H), 4.86 (dd, J = 11.5, 2.5 Hz, 1H), 4.64 – 4.45 (m, 1H), 4.33 (dd, J = 
11.5, 1.8 Hz, 1H), 4.28 – 4.19 (m, 1H), 2.03 – 1.79 (m, 1H), 1.09 (d, J = 7.2 Hz, 3H); δC 
(75 MHz, CDCl3) 133.8 (CH), 116.9 (CH2), 77.6 (CH2), 59.7 (CH), 30.7 (CH), 9.5 (CH3); 
Other data as above.  (see Appendix B for crystallographic data) 
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4-Propyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (302)  
 
 
 
Under an inert atmosphere (nitrogen), 3-vinylidenehexyl sulfamate 264 (54 mg, 0.26 
mmol) was dissolved in dry dichloromethane (0.7 mL) and PPh3AuNTf2 287 (10.0 mg, 
11.4 µmol) was added.  The reaction mixture was stirred for 18 h, then filtered through a 
plug of silica with diethyl ether and concentrated in vacuo affording the title compound as 
a colourless oil (50 mg, 0.24 mmol, 92%).  Rf 0.41 (dichloromethane); δH (400 MHz, 
CDCl3) 5.97 - 5.85 (m, 1H), 5.30 (d, J = 11.1 Hz, 1H), 5.12 (d, J = 17.7 Hz, 1H), 4.73 - 
4.64 (m, 1H), 4.60 (ddd, J = 11.8, 5.6, 4.0 Hz, 1H), 4.28 (s, 1H), 2.04 - 1.96 (m, 1H), 1.91 
- 1.81 (m, 1H), 1.81 - 1.71 (m, 1H), 1.56 - 1.35 (m, 2H), 1.34 - 1.20 (m, 1H), 0.91 (t, J = 
7.2 Hz, 3H); δC (101 MHz, CDCl3) 139.9 (CH), 115.1 (CH2), 69.2 (CH2), 63.0 (C), 43.2 
(CH2), 32.2 (CH2), 16.2 (CH2), 14.2 (CH3); νmax/cm-1 3263, 2963, 2876, 1641, 1407, 
1354; m/z (ESI+) 223 (M + NH4+, 100%), 185 (5%); HRMS (ESI+) found 223.1113, 
C8H19O3N2S (M + NH4)+ requires 223.1111. 
 
4-Hexyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (303) 
 
 
 
Under an inert atmosphere (nitrogen), 3-vinylidenenonyl sulfamate 265 (50 mg, 0.2 
mmol) was dissolved in dry dichloromethane (0.7 mL) and PPh3AuNTf2 287 (7.8 mg, 
10.0 µmol) was added.  The reaction mixture was stirred at room temperature for 48 
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hours.  The reaction mixture was filtered through a plug of silica with diethyl ether and 
concentrated in vacuo.  Purification by column chromatography (gradient elution: 1:1 
petrol ether/dichloromethane to dichloromethane) gave the desired material as a yellow 
oil (35 mg, 0.14 mmol, 68%).  δH (300 MHz, CDCl3) 5.91 (dd, J = 17.5, 10.8 Hz, 1H), 
5.30 (d, J = 11.1 Hz, 1H), 5.12 (d, J = 17.7 Hz, 1H), 4.77 - 4.48 (m, 2H), 4.16 (s, 1H), 
2.01 (m, 1H), 1.92 - 1.70 (m, 2H), 1.60 - 1.51 (m, 1H), 1.44 - 1.14 (m, 8H), 0.88 (dd, J = 
9.3, 4.2 Hz, 3H); δC (75 MHz, CDCl3) 140.0 (CH), 115.2 (CH2), 69.2 (CH2), 63.0 (C), 
41.1 (CH2), 32.3 (CH2), 31.7 (CH2), 29.4 (CH2), 22.8 (CH2), 22.7 (CH2), 14.2 (CH3); 
νmax/cm-1 3264, 2956, 2931, 2859, 1642, 1407, 1356, 1186, 777; m/z (ESI+) 270 (M + 
Na+, 100%); HRMS (ESI+) found 270.1138, C11H21O3NNaS (M + Na)+ requires 
270.1134. 
 
4-(Cyclohexylmethyl)-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (304) 
 
 
 
Under an inert atmosphere (nitrogen), 3-(cyclohexylmethyl)penta-3,4-dien-1-yl sulfamate 
279 (100 mg, 0.38 mmol) was dissolved in dry dichloroethane (1.4 mL) and PPh3AuNTf2 
287 (17.2 mg, 22 µmol) was added. The reaction mixture was stirred at 40 °C for 4 days.  
The room temperature reaction mixture was filtered through a plug of silica with diethyl 
ether and concentrated in vacuo.  Purification by column chromatography (2:1 petroleum 
ether/diethyl ether) gave the desired material as a colourless oil (37 mg, 0.14 mmol, 
37%).  δH (300 MHz, CDCl3) 6.00 (dd, J = 17.8, 11.1 Hz, 1H), 5.31 (d, J = 11.1 Hz, 1H), 
5.15 (d, J = 17.8 Hz, 1H), 4.77 – 4.64 (ddd, J = 11.8, 9.4, 3.2, 1H), 4.56 (ddd, J = 11.8, 
5.0, 4.1 Hz, 1H), 4.12 (s, 1H), 2.06 – 1.83 (m, 2H), 1.72 – 1.37 (m, 6H), 1.31 – 1.04 (m, 
4H), 1.04 – 0.82 (m, 3H); δC (101 MHz, CDCl3) 140.2 (CH), 115.0 (CH2), 69.1 (CH2), 
63.4 (C), 49.4 (CH2), 35.3 (CH2), 35.0 (CH2), 33.3 (CH2), 33.0 (CH), 26.4 (CH2), 26.4 
(CH2), 26.1 (CH2); νmax/cm-1 3381, 2921, 2850, 1557, 1449, 1348, 1176, 926; m/z (ESI+) 
282 (M + Na+, 100%), 278 (40%), 163 (30%); HRMS (ESI+) found 260.1319, 
C12H22O3NS (M + H)+ requires 260.1315.  
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4-(2-Benzyloxy)ethyl)-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (305) 
 
 
 
Under an inert atmosphere (nitrogen), 3-(2-(Benzyloxy)ethyl)penta-3,4-dien-1-yl 
sulfamate 266 (50 mg, 0.17 mmol) was dissolved in dry dichloromethane (0.7 mL) and 
PPh3AuNTf2 287 (6.6 mg, 8.4 µmol) was added.  The reaction mixture was stirred at 
room temperature for 5 days. The room temperature reaction mixture was filtered through 
a plug of silica with diethyl ether and concentrated in vacuo.  Purification by column 
chromatography (9:1 dichloromethane/ ethyl acetate) gave the desired material as a 
colourless oil (45 mg, 0.15 mmol, 90%).  δH (300 MHz, CDCl3) 7.47 – 7.26 (m, 5H), 6.00 
(ddd, J = 17.7, 11.0, 0.6 Hz, 1H), 5.78 (s, 1H), 5.34-5.12 (m, 2H), 4.72 (td, J = 11.4, 2.4 
Hz, 1H), 4.60-4.41 (m, 3H), 3.73 – 3.53 (m, 2H), 2.15 – 1.94 (m, 2H), 1.89 – 1.74 (m, 
2H); δC (75 MHz, CDCl3) 140.3 (CH), 137.1 (C), 128.7 (CH), 128.1 (CH), 128.0 (CH), 
115.4 (CH2), 73.5 (C), 68.8 (CH2), 65.6 (CH2), 62.4 (CH2), 40.1 (CH2), 30.6 (CH2); 
νmax/cm-1 3247, 2874, 1703, 1496, 1455, 1407, 1358, 1187, 778; m/z (ESI+) 315 (M + 
NH4+, 90%), 298 (M + H)+, 100%), 149 (25%); HRMS (ESI+) found 298.1115, 
C14H20O4NS (M + H)+ requires 298.1108. 
 
4-Isopropyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (306) 
 
 
 
Under an inert atmosphere (nitrogen), 3-isopropylpenta-3,4-dien-1-yl sulfamate 278 (150 
mg, 0.7 mmol) was dissolved in dry dichloroethane (2.1 mL) and PPh3AuNTf2 287 (28.7 
mg, 36.6 µmol) was added.  The reaction mixture was heated to 60 °C and stirred for 24 
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hours.  The reaction mixture was filtered through a plug of silica using diethyl ether.  
Purification by column chromatography (gradient elution: 8:1 petroleum 
ether/dichloromethane to dichloromethane) afforded the title compound as a white solid 
(5 mg, 24.4 µmol, 3%).  δH (400 MHz, CDCl3) 5.87 (ddd, J = 17.9, 11.2, 1.0 Hz, 1H), 
5.40 (d, J = 11.2 Hz, 1H), 5.08 (d, J = 17.9 Hz, 1H), 4.71 (ddd, J = 11.7, 11.0, 2.6 Hz, 
1H), 4.53 (dt, J = 11.8, 4.1 Hz, 1H), 4.12 (s, 1H), 2.02 (ddd, J = 14.7, 3.8, 2.7 Hz, 1H), 
1.97 – 1.76 (m, 2H), 0.94 (d, J = 6.8 Hz, 3H), 0.89 (d, J = 6.8 Hz, 3H); δC (100 MHz, 
CDCl3) 136.3 (CH), 116.7 (CH2), 69.1 (CH2), 66.0 (C), 38.1 (CH), 30.2 (CH2), 16.5 
(CH3), 16.1 (CH3); νmax/cm-1 3263, 2970, 2881, 1424, 1409, 1359, 1187, 1048, 882, 778. 
 
3-Allyl-4-hexyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (307) 
 
 
 
To a solution of 4-hexyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide 303 (300 mg, 1.2 mmol) 
in dichloromethane (8.7 mL) was added benzyltributylammonium bromide (21.4 mg, 60 
µmol), allyl bromide (0.4 mL, 4.8 mmol) and sodium hydroxide (5M; 1.7 mL) were 
added and allowed to stir at room temperature for 24 hours.  The separated aqueous layer 
was further extracted with chloroform (3 x 5 mL).  The combined organic phase was 
dried (Na2SO4) and concentrated in vacuo.  Purification by column chromatography (9:1 
petroleum ether/diethyl ether to 3:2 petroleum ether/diethyl ether) afforded the title 
compound as a clear oil (299 mg, 1.0 mmol, 87%).  δH (300 MHz, CDCl3) 5.91 – 5.71 (m, 
2H), 5.30 – 5.17 (m, 4H), 4.78 – 4.67 (m, 2H), 4.21 (t, J = 7.1 Hz, 2H), 3.83 (d, J = 6.4 
Hz, 4H), 2.41 – 2.28 (m, 2H), 2.04 – 1.88 (m, 2H), 1.50 – 1.20 (m, 4H), 1.00 – 0.79 (m, 
3H); δC (100 MHz, CDCl3) 139.4 (CH2), 135.5 (CH2), 117.1 (CH), 115.5 (CH), 68.5 
(CH2), 67.4 (C), 48.3 (CH2), 37.3 (CH2), 31.8 (CH2), 31.4 (CH2), 29.6 (CH2), 23.8 (CH2), 
22.7 (CH2), 14.2 (CH3); νmax/cm-1 3083, 2930, 2858, 1379, 1353, 1175, 922, 787; m/z 
(ESI+) 305 (M + NH4+, 100%), 288 (M + H+, 55%); HRMS (ESI+) found 288.1624, 
C14H26O3NS (M + H)+ requires 288.1628.  
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3-Allyl-4-propyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide (309) 
  
 
 
To a stirring solution of 4-propyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide 302 (735 mg, 
3.6 mmol) in dichloromethane (26 mL) was added benzyltributylammonium bromide (64 
mg, 179 µmol), allyl bromide (1.2 mL, 14.3 mmol) and sodium hydroxide solution (5M).  
The reaction mixture was stirred for 24 hours.  Purification by column chromatography 
(4:1 petroleum ether/ethyl acetate) afforded the title compound as a colourless oil (728 
mg, 3.0 mmol, 84%).  δH (300 MHz, CDCl3) 6.09 (dd, J = 17.7, 11.1 Hz, 1H), 5.94 (dddd, 
J = 17.1, 10.2, 6.2, 5.5 Hz, 1H), 5.34 – 5.08 (m, 4H), 4.72 – 4.52 (m, 2H), 3.93 (ddt, J = 
17.0, 5.4, 1.6 Hz, 1H), 3.74 (ddt, J = 17.0, 6.2, 1.4 Hz, 1H), 2.24 – 2.08 (m, 1H), 2.05 – 
1.68 (m, 3H), 1.51 – 1.19 (m, 2H), 0.92 (t, J = 7.3 Hz, 3H); δC (75 MHz, CDCl3) 139.3 
(CH), 135.5 (CH), 117.1 (CH2), 115.5 (CH2), 68.5 (CH2), 67.4 (C), 48.3 (CH2), 39.4 
(CH2), 31.3 (CH2), 17.2 (CH2), 14.3 (CH3); νmax/cm-1 3087, 2964, 2876, 1642, 1379, 
1352, 1175; m/z (ESI+) 263 (M + NH4+, 70%), 246 (M + H+, 100%); HRMS (ESI+) found 
246.1162, C11H20O3NS (M + H)+ requires 246.1158. 
 
4-(Allylamino)-4-vinylheptanenitrile (310) 
 
 
 
3-Allyl-4-propyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide 309 (100 mg, 0.41 mmol) was 
dissolved in dry dimethylformamide (1.4 mL) and potassium cyanide (133 mg, 2.04 
mmol) was added and stirred at 40 °C for 2 days.  The reaction mixture was diluted with 
ether (2 mL) and H2SO4 (20% aqueous; 2 mL) was added and stirred for 5 hours.  The 
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mixture was neutralised with solid sodium carbonate and extracted with diethyl ether (3 x 
5 mL).  The combined organic phase was washed with water (x 2), brine and concentrated 
in vacuo to give the desired material as a clear oil (61 mg, 0.3 mmol, 78%).  δH (300 
MHz, CDCl3) 5.90 (ddt, J = 17.1, 10.2, 5.8 Hz, 1H), 5.58 (dd, J = 17.5, 10.9 Hz, 1H), 
5.27-5.01 (m, 4H), 3.02 (dt, J = 5.8, 1.5 Hz, 2H), 2.32 (ddd, J = 8.3, 6.9, 1.0 Hz, 2H), 
1.95-1.63 (m, 2H), 1.54-1.08 (m, 4H), 0.92 (t, J = 7.2 Hz, 3H); δC (75 MHz, CDCl3) 
143.0 (CH), 137.0 (CH), 120.8 (C), 115.5 (CH2), 114.9 (CH2), 58.5 (C), 44.3 (CH2), 39.0 
(CH2), 31.5 (CH2), 16.4 (CH2), 14.4 (CH3), 11.3 (CH2); νmax/cm-1 3083, 2959, 2933, 2873, 
2246, 1643, 1458, 1416, 918; m/z (ESI+) 193 (M+H+, 100%); HRMS (ESI+) found 
193.1695, C12H21N2 (M + H)+ requires 193.1699. 
 
(E)-N-(1-Allyl-5-propyl-5-vinylpyrrolidin-2-ylidene)acetamide (314) 
 
 
 
Under an inert atmosphere (nitrogen), diisopropylethylamine (134 mg, 180 µl, 1.04 
mmol) was added dropwise to 4-(allylamino)-4-vinylheptanitrile 310 in dry 
dichloromethane (2.2 mL).  The reaction mixture was cooled to 0°C and acetic anhydride 
(32 mg, 29 µL, 0.31 mmol) was added dropwise followed by dimethylaminopyridine (32 
mg, 0.26 mmol).  The reaction mixture was heated to reflux for 48 hours.  The room 
temperature reaction mixture was quenched with water (2 mL) followed by H3PO4 (5% 
wt/v; 1 mL) and the organic layer was separated.  The aqueous layer was further extracted 
with dichloromethane (2 x 5 mL) and the combined organic phase was washed with 
saturated sodium bicarbonate solution and dried (Na2SO4) and concentrated in vacuo.  
Purification by column chromatography (1:1 petroleum ether/ethyl acetate) gave the 
desired material as a yellow oil (24 mg, 0.1 mmol, 43%).  δH (400 MHz, CDCl3) 5.90 
(dddd, J = 17.1, 10.2, 6.9, 5.4 Hz, 1H), 5.78 (dd, J = 17.4, 10.8 Hz, 1H), 5.20 – 5.00 (m, 
4H), 4.09 (dd, J = 15.4, 4.7 Hz, 1H), 3.69 (dd, J = 15.3, 6.9 Hz, 1H), 3.13 – 2.94 (m, 1H), 
157 
 
2.94 – 2.76 (m, 1H), 2.14 (s, 3H), 1.95 (t, J = 7.9 Hz, 2H), 1.72 (ddd, J = 13.7, 12.1, 5.0 
Hz, 1H), 1.58 (ddd, J = 13.7, 12.0, 4.4 Hz, 1H), 1.43 – 1.05 (m, 2H), 0.92 (t, J = 7.3 Hz, 
3H); δC (100 MHz, CDCl3) 184.3 (C), 170.1 (C), 140.1 (CH), 133.7 (CH), 117.1 (CH2), 
114.7 (CH2), 69.3 (C), 44.8 (CH2), 38.9 (CH2), 31.6 (CH2), 29.1 (CH2), 28.0 (CH3), 17.0 
(CH2), 14.3 (CH3); νmax/cm-1 2961, 2875, 1642, 1540, 1263, 1249, 990, 925; m/z (ESI+) 
235 (M + H+, 100%), 194 (70%); HRMS (ESI+) found 235.1806, C14H23ON2 (M + H)+ 
requires 235.1805.  
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6.1.4 Experimental for Chapter 5 
 
5-(Ethoxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (420)162 
 
 
 
Under an inert atmosphere (nitrogen), triethylorthoformate (28.9 mL, 174 mmol) was 
added to Meldrum’s acid 419 (5.0 g, 35 mmol). The stirring mixture was heated to 100 oC 
and stirred for 4 hours.  The room temperature reaction mixture was concentrated in 
vacuo, giving the desired product as a yellow-orange unstable solid (3.44 g, 17.2 mmol, 
49% crude).  δH (200 MHz, CDCl3) 8.24 (s, 1H), 4.51 (q, J = 7.2 Hz, 2H), 1.73 (s, 6H,), 
1.53 (t, J = 7.2 Hz, 3H); δC (50 MHz, CDCl3) 177.1 (C), 174.0 (C), 160.7 (C), 107.1 
(CH), 95.6 (CH2), 27.3 (CH3), 15.6 (CH3). (reacted on as unstable)   
 
5-(Hydroxymethylene)-2,2-dimethyl-1,3-dioxane-4,6-dione (421)163 
 
 
 
To a stirring solution of 2,2-dimethyl-5-ethoxymethylene-1,3-dioxane-4,6-dione 420 (4.3 
g, 22 mmol) in tetrahydrofuran (25 mL) was added hydrochloric acid (2M; 43 mL, 86 
mmol) in one portion and the reaction mixture stirred at room temperature for one hour.  
Saturated sodium chloride (25 mL) was added and the reaction mixture was extracted 
with diethyl ether (3 x 50 mL).  The combined organic phase was dried (MgSO4) and 
concentrated in vacuo giving a yellow solid (3.6 g, 21 mmol, 95%).  δH (400 MHz, 
CDCl3) 8.52 (s, 1H), 1.73 (s, 6H) (reacted on as unstable). 
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Methyl benzenesulfinate (437)201 
 
 
 
To a solution of diphenyldisulfide 436 (10 g, 46 mmol) in methanol (800 mL) was added 
sodium carbonate (24.3 g, 229 mmol) followed by bromine (7.0 mL).  The reaction 
mixture was stirred for 3 hours and concentrated in vacuo.  The reaction mixture was 
partitioned between dichloromethane (600 mL) and water (400 mL).  The layers were 
separated and the aqueous layer further extracted with dichloromethane (9 x 50 mL).  The 
combined organic phases were combined, dried (Na2CO3) and concentrated in vacuo 
giving a yellow oil (13.4 g, 86 mmol, 93%).  δH (200 MHz, CDCl3) 7.64 - 7.57 (m, 2H), 
7.50 - 7.42 (m, 3H), 3.38 (s, 3H); δC (50 MHz, CDCl3) 144.1 (C), 132.4 (CH), 129.3 
(CH), 125.6 (CH), 49.8 (CH3); νmax/cm-1 3060, 2942, 1445, 1124. 
 
2,2-Dimethyl-1,3-dioxan-5-one (430)202 
 
 
 
To a cold solution (0 °C) of 5-amino-5-hydroxymethyl-2,2-dimethyl-1,3-dioxane 431 
(11.7 g, 73 mmol) and potassium phosphate (9.9 g, 73 mmol) in water (241 mL) was 
added dropwise via an addition funnel a solution of sodium periodate (15.6 g, 73 mmol) 
in water (211 mL) over 3 hours.  The mixture was allowed to stir for an additional hour at 
5 °C.  The reaction mixture was heated to room temperature and stirred for an additional 
17 hours.  Sodium thiosulphate (18.0 g, 73 mmol) was added and the resulting solution 
allowed to stir for 30 minutes.  The reaction mixture was extracted with dichloromethane 
(15 x 50 mL).  The combined organic phase was dried (Na2CO3), filtered and 
concentrated in vacuo giving a yellow oil (6.0 g, 46 mmol, 63%).  δH (200 MHz, CDCl3) 
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4.03 (s, 4H), 1.34 (s, 6H); δC (50 MHz, CDCl3) 208.1 (C=O), 100.1 (C), 66.8 (CH2), 23.4 
(CH3); νmax/cm-1 2990, 1751, 1374, 1215, 1088. 
 
2,2-Dimethyl-1,3-dioxan-5-ol (439)203 
 
 
 
To a solution of 2,2-dimethyl-5-oxo-1,3-dioxane 430 (4.1 g, 31.7 mmol) in dry 
tetrahydrofuran (100 mL) at 0 °C was added portion wise over 10 minutes, lithium 
aluminium hydride (1.2 g, 31.7 mmol).  The resulting solution was warmed to room 
temperature and stirred for 1 hour.  The reaction mixture was cooled to 0 °C and 
quenched with water (1.2 mL) then 10% aqueous sodium hydroxide solution (1.2 mL) 
and finally water (3.5 mL).  The reaction mixture was diluted with ethyl acetate (100 
mL).  The precipitate was filtered off and the separated organic layer dried (Na2SO4) and 
concentrated in vacuo to afford the title compound as a clear oil (3.7 g, 28 mmol, 89%).  
δH (200 MHz, CDCl3) 4.19 - 3.99 (m, 2H), 3.85 - 3.67 (m, 2H), 3.53 (br s, 1H), 2.85 – 
2.74 (m, 1H),1.46 (d, J = 0.5 Hz, 3H), 1.43 (d, J = 0.5 Hz, 3H); δC (50 MHz, CDCl3) 97.8 
(C), 64.7 (CH2), 62.9 (CH), 27.3 (CH3), 18.6 (CH3); νmax/cm-1 3420, 2993, 2873, 1373, 
1197, 1081, 822. 
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2,2-Dimethyl-1,3-dioxan-5-yl 4-methylbenzenesulfonate (440)204 
 
 
 
To a solution of 2,2-dimethyl-1,3-dioxan-5-ol 439 (3.4 g, 25.9 mmol) and p-
toluenesulfonyl chloride (5.4 g, 28.1 mmol) in chloroform (5.5 mL) was added pyridine 
(2.7 mL) at 0 °C over a period of 10 minutes and then DMAP (2 mg) was added.  The 
reaction mixture was partitioned between chloroform (20 mL) and water (20 mL).  The 
separated aqueous layer was further extracted with chloroform (2 x 10 mL).  The 
combined organic phase was dried (Na2SO4) and concentrated in vacuo.  Purification by 
column chromatography (5:1 petroleum ether / ethyl acetate) gave the desired material as 
a white solid (6.4 g, 22.4 mmol, 84%).  δH (200 MHz, CDCl3) 4.25 - 3.98 (m, 1H), 2.53 
(dd, J 18.0, 5.7 Hz, 1H), 2.17 (dd, J 18.0, 10.0 Hz, 1H), 1.87 - 1.03 (m, 6H), 1.24 (s, 3H), 
1.17 (s, 3H), 1.00 - 0.70 (m, 3H); δC (50 MHz, CDCl3) 145.2 (C), 133.6 (C), 130.1 (CH), 
127.8 (CH), 98.6 (C), 72.1 (CH), 62.1 (CH2), 61.9 (CH2), 24.3 (CH3), 22.5 (CH3), 21.7 
(CH3); νmax / cm-1 3072, 2983, 1598, 1175. 
 
1,3-Dioxan-5-yl 4-methylbenzenesulfonate (447)168 
 
 
 
To a solution of glycerol formal 446 (16.6 g, 0.16 mol) and tosyl chloride (31.8 g, 0.17 
mol) in chloroform (50 mL) was added pyridine (16 mL) at 0 °C and finally DMAP (5 
mg) was added.  After stirring for 12 hours the mixture was partitioned between water (20 
mL) and chloroform (20 mL).  The separated aqueous layer was further extracted with 
chloroform (2 x 15 mL).  The combined organic layer was dried (Na2SO4) and 
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concentrated in vacuo.  Recrystallisation using ethyl acetate / petroleum ether gave the 
desired material as a white solid (14.5 g, 55.9 mmol, 58%).  δH (200 MHz, CDCl3) 7.90 – 
7.71 (m, 2H), 7.36 (dd, J = 8.1, 0.5 Hz, 2H), 4.86 – 4.68 (m, 2H), 4.55 – 4.36 (m, 1H), 
4.09 – 3.65 (m, 4H), 2.45 (s, 3H); δC (50 MHz, CDCl3) 145.1 (C), 133.2 (C), 129.8 (CH), 
127.6 (CH), 93.2 (CH2), 70.4 (CH), 68.3 (CH2), 21.4 (CH3); νmax / cm-1 3084, 2991, 1586, 
1161. 
 
4H-1,3-Dioxine (448)205 
 
 
 
Potassium hydroxide (46.7 g, 0.8 mol) was suspended in triethylene glycol (406 mL) and 
stirred at 100 °C until a homogeneous solution was obtained.  The solution was allowed 
to cool to 50 °C and 1,3-dioxan-5-yl 4-methylbenzenesulfonate 447 (123 g, 475 mmol) 
was added in one portion.  The solution was heated slowly to 200 °C whilst stirring. The 
dioxene and water formed were condensed on a cold trap.  Purification by distillation 
followed by drying (Na2SO4) gave the desired material as a colourless oil (17.7 g, 0.2 
mol, 42%).  δH (200 MHz, CDCl3) 6.56 (dt, J = 6.4, 1.9 Hz, 1H), 5.05 (s, 2H), 4.90 (dt, J 
= 6.4, 2.6 Hz, 2H), 4.24 (dd, J = 2.6, 2.0 Hz, 1H); δC (50 MHz, CDCl3) 143.1 (CH), 102.4 
(CH), 90.0 (CH2), 63.1 (CH2). νmax/cm-1 2950, 2862, 2806, 1651, 1476, 1210, 1169, 1120.  
 
3-Iodoprop-1-ene (461)173 
 
 
 
Allyl bromide 460 (72.6 g, 52 mL, 0.6 mol) and sodium iodide (113 g, 0.8 mol) were 
dissolved in acetone (200 mL) and heated to 100 °C for 3.5 hours.  The reaction mixture 
was diluted with water (500 mL).  The separated organic layer was washed with dilute 
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sodium bisulfite solution and then water.  The organic layer was dried (Na2SO4) and 
concentrated in vacuo.  Purification by distillation afforded the title compound as a clear 
oil (82.0 g, 0.5 mol, 81%).  δH (200 MHz, CDCl3) 6.22 – 5.90 (m, 1H), 5.24 (d, J = 16.8 
Hz, 1H), 4.96 (d, J = 9.8 Hz, 1H), 3.85 (d, J = 7.8 Hz, 2H); δC (50 MHz, CDCl3) 135.0 
(CH), 117.2 (CH2), 5.0 (CH2); νmax/cm-1 3084, 2977, 1721, 1149, 919.  
 
4-(Iodomethyl)-1,3-dioxane (462)132 
 
 
 
To a suspension of p-formaldehyde (23.5 g, 0.8 mol) in dichloromethane (91 mL) at 0 °C 
was added concentrated H2SO4 (15.3 mL) and the mixture stirred at 0°C for 10 minutes.  
To the resulting solution allyl iodide 461 (74.6 g, 0.4 mol) was added drop wise over 10 
minutes and the reaction mixture stirred overnight.  The reaction mixture was quenched 
with saturated sodium bicarbonate solution and extracted with dichloromethane.  
Purification by distillation gave the desired material as a brown oil (26.0 g, 0.1 mol, 
24%).  δH (200 MHz, CDCl3) 5.07 (d, J = 6.3 Hz, 1H), 4.68 (d, J = 6.4 Hz, 1H), 4.33 – 
3.52 (m, 3H), 3.18 (dd, J = 6.0, 1.5 Hz, 2H), 1.89 – 1.63 (m, 2H); δC (50 MHz, CDCl3) 
94.0 (CH2), 75.9 (CH), 66.3 (CH2), 32.0 (CH2), 7.9 (CH2); νmax/ cm-1 2853, 1475, 1151. 
 
5-Butyl-2,2-dimethyldihydrofuran-3(2H)-one (465)175  
 
 
 
Under an inert atmosphere (nitrogen), a solution of CuBr.DMS (206 mg, 1 mmol) in dry 
tetrahydrofuran (10 mL) was cooled to -50 °C, whilst stirring.  A solution of 
butylmagnesium chloride in tetrahydrofuran (1 mL, 2 mmol) was added to the reaction 
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mixture and stirring continued for 30 minutes.  The reaction mixture was heated to -30 °C 
and the stirring continued for a further 30 minutes.  The reaction mixture was once again 
cooled to -50 °C and a solution of 2,2-dimethylfuran-3(2H)-one 464 (94 mg, 0.8 mmol) in 
dry tetrahydrofuran (2 mL) was added.  The reaction mixture was poured into saturated 
ammonium chloride solution (30 mL).  The solution was extracted with ethyl acetate (2 x 
25 mL) and the combined organic phases were washed with brine and dried (NaSO4) and 
concentrated in vacuo.  Purification by column chromatography (3:1 petroleum ether / 
ethyl acetate) gave the desired material as a clear oil (48 mg, 282 µmol, 34%).  δH (200 
MHz, CDCl3) 4.21 – 4.03 (m, 1H), 2.53 (dd, J = 18.0, 5.7, 1H), 2.27 – 2.06 (m, 1H), 1.48 
– 1.27 (m, 5H), 1.27 – 1.20 (s, 6H), 1.19 – 1.12 ( m, 4H); δC (50 MHz, CDCl3) 218.4 
(C=O), 80.8 (C), 73.0 (CH), 42.2 (CH2), 35.9 (CH2), 27.7 (CH2), 24.6 (CH2), 22.9 (CH3), 
21.9 (CH3), 14.2 (CH3); νmax/cm-1 2960, 2932, 2863, 1756, 1176, 1112.  
 
6-Butyl-2,2-dimethyl-1,3-dioxan-4-one (467) 
 
 
 
5-Butyl-2,2-dimethyldihydrofuran-3(2H)-one 465 (250 mg, 1.5 mmol) and sodium 
hydrogen carbonate (125 mg, 1.5 mmol) were dissolved in dichloromethane (20 mL).  To 
this stirring solution was added a solution of meta-chloroperoxybenzoic acid (256 mg, 1.5 
mmol) in dichloromethane (20 mL) and stirred for 2 hours.  The reaction mixture was 
diluted with dichloromethane (20 mL) and washed with 5% sodium hydrogen carbonate 
solution and brine.  Purification by column chromatography afforded the title compound 
as a clear oil (95 mg, 0.5 mmol, 34%).  δH (200 MHz, CDCl3) 4.25 – 3.98 (m, 1H), 2.53 
(dd, J = 18.0, 5.7 Hz, 1H), 2.17 (dd, J = 18.0, 10.0 Hz, 1H), 1.87 – 1.73 (m, 6H), 1.24 (s, 
3H), 1.17 (s, 3H), 1.00 – 0.70 (m, 3H); νmax/cm-1 2958, 2931, 2863, 1755, 1175, 1112. 
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2-(tert-butyl)-6-methyl-4H-1,3-dioxin-4-one (472)161 
 
 
 
Under an inert atmosphere (nitrogen), in a microwave vial, 2,2,6-trimethyl-4H-1,3-
dioxin-4-one 468 (0.1 g, 0.1 mL, 0.8 mmol) and pivaldehyde (1.6 mL, 1.3 g, 15.1 mmol) 
were dissolved in ethyl acetate (4 mL) in the presence of molecular sieves (1.5 g).  This 
was stirred in the microwave reactor at 120 °C for 20 minutes.  The reaction mixture was 
concentrated in vacuo, and purified by column chromatography affording the title 
compound (56 mg, 0.3 mmol, 38%).  δH (200 MHz, CDCl3) 5.26 (s, 1H), 5.01 (s, 3H), 
2.01 (s, 9H); δC (50 MHz, CDCl3) 172.2 (C=O), 106.1 (CH), 95.9 (CH), 34.4 (C), 31.0 
(C), 24.1 (CH3), 19.4 (CH3). νmax/cm-1 2967, 2877, 1736, 1630, 1394, 1344, 1218, 1080. 
 
Ethyl 3-hydroxybutanoate (476)206  
 
 
 
Ethyl acetoacetate 475 (5.0 g, 38.5 mmol) in ethanol (100 mL) was treated with sodium 
borohydride (719 mg, 19 mmol) at 0 °C.  The reaction mixture was warmed to room 
temperature and stirred for 16 hours.  The reaction mixture was quenched with water and 
extracted with ethyl acetate.  The combined organic phase was dried (Na2SO4) and 
concentrated in vacuo to afford the title compound (4.1 g, 31.1 mmol, 82%).  δH 
(200MHz, CDCl3) 4.22 - 4.11 (m, 3H), 2.95 (br s, 1H), 2.52 – 2.36 (m, 2H), 1.35 – 1.15 
(m, 6H); δC (50 MHz, CDCl3) 173.8 (C=O), 64.2 (CH), 61.1 (CH2), 44.4 (CH2), 23.4 
(CH3), 14.9 (CH3); νmax/cm-1 3441, 2978, 2936, 1717, 1401, 1374, 1296, 1179.  
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Benzyl 3-hydroxybutanoate (478)207 
 
 
 
Benzyl acetoacetate 477 (20 g, 0.1 mol) was dissolved in dry tetrahydrofuran (1.0 L) and 
water (200 mL).  At 0°C, sodium borohydride (1.1 g, 30 mmol) was added and the 
reaction mixture stirred for 20 minutes.  Sodium borohydride (0.4 g, 10 mmol) was added 
after a further 15 minutes a final portion of sodium borohydride (0.4 g, 10 mmol) was 
added.  The reaction mixture was stirred for 1 hour and water (500 mL) was added slowly 
to the reaction mixture.  The separated aqueous phase was extracted with diethyl ether (5 
x 180 mL) and the combined organic phase dried (MgSO4) and concentrated in vacuo 
affording the title compound as a yellow liquid (19.6 g, 0.1 mol, 97%).  δH (200MHz, 
CDCl3) 7.43 – 7.30 (m, 5H), 5.15 (s, 2H), 4.30 – 4.12 (m, 1H), 2.95 (d, J = 3.6 Hz, 1H), 
2.57 – 2.44 (m, 2H), 1.26 – 1.16 (m, 3H); δC (50 MHz, CDCl3) 171.2 (C=O), 145.4 (C), 
129.2 (CH), 124.8 (CH), 121.2 (CH), 66.4 (CH2), 63.7 (CH), 43.7 (CH2), 22.5 (CH3); 
νmax/cm-1 3413, 2976, 2932, 1753, 1398, 1372. 
 
3-Hydroxybutanoic acid (479)208 
 
 
 
Method 1: Ethyl 3-hydroxybutanoate 476 (500 mg, 3.8 mmol) was added to KOH (10% 
aqueous solution) at 0°C and stirred for one hour.  The solution was acidified (3M HCl) 
to a pH of 6.  The aqueous phase was extracted with a 3:1 mixture of chloroform / 
isopropyl alcohol.  The combined organic phase was dried (Na2SO4) and concentrated in 
vacuo, giving the desired material as a yellow oil (2.2 g, 21.4 mmol, 78%).  
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Method 2: Benzyl 3-hydroxybutanoate 478 (16.6 g, 85.3 mmol) was dissolved in ethyl 
acetate (180 mL) and Pd/C (10%; 5.1 g) was added and the reaction mixture placed under 
an atmosphere of hydrogen for 67 hours.  The resction mixture was filtered through celite 
and concentrated in vacuo to give the desired product as a yellow liquid (5.7 g, 54.8 
mmol, 64%).  δH (200MHz, CDCl3) 7.43 – 7.30 (m, 5H), 5.15 (s, 2H), 4.30 – 4.12 (m, 
1H), 2.95 (d, J = 3.6 Hz, 1H), 2.57 – 2.44 (m, 2H), 1.26 – 1.16 (m, 3H); δC (50 MHz, 
CDCl3) 177.0 (C=O), 64.1 (CH), 42.3 (CH), 22.1 (CH3); νmax/cm-1 2978, 1729, 1382, 
1300, 1186, 1056. 
 
2-(tert-butyl)-6-methyl-1,3-dioxan-4-one (473)209  
 
 
 
3-Hydroxybutanoic acid 479 (1.0 g, 9.8 mmol) and pivaldehyde (2.5 g, 29.5 mmol) were 
dissolved in benzene (30 mL).  Pyridinium p-toluenesulfonate (246 mg, 1.0 mmol) and 
molecular sieves (4Å sieves; 2.2 g) were added.  The reaction mixture was stirred at 
reflux for 46 hours.  The room temperature reaction mixture was filtered and diluted with 
dichloromethane.  Saturated sodium hydrogen carbonate solution was added.  The 
separated aqueous layer was further extracted with dichloromethane (2 x 25 mL).  The 
combined organic phase was washed with saturated sodium hydrogen carbonate solution 
and dried (Na2SO4) and concentrated in vacuo to afford the title compound (1.5 g, 6.6 
mmol, 68%).  δH (400 MHz, CDCl3) 4.90 (s, 1H), 3.97 (dqd, J = 10.5, 6.1, 4.3 Hz, 1H), 
2.65 (dd, J = 17.7, 4.3 Hz, 1H), 2.36 (dd, J = 17.7, 10.7 Hz, 1H), 1.32 (d, J = 6.1 Hz, 3H), 
0.98 (s, 9H); δC (100 MHz, CDCl3) 168.3 (C=O), 108.6 (CH), 70.4 (CH), 37.8 (CH2), 
35.2 (C), 24.0 (CH3), 21.2 (CH3); νmax/cm-1 2980.6, 2966, 2919, 2874, 1727, 1482, 1455, 
1421. 
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2-Isopropyl-6-methyl-1,3-dioxan-4-one (480)209 
 
 
 
3-Hydroxybutanoic acid 479 (1.4 g, 13.3 mmol), isobutyraldehyde (2.9 g, 39.9 mmol) and 
pyridinium p-toluenesulfonate (333 mg, 0.1 mmol) were dissolved in benzene (40 mL) in 
the presence of molecular sieves (4 Å; 2.8 g).  The reaction mixture was refluxed for 16 
hours.  The room temperature reaction mixture was concentrated in vacuo.  The residue 
was dissolved in dichloromethane (50 mL) and washed with saturated sodium hydrogen 
carbonate solution (3 x 20 mL) and the combined organic phase dried (Na2SO4) and 
concentrated in vacuo giving a clear oil (1.7 g, 10.9 mmol, 82%).  δH (200 MHz, CDCl3 ) 
5.10 (d, J = 4.3 Hz, 1H), 4.01 (dqd, J = 10.6, 6.1, 4.3 Hz, 1H), 2.68 (dd, J = 17.7, 4.3 Hz, 
1H), 2.40 (dd, J = 17.8, 10.7 Hz, 1H), 2.13 – 1.72 (m, 1H), 1.35 (d, J = 6.1 Hz, CH3), 1.02 
(d, J = 6.9 Hz, 3H), 1.01 (d, J = 6.9 Hz, 3H); δC (50 MHz, CDCl3) 168.3 (C=O), 106.6 
(CH), 70.4 (CH), 37.6 (CH2), 32.6 (CH), 21.7 (CH3), 16.0 (CH3); νmax/cm-12981, 2845, 
1738, 1382, 1338, 1249. 
 
6-(Phenylsulfonyl)-3,4-dihydro-2H-pyran (484) 
 
 
 
Flask 1. Preparation of the enol triflate 482: A solution of KHMDS (1M in 
tetrahydrofuran) in tetrahydrofuran (6.8 mL) was cooled to -78 °C.  A mixture of N-
phenyl-bis(trifluoromethanesulfonimide) (0.86 g, 2.4 mmol) and δ-valerolactone 481 (0.2 
g, 2.0 mmol) in tetrahydrofuran (10 mL) was added over a period of 1 hour.  After 
addition was complete, the reaction mixture was allowed to stir for 15 minutes at -78 °C.   
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Flask 2. Preparation of sodium benzenethiolate: Benzenethiol (264 mg, 2.4 mmol) was 
added to a suspension of sodium hydride (60% dispersion in oil; 0.16g, 4.0 mmol) in 
tetrahydrofuran (2 mL) and stirred for 15 minutes and cooled to -78 °C. 
 
Flask 3. Preparation of the Ni(0) Catalyst: To a solid mixture of Ni(Ph3P)2Br2 (149 mg, 
0.2 mmol), triphenylphosphine (105 mg, 0.4 mmol) and zinc powder (78 mg, 1.2 mmol) 
was added tetrahydrofuran (4.6 mL) at room temperature.  The green solid suspension 
was stirred until a dark red solution was formed (about 1 min).  
 
The contents of flask 1 (the enol triflate) were transferred by cannula to flask 2 (the 
sodium benzenethiolate) at -78 °C whereupon the contents of flask 3 [the Ni(0) catalyst] 
were added.  The cooling bath was removed and the reaction mixture stirred at room 
temperature for 2 hours.  Aqueous 5% sodium hydroxide (50 mL) was added and the 
reaction mixture was extracted with diethyl ether.  The combined organic layers were 
dried (Na2SO4) and concentrated in vacuo.  Purification by column chromatography on 
alumina (hexanes containing 0.5% NEt3) to give a mixture of the sulfide 483 and the 
triflate starting material 482.  This was reacted on. 
 
The sulfide 483 in dichloromethane (5 mL) and sodium bicarbonate (702 mg, 8.4 mmol) 
was cooled to -78 °C. m-CPBA (385 mg, 2.2 mmol) in dichloromethane (5 mL) was 
added dropwise over 10 minutes.  The reaction mixture was stirred at -78 °C for 3 hours 
and then warmed to room temperature and stirred for an additional 18 hours.  The 
reaction mixture was quenched with saturated Na2S2O3 solution (5 mL).  The separated 
aqueous phase was further extracted with dichloromethane (2 x 10 mL) and the combined 
organic phase concentrated in vacuo.  Purification by column chromatography (gradient 
elution: 4:1 petroleum ether / ethyl acetate to 2:1 petroleum ether to ethyl acetate) giving 
a clear oil (103 mg, 0.5 mmol, 25% (over 2 steps)). δH (400 MHz, CDCl3) δ 7.97 – 7.89 
(m, 2H), 7.66 – 7.48 (m, 3H), 6.14 (t, J = 4.0 Hz, 1H), 4.08 – 4.01 (m, 2H), 2.23 (td, J = 
6.4, 4.1 Hz, 2H), 1.89 – 1.78 (m, 2H).  Attempted purification by column chromatography 
led to decomposition of material. 
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2-(tert-butyl)-5,6-dimethyl-1,3-dioxan-4-one (485)160 
 
 
 
At 0 °C to diisopropylamine (2.3 mL, 1.6 mmol) in tetrahydrofuran (0.25 mL) was added 
n-butyllithium (2.5 M in hexanes; 1.6 mmol). The yellow solution was cooled down to -
78 °C and diluted with tetrahydrofuran (2.3 mL).  A solution of 2-tert-butyl-6-methyl-1,3-
dioxan-4-one 473 (250 mg, 1.5 mmol) in tetrahydrofuran (1 mL) was dropped into the 
solution at -78 °C and the solution stirred for 30 minutes.  After the addition of the methyl 
iodide (0.65 mL, 2.9 mmol) the reaction mixture was allowed to reach room temperature 
over 16 hours.  Buffer solution (pH 7; 5 mL) was added in one portion after warming to 
room temperature.  It was extracted with diethyl ether (3 x 5 mL) and the combined 
organic phase dried (Na2SO4) and concentrated in vacuo to give a white solid (167 mg, 
0.9 mmol, 62%). δH (400 MHz, CDCl3) 4.95 (s, 1H), 3.64 (dq, J = 10.5, 6.1 Hz, 1H), 2.36 
(dq, J = 10.4, 7.3 Hz, 1H), 1.36 (d, J = 6.1 Hz, 3H), 1.27 (d, J = 7.3 Hz, 3H), 0.98 (s, 9H); 
δC (75 MHz, CDCl3) 171.7 (C=O), 108.2 (CH), 65.7 (CH), 43.0 (CH), 35.2 (C), 23.9 
(CH3), 19.6 (CH3), 12.4 (CH3); νmax/cm-1 2979, 1750, 1476, 1458, 1408, 1388. 
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Appendix A: X-ray data of cis-6-cyclohexyl-4-vinyl-1,2,3-oxathiazinane 2,2-dioxide 
(217)  
 
Structure determination for X83875: Mari Higginbotham MCH260B 
 
Displacement ellipsoids drawn at the 50% probability level. 
NH..O Hydrogen bonding  
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Data collection 
A single crystal was coated in Paratone-N heavy oil then placed on a Mitigen  MicroMount fixed 
to the goniometer head which  was put in a cold stream of nitrogen gas (100K) on a Bruker 
Nonius X8 Apex2 CCD diffractometer.  Data were integrated using SAINT then scaled with 
SADABS  Structure solution and refinement  were performed using the SHELXTL suite of 
programs.  
Program reference: 
APEX2 (  SAINT, SADABS, SHELXTL) Bruker AXS Inc., Madison, Wisconsin, USA.  2004-
2010 
 
Table 1.  Crystal data and structure refinement for 3875./ MCH260B 
Identification code  3875 
Empirical formula  C11 H19 N O3 S 
Formula weight  245.33 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P2(1)/c 
Unit cell dimensions a = 19.8419(15) Å = 90°. 
 b = 5.3049(4) Å = 90.646(4)°. 
 c = 11.5941(9) Å  = 90°. 
Volume 1220.31(16) Å3 
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Z 4 
Density (calculated) 1.335 Mg/m3 
Absorption coefficient 0.258 mm-1 
F(000) 528 
Crystal size 0.56 x 0.38 x 0.24 mm3 
Theta range for data collection 3.51 to 32.06°. 
Index ranges -29<=h<=29, -7<=k<=7, -17<=l<=17 
Reflections collected 27110 
Independent reflections 4215 [R(int) = 0.0325] 
Completeness to theta = 25.00° 99.7 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9406 and 0.8689 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4215 / 0 / 154 
Goodness-of-fit on F2 1.049 
Final R indices [I>2sigma(I)] R1 = 0.0329, wR2 = 0.0846 
R indices (all data) R1 = 0.0417, wR2 = 0.0890 
Largest diff. peak and hole 0.662 and -0.366 e.Å-3 
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Table 2.   Bond lengths [Å] and angles [°] for 3875. 
_____________________________________________________ 
S(2)-O(22)  1.4238(8) 
S(2)-O(21)  1.4379(8) 
S(2)-O(1)  1.5792(7) 
S(2)-N(3)  1.6254(9) 
O(1)-C(6)  1.4946(11) 
N(3)-C(4)  1.5011(12) 
N(3)-H(3)  0.838(15) 
C(4)-C(13)  1.5022(14) 
C(4)-C(5)  1.5350(13) 
C(4)-H(4)  1.0000 
C(5)-C(6)  1.5240(13) 
C(5)-H(5A)  0.9900 
C(5)-H(5B)  0.9900 
C(6)-C(7)  1.5253(13) 
C(6)-H(6)  1.0000 
C(7)-C(8)  1.5362(14) 
C(7)-C(12)  1.5365(14) 
C(7)-H(7)  1.0000 
C(8)-C(9)  1.5328(15) 
C(8)-H(8A)  0.9900 
C(8)-H(8B)  0.9900 
C(9)-C(10)  1.5314(16) 
C(9)-H(9A)  0.9900 
C(9)-H(9B)  0.9900 
C(10)-C(11)  1.5317(16) 
C(10)-H(10A)  0.9900 
C(10)-H(10B)  0.9900 
C(11)-C(12)  1.5326(14) 
C(11)-H(11A)  0.9900 
C(11)-H(11B)  0.9900 
C(12)-H(12A)  0.9900 
C(12)-H(12B)  0.9900 
C(13)-C(14)  1.3228(15) 
C(13)-H(13)  0.9500 
C(14)-H(14A)  0.947(17) 
C(14)-H(14B)  0.973(16) 
 
O(22)-S(2)-O(21) 119.56(5) 
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O(22)-S(2)-O(1) 105.57(4) 
O(21)-S(2)-O(1) 108.48(4) 
O(22)-S(2)-N(3) 109.24(5) 
O(21)-S(2)-N(3) 107.80(5) 
O(1)-S(2)-N(3) 105.30(4) 
C(6)-O(1)-S(2) 114.74(6) 
C(4)-N(3)-S(2) 113.10(6) 
C(4)-N(3)-H(3) 111.5(9) 
S(2)-N(3)-H(3) 110.7(10) 
N(3)-C(4)-C(13) 108.67(8) 
N(3)-C(4)-C(5) 110.12(7) 
C(13)-C(4)-C(5) 111.53(8) 
N(3)-C(4)-H(4) 108.8 
C(13)-C(4)-H(4) 108.8 
C(5)-C(4)-H(4) 108.8 
C(6)-C(5)-C(4) 112.17(8) 
C(6)-C(5)-H(5A) 109.2 
C(4)-C(5)-H(5A) 109.2 
C(6)-C(5)-H(5B) 109.2 
C(4)-C(5)-H(5B) 109.2 
H(5A)-C(5)-H(5B) 107.9 
O(1)-C(6)-C(5) 108.82(7) 
O(1)-C(6)-C(7) 105.51(7) 
C(5)-C(6)-C(7) 115.90(8) 
O(1)-C(6)-H(6) 108.8 
C(5)-C(6)-H(6) 108.8 
C(7)-C(6)-H(6) 108.8 
C(6)-C(7)-C(8) 114.13(8) 
C(6)-C(7)-C(12) 110.49(8) 
C(8)-C(7)-C(12) 110.05(8) 
C(6)-C(7)-H(7) 107.3 
C(8)-C(7)-H(7) 107.3 
C(12)-C(7)-H(7) 107.3 
C(9)-C(8)-C(7) 110.61(8) 
C(9)-C(8)-H(8A) 109.5 
C(7)-C(8)-H(8A) 109.5 
C(9)-C(8)-H(8B) 109.5 
C(7)-C(8)-H(8B) 109.5 
H(8A)-C(8)-H(8B) 108.1 
C(10)-C(9)-C(8) 111.04(9) 
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C(10)-C(9)-H(9A) 109.4 
C(8)-C(9)-H(9A) 109.4 
C(10)-C(9)-H(9B) 109.4 
C(8)-C(9)-H(9B) 109.4 
H(9A)-C(9)-H(9B) 108.0 
C(9)-C(10)-C(11) 110.95(9) 
C(9)-C(10)-H(10A) 109.4 
C(11)-C(10)-H(10A) 109.4 
C(9)-C(10)-H(10B) 109.4 
C(11)-C(10)-H(10B) 109.4 
H(10A)-C(10)-H(10B) 108.0 
C(10)-C(11)-C(12) 111.38(9) 
C(10)-C(11)-H(11A) 109.4 
C(12)-C(11)-H(11A) 109.4 
C(10)-C(11)-H(11B) 109.4 
C(12)-C(11)-H(11B) 109.4 
H(11A)-C(11)-H(11B) 108.0 
C(11)-C(12)-C(7) 111.07(8) 
C(11)-C(12)-H(12A) 109.4 
C(7)-C(12)-H(12A) 109.4 
C(11)-C(12)-H(12B) 109.4 
C(7)-C(12)-H(12B) 109.4 
H(12A)-C(12)-H(12B) 108.0 
C(14)-C(13)-C(4) 123.37(11) 
C(14)-C(13)-H(13) 118.3 
C(4)-C(13)-H(13) 118.3 
C(13)-C(14)-H(14A) 121.1(9) 
C(13)-C(14)-H(14B) 122.5(9) 
H(14A)-C(14)-H(14B) 116.4(13) 
_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
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Table 3.  Torsion angles [°] for 3875. 
________________________________________________________________ 
O(22)-S(2)-O(1)-C(6) 170.61(6) 
O(21)-S(2)-O(1)-C(6) -60.10(7) 
N(3)-S(2)-O(1)-C(6) 55.09(7) 
O(22)-S(2)-N(3)-C(4) -166.05(7) 
O(21)-S(2)-N(3)-C(4) 62.59(8) 
O(1)-S(2)-N(3)-C(4) -53.07(7) 
S(2)-N(3)-C(4)-C(13) 178.83(7) 
S(2)-N(3)-C(4)-C(5) 56.40(9) 
N(3)-C(4)-C(5)-C(6) -58.54(10) 
C(13)-C(4)-C(5)-C(6) -179.27(8) 
S(2)-O(1)-C(6)-C(5) -59.39(9) 
S(2)-O(1)-C(6)-C(7) 175.62(6) 
C(4)-C(5)-C(6)-O(1) 58.77(10) 
C(4)-C(5)-C(6)-C(7) 177.42(8) 
O(1)-C(6)-C(7)-C(8) 65.82(10) 
C(5)-C(6)-C(7)-C(8) -54.64(11) 
O(1)-C(6)-C(7)-C(12) -169.54(8) 
C(5)-C(6)-C(7)-C(12) 70.00(11) 
C(6)-C(7)-C(8)-C(9) -177.47(9) 
C(12)-C(7)-C(8)-C(9) 57.66(11) 
C(7)-C(8)-C(9)-C(10) -57.46(12) 
C(8)-C(9)-C(10)-C(11) 55.82(12) 
C(9)-C(10)-C(11)-C(12) -54.98(12) 
C(10)-C(11)-C(12)-C(7) 55.83(12) 
C(6)-C(7)-C(12)-C(11) 176.18(8) 
C(8)-C(7)-C(12)-C(11) -56.89(11) 
N(3)-C(4)-C(13)-C(14) 126.83(11) 
C(5)-C(4)-C(13)-C(14) -111.59(12) 
________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
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Table 4.  Hydrogen bonds for 3875 [Å and °]. 
____________________________________________________________________________ 
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________ 
 N(3)-H(3)...O(21)#1 0.838(15) 2.356(15) 3.1188(12) 151.7(13) 
____________________________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
#1 x,y+1,z      
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Appendix B: X-ray data for (4S,5R)-5-methyl-4-vinyl-1,2,3-oxathiazinane 2,2-
dioxide (300) 
  
MCH360C crystal structure 
 
 
Perspective view of MCH360C. Displacement ellipsoids drawn at the 50% probability 
level   
 
The crystal structure is an inverted twin. Both RS and SR forms exist. The major 
component in this crystal is shown above. 
 
Table 1.  Crystal data and structure refinement for MCH360C/4216. 
Identification code  4216 
Empirical formula  C6 H11 N O3 S 
Formula weight  177.22 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
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Space group  P2(1)2(1)2(1) 
Unit cell dimensions a = 6.7599(5) Å α= 90°. 
 b = 8.3411(6) Å β= 90°. 
 c = 14.1011(11) Å γ = 90°. 
Volume 795.09(10) Å3 
Z 4 
Density (calculated) 1.480 Mg/m3 
Absorption coefficient 0.365 mm-1 
F(000) 376 
Crystal size 0.56 x 0.40 x 0.34 mm3 
Theta range for data collection 2.84 to 36.03°. 
Index ranges -11<=h<=11, -13<=k<=13, -23<=l<=22 
Reflections collected 26398 
Independent reflections 3734 [R(int) = 0.0196] 
Completeness to theta = 25.00° 99.8 %  
Absorption correction None 
Max. and min. transmission 0.8860 and 0.8218 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 3734 / 0 / 102 
Goodness-of-fit on F2 1.085 
Final R indices [I>2sigma(I)] R1 = 0.0206, wR2 = 0.0569 
R indices (all data) R1 = 0.0214, wR2 = 0.0574 
Absolute structure parameter 0.48(3) 
Largest diff. peak and hole 0.394 and -0.294 e.Å-3 
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 Table 2.   Bond lengths [Å] and angles [°] for  4216. 
_____________________________________________________  
N(1)-C(6)  1.4876(7) 
N(1)-S(2)  1.6183(6) 
N(1)-H(1)  0.886(11) 
O(1)-S(2)  1.4356(5) 
O(2)-S(2)  1.4239(6) 
S(2)-O(3)  1.5810(5) 
O(3)-C(4)  1.4790(9) 
C(4)-C(5)  1.5257(10) 
C(4)-H(4A)  0.9900 
C(4)-H(4B)  0.9900 
C(5)-C(9)  1.5311(9) 
C(5)-C(6)  1.5469(8) 
C(5)-H(5)  1.0000 
C(6)-C(7)  1.5024 
C(6)-H(6)  1.0000 
C(7)-C(8)  1.3265 
C(7)-H(7)  0.9500 
C(8)-H(8A)  0.9500 
C(8)-H(8B)  0.9500 
C(9)-H(9A)  0.9800 
C(9)-H(9B)  0.9800 
C(9)-H(9C)  0.9800 
 
C(6)-N(1)-S(2) 113.48(4) 
C(6)-N(1)-H(1) 111.9(7) 
S(2)-N(1)-H(1) 110.6(7) 
O(2)-S(2)-O(1) 119.64(3) 
O(2)-S(2)-O(3) 105.92(3) 
O(1)-S(2)-O(3) 107.51(3) 
O(2)-S(2)-N(1) 109.56(3) 
O(1)-S(2)-N(1) 108.06(3) 
O(3)-S(2)-N(1) 105.22(3) 
C(4)-O(3)-S(2) 113.95(4) 
O(3)-C(4)-C(5) 110.69(5) 
O(3)-C(4)-H(4A) 109.5 
C(5)-C(4)-H(4A) 109.5 
O(3)-C(4)-H(4B) 109.5 
C(5)-C(4)-H(4B) 109.5 
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H(4A)-C(4)-H(4B) 108.1 
C(4)-C(5)-C(9) 111.89(5) 
C(4)-C(5)-C(6) 109.26(5) 
C(9)-C(5)-C(6) 112.95(5) 
C(4)-C(5)-H(5) 107.5 
C(9)-C(5)-H(5) 107.5 
C(6)-C(5)-H(5) 107.5 
N(1)-C(6)-C(7) 111.16(3) 
N(1)-C(6)-C(5) 110.99(4) 
C(7)-C(6)-C(5) 111.66(3) 
N(1)-C(6)-H(6) 107.6 
C(7)-C(6)-H(6) 107.6 
C(5)-C(6)-H(6) 107.6 
C(8)-C(7)-C(6) 126.59(4) 
C(8)-C(7)-H(7) 116.7 
C(6)-C(7)-H(7) 116.7 
C(7)-C(8)-H(8A) 120.0 
C(7)-C(8)-H(8B) 120.0 
H(8A)-C(8)-H(8B) 120.0 
C(5)-C(9)-H(9A) 109.5 
C(5)-C(9)-H(9B) 109.5 
H(9A)-C(9)-H(9B) 109.5 
C(5)-C(9)-H(9C) 109.5 
H(9A)-C(9)-H(9C) 109.5 
H(9B)-C(9)-H(9C) 109.5 
_____________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
183 
 
 Table 3.  Torsion angles [°] for 4216. 
________________________________________________________________  
C(6)-N(1)-S(2)-O(2) 166.00(4) 
C(6)-N(1)-S(2)-O(1) -62.10(5) 
C(6)-N(1)-S(2)-O(3) 52.53(5) 
O(2)-S(2)-O(3)-C(4) -170.15(5) 
O(1)-S(2)-O(3)-C(4) 60.86(5) 
N(1)-S(2)-O(3)-C(4) -54.15(5) 
S(2)-O(3)-C(4)-C(5) 60.71(6) 
O(3)-C(4)-C(5)-C(9) 66.17(7) 
O(3)-C(4)-C(5)-C(6) -59.67(7) 
S(2)-N(1)-C(6)-C(7) 177.90(2) 
S(2)-N(1)-C(6)-C(5) -57.17(5) 
C(4)-C(5)-C(6)-N(1) 58.50(6) 
C(9)-C(5)-C(6)-N(1) -66.73(6) 
C(4)-C(5)-C(6)-C(7) -176.86(4) 
C(9)-C(5)-C(6)-C(7) 57.92(5) 
N(1)-C(6)-C(7)-C(8) 2.02(5) 
C(5)-C(6)-C(7)-C(8) -122.53(6) 
________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
  
 
 
Table 4.  Hydrogen bonds for 4216  [Å and °]. 
____________________________________________________________________________  
D-H...A d(D-H) d(H...A) d(D...A) <(DHA) 
____________________________________________________________________________  
 N(1)-H(1)...O(1)#1 0.886(11) 2.092(11) 2.9440(8) 160.9(10) 
____________________________________________________________________________  
Symmetry transformations used to generate equivalent atoms:  
#1 -x+2,y+1/2,-z+1/2       
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Gold(I)-catalysed synthesis of cyclic sulfamidates by intramolecular
allene hydroaminationw
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Six-membered cyclic sulfamidates are prepared in high yields by
treatment of allenic sulfamates with readily available gold(I)
complexes. The reaction enables formation of N-substituted
quaternary centres and complements existing processes for
sulfamidate formation.
Cyclic sulfamidates are versatile intermediates for the synthesis
of substituted amines including amino alcohols.1 They undergo
SN2 reaction at the oxygen-bearing carbon with a variety of
nucleophiles (Scheme 1).
Traditionally they are prepared from the corresponding
amino alcohols via formation of the sulfamidite with thionyl
chloride and subsequent Ru-catalysed oxidation (Scheme 2, A).1
In recent years, a number of procedures have emerged for
the preparation of this useful class of compounds via catalytic
C–N bond formation.2 This area has to-date been dominated
by metal-catalysed generation of a nitrenoid from a linear
sulfamate precursor under oxidising conditions (Scheme 2, B).
Subsequent aziridination or C–H bond insertion leads to a
range of substitution patterns.
Transition-metal catalysed hydroamination is an increasingly
useful method for the preparation of amines,3 but to our
knowledge has not been explored using unsaturated sulfamates
as cyclisation precursors. Given the high reactivity of allenes
and the use of gold complexes to promote hydroamination with
unsaturated tosyl sulfonamides,4 we decided to investigate the
viability of gold-catalysed sulfamidate synthesis using allenic
sulfamates (Scheme 2, C).
Our initial test substrate 1 (Table 1) was prepared in three steps
from cyclohexane carbaldehyde.5 To our delight, treatment of 1
with commercially available PPh3AuNTf2 (Gagosz’s complex)
6
or PPh3AuCl/AgOTf
7 at room temperature in dichloromethane
led to the clean formation of sulfamidate 2 (entries 4 and 5).
Use of other ligands and counterions on gold (entries 6–8) gave
Scheme 1 Reactivity of cyclic sulfamidates.
Scheme 2 Synthetic approaches to sulfamidates.
Table 1 Initial experiments and controls
Entry Catalyst Yield 2/%a dr cis : trans
1 None 0 NA
2 AgOTf 0 NA
3 TfOH 0 NA
4 (Ph3P)AuCl/AgOTf 74 1.7 : 1
5 (Ph3P)AuNTf2 99 1.2 : 1
6 IPrAuCl/AgOTf 48 1 : 1
7 (2,4-Di-tBuPhO)3PAuCl/AgOTf 43 2 : 1
8 (2,4-Di-tBuPhO)3PAuCl/AgNTf2 82 1 : 1
a Reactions conducted on a 50 mg scale.
Institute of Chemical Sciences, Heriot-Watt University, Riccarton,
Edinburgh EH14 4AS, UK. E-mail: m.w.p.bebbington@hw.ac.uk;
Fax: +44 (0)131 451 3180; Tel: +44 (0) 131 451 8071
w Electronic supplementary information (ESI) available: 1H and 13C
NMR spectra for sulfamidate products with characterisation data.
CCDC 871548. For ESI and crystallographic data in CIF or other
electronic format see DOI: 10.1039/c2cc33711h
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better diastereoselectivity in some cases, but with diminished yield
(See supporting information). Control experiments without any
catalyst, with AgOTf only and with TfOH confirmed that the gold
complex was necessary for reaction to occur (entries 1–3).
We then prepared a range of substituted substrates designed
to demonstrate the scope of the reaction using Gagosz’s
complex, which had given us the highest yield of 2, as catalyst
(Table 2).8 Sulfamidate 4 was formed as exclusively the
E-alkene (Entry 1) in excellent yield. Sulfamate 5, leading to
the formation of sulfamidate 6 containing a trisubstituted
olefin, was also a viable substrate under these conditions.
Sulfamates 7, 9 and 11, derived from secondary alcohols, gave
mixtures of 1,3-cis and trans isomers.
In the case of sulfamidate 2 the diastereomers were separable
and the major product was shown to be the 1,3-cis isomer
(cis-2) by a single crystal X-ray diffraction study (see ESIw);z
the other 1,3-disubstituted products were assigned by analogy.9
The 2-substituted product 14 was formed as a 3 : 1 mixture of
diastereomers.
Notably, these examples are complementary to the product
distribution arising from the Rh-nitrene chemistry of sulfamates,
where insertion into tertiary C–H bonds is faster than that
into allylic and benzylic C–H bonds, and aziridination often
predominates over allylic C–H insertion.10
A control experiment, performed by subjecting the separable
diastereomer cis-2 to the original reaction conditions, showed
that no equilibrium existed between the diastereomers. This is
consistent with a kinetically-controlled cyclisation, which is
common in other gold-catalysed hydroaminations.3
Mechanistically, we anticipate that the reaction occurs via an
outer sphere mechanism11 (Scheme 3) leading to anti amino-
auration of the allene. The cis and trans diastereomeric products
may arise from the conformations A and A0 indicated.
Protonation of the vinyl gold intermediates B and B0 would
then give the observed products and regenerate the catalyst.
Addition of protic additives (H2O, AcOH, TfOH) to the reaction
mixture did not accelerate the reaction to a measurable extent,
suggesting that the final protonation is not the rate-determining
step of this process.
The diastereoselectivity observed in the formation of 2, 8, 10
and 12 is lower than that normally found in related cyclisations.12
The explanation for this is currently unclear. At present, we
postulate that A and A0 (Scheme 3) are in equilibrium13 and that
the observed diastereoselectivity for the cis products is due to
faster and irreversible cyclisation of A, which has both the
substituent R and the allene in equatorial positions. This would
compare favourably with cyclisation of A0, where the allene is in
the axial position. However, further studies will be required to
establish a well-defined stereochemical model in these systems.
We next decided to determine whether the reaction was
suitable for the formation of N-substituted quaternary centres
(Table 3, overleaf), since this is very rare for catalytic hydro-
aminations.14 Gratifyingly, cyclisation of sulfamates 15, 17, 19
and 21 occurred cleanly to give the respective products 16, 18,
20 and 22 (Entries 1–4). The current limit of the method was
reached in the case of substrate 23, which gave only a trace
(B3%) of product 24 after 5 days at 40 1C (Entry 5).
Such unsaturated amine derivatives are difficult to access by
other methods15 and have considerable potential for further
functionalisation. A general catalytic asymmetric approach
to C-tertiary amines has so far proved elusive.15 Given our
results, this new hydroamination reaction has the potential to
address this important problem.16,17
In summary, we have demonstrated the first gold-catalysed
preparation of cyclic sulfamidates, leading to a range of
substituted and sterically hindered products under mild conditions.
Table 2 Substrate scope
Entry Sulfamate Productsa Yield (%)
1 94%
2 66%
3
95%b (cis/trans
dr 1.8 : 1)
4 93%b (2 : 1)
5 95% (1.8 : 1)
6 75% (3 : 1)c
a 5 mol% Ph3PAuNTf2, DCM, r.t. 24-120 h, see ESI.
b Solvent: DCE,
temperature 40 1C. c Relative stereochemistry not determined.
Scheme 3 Possible stereochemical rationale.
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Further studies on the scope and limitations of this reaction
will be reported in due course. Development of an asymmetric
version of this process and other metal-catalysed reactions of
sulfamates are also underway in our laboratories.
The authors thank the EPSRC (for a DTA to M.C.M.H.),
the EPSRC National Mass Spectrometry Service for mass
spectra, Dr G. M. Rosair for assistance with X-ray crystallo-
graphy and Dr A.-L. Lee for helpful discussions.
Notes and references
z X-ray crystallographic data for cis-2 (CCDC 871548): C11H19NO3S,
M = 245.33, monoclinic, a = 19.8419(15), b = 5.3049(4), c =
11.5941(9), b = 90.646(4), V = 1220.31(16) A˚3, T = 100(2)K, space
group P21/c, Z = 4, Mo-Ka radiation (l = 0.71073 A˚), GOF =
1.049, agreement index R1 = 0.0329, 27 110 reflections measured, 4215
unique(Rint = 0.0325) which were used in all calculations. The final
oR(F2) was 0.890.
1 For a recent review, see J. F. Bower, J. Rujirawanich and
T. Gallagher, Org. Biomol. Chem., 2010, 8, 1505.
2 For a review of C–H amination, see D. N. Zalatan and J. Du Bois,
Top. Curr. Chem., 2010, 292, 347.
3 For a review of hydrofunctionalisation of multiple bonds, see
(a) A. S. K. Hashmi and M. Buehrle, Aldrichim. Acta, 2010,
43, 27; for reviews of nucleophilic cyclisation of allenes, see
(b) N. Nishina and Y. Yamamoto, Tetrahedron, 2009, 65, 1799 and
(c) N. Krause and C. Winter, Chem. Rev., 2011, 111, 1994; for a review
of gold-catalysed hydroamination, see (d) R. A. Widenhoefer and
X. Han, Eur. J. Org. Chem., 2006, 20, 4555. For a relevant example,
see (e) N. T. Patil, L. M. Lutete, N. Nishina and Y. Yamamoto,
Tetrahedron Lett., 2006, 47, 4749.
4 The Rh-nitrene chemistry of such compounds has been investi-
gated and products arising from formation of a metal-stabilised
2-aminoallyl intermediate predominate, in contrast to our work.
See G. C. Feast, L. W. Page and J. Robertson, Chem. Commun.,
2010, 46, 2835.
5 Allenic alcohols were prepared either by Johnson-Claisen rearran-
gements of the corresponding propargyl alcohols, see (a) S. Ma and
W. Gao, J. Org. Chem., 2002, 67, 6104 or alternatively by Crabbe´
homologation of homopropargyl alcohols see (b) B. M. Trost,
A. B. Pinkerton and M. Seidel, J. Am. Chem. Soc., 2001,
123, 12466. Sulfamate formation was conducted according to
standard procedures, see (c) C. G. Espino, P. M. Wehn, J. Chow
and J. Du Bois, J. Am. Chem. Soc., 2001, 123, 6935.
6 N. Me´zailles, L. Ricard and F. Gagosz, Org. Lett., 2005, 7, 4133.
7 A. S. K. Hashmi, Gold Bull., 2004, 37, 51.
8 Reaction times were between 24–120 h, see supporting
information.
9 The 1H NMR signals in the olefinic region of the spectra differ
consistently for the cis and trans 1,3-isomers; see ESIw for details.
10 For lead references and mechanistic studies, see (a) K. Williams Fiori,
C. G. Espino, B. H. Brodsky and J. Du Bois, Tetrahedron, 2009,
65, 3042. For recent work targeted at allylic C–H nitrene insertion
using sulfamidates, see (b) E. Milczek, N. Boudet and S. Blakey,
Angew. Chem., Int. Ed., 2008, 47, 6825; (c) M. E. Harvey,
D. G. Musaev and J. Du Bois, J. Am. Chem. Soc., 2011, 133, 17207
(Ru catalysis) and (d) S. M. Paradine and M. C. White, J. Am. Chem.
Soc., 2012, 134, 2036 (Fe catalysis). Notably, there are no examples of
insertion into tertiary allylic C–H bonds in these reports.
11 For mechanistic studies, see (a) Z. Zhang, C. Liu, R. E. Kinder,
X. Han, H. Qian and R. A. Widenhoefer, J. Am. Chem. Soc., 2006,
128, 9066; (b) Z. Zhang and R. A. Widenhoefer, Org. Lett., 2008,
10, 2079; (c) J. J. Kennedy-Smith, S. T. Staben and F. D. Toste,
J. Am. Chem. Soc., 2004, 126, 4526; (d) J. Zhang, C.-G. Yang and
C. He, J. Am. Chem. Soc., 2006, 128, 1798; (e) A. S. K. Hashmi,
J. P. Weyrauch, W. Frey and J. W. Bats, Org. Lett., 2004, 6, 4391;
(f) Y. Liu, F. Song, Z. Song, M. Liu and B. Yan, Org. Lett., 2005,
7, 5409.
12 Diastereoselectivities for Au-catalysed exo-hydroamination to give
6-membered rings typically vary from 4 : 1 to 7 : 1. See ref. 11a.
13 Fluxionality of an Au(I)-allene complex: T. J. Brown, A. Sugie,
M. G. D. Leed and R. A. Widenhoefer, Chem.–Eur. J., 2012, 18, 6959.
14 There are only a few examples of hydroamination to form
C-tertiary amines; none involves a 6-exo-trig cyclisation, see
(a) R. E. Kinder, Z. Zhang and R. A. Widenhoefer, Org. Lett.,
2008, 10, 3157; (b) C. Winter and N. Krause, Angew. Chem., Int.
Ed., 2009, 48, 6339; (c) R. L. Lalonde, Z. J. Wang, M. Mba,
A. D. Lackner and F. D. Toste, Angew. Chem., Int. Ed., 2010,
49, 598.
15 For relevant reviews, see (a) M. Shibasaki and M. Kanai, Chem.
Rev., 2008, 108, 2853 and (b) J. Clayden, M. Donnard, J. Lefranc
and D. J. Tetlow, Chem. Commun., 2011, 47, 4624.
16 For a review of asymmetric catalysis with gold complexes, see
A. Pradal, P. Y. Toullec and V. Michelet, Synthesis, 2011, 1501.
17 For examples of catalytic asymmetric hydroamination of allenes,
see (a) R. L. Lalonde, B. D. Sherry, E. J. Kang and F. D. Toste,
J. Am. Chem. Soc., 2007, 129, 2452; (b) Z. Zhang, C. F. Bender and
R. A. Widenhoefer, Org. Lett., 2007, 9, 2887; (c) K. L. Butler,
M. Tragni and R. A. Widenhoefer, Angew. Chem., Int. Ed., 2012,
51, 5175. See also ref. 14b and c.
Table 3 Formation of N-substituted quaternary centres
Entry Sulfamate Producta Yield (%)
1 92%
2 68%
3 37%
4 90%
5 Traceb
a 5 mol% Ph3PAuNTf2, DCM, r.t. 24–120 h, see ESI.
b B3% of 90%
pure product isolated.
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